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ABSTRACT
Many patients undergoing long-term catheterisation experience encrustation of their 
catheters. The problem stems from infection by urease producing bacteria particularly 
Proteus mirabilis. Pr. mirabilis is a major pathogen of the catheterised urinary tract, 
and its presence is strongly correlated with catheter obstruction. This urease producing 
organism colonizes the catheter surface and produces biofilm communities embedded 
in a polysaccharide matrix. The urease enzyme hydrolyses urea to ammonia and 
carbon dioxide, elevating the urinary pH. Under these alkaline conditions crystals of 
magnesium and calcium phosphates form and become trapped in the organic matrix. 
The resulting crystalline biofilm can block the catheter lumen or eye-hole seriously 
compromising patients’ health and welfare. Urinary incontinence due to urine 
bypassing the catheter can lead to breakdown of skin, bedsores and all consequent 
problems. Urinary retention is painful and if it goes unnoticed can lead ascending 
infection and pyelonephritis. Currently there are no effective procedures for 
controlling this problem.
Bacteria, once they are embedded in a biofilm, are very difficult to eliminate by 
antibacterial agents. Conceptually the simplest way to protect a medical device from 
colonization by biofilm would be to impregnate it with a broad range antimicrobial 
agent that eluted into the medium, and attacked bacteria before they attached to the 
surface and adopted the resistant biofilm phenotype. There have been two factors 
limiting the long-term effectiveness of antimicrobial coated and impregnated 
catheters. It has not been possible to load catheters with sufficient active agents or to 
control the release of the agent so that effective concentrations are released for the 
lifetime of the device. Exploitation of the catheter retention balloon as the reservoir 
for an active agent could solve both these problems. The balloon could be inflated 
with 10 ml of solutions containing high concentrations of an agent. The wall of the 
catheter balloon would provide a diffusion barrier, which could control the release of 
active agents into the bladder urine.
The general aim of this study was to develop a novel strategy for controlling this 
problem which specifically targeted Pr. mirabilis. The objectives were to: (a) establish 
whether Pr. mirabilis strains isolated from the catheterised urinary tract were fully 
sensitive to the biocide triclosan; (b) determine the minimal bactericidal 
concentrations for triclosan of clinical Pr. mirabilis isolates growing in urine; (c) 
investigate what concentrations of triclosan could be delivered through the balloons of 
catheters; (d) determine if inflating the catheter balloon with triclosan would delay or 
prevent catheter blockage by crystalline Pr. mirabilis biofllms; (e) ascertain what 
triclosan concentrations were required in the urine to eliminate established Pr. 
mirabilis biofilms; (f) investigate whether resistant cells emerged when populations of 
Pr. mirabilis were exposed to triclosan, and if so, whether the triclosan resistant cells 
exhibited cross-resistance to antibiotics; (g) examine how the triclosan strategy 
influenced the development of catheter biofilm communities by a variety of species 
that cause CA-UTI.
Isolates of Pr. mirabilis from encrusted catheters were found to be extremely sensitive 
to triclosan (minimum inhibitory concentration (MIC) in agar ranging from 0.1 -  0.3 
pg/ml). At concentrations of 0.2 pg/ml in artificial urine, it prevented the rise in pH
that is normally produced by Pr. mirabilis. Concentrations of 100 pg/ml were required 
however to produce bactericidal effects.
A simple laboratory model of the catheterised bladder was used to examine whether 
triclosan could be delivered through the retention balloon. In experiments with all­
silicone catheters, balloons were inflated with triclosan (10 mg/ml in 5% w/v PEG). 
High pressure liquid chromatography detected the presence of triclosan at 0 .02-0 .16  
pg/ml in urine samples taken from the bladder chamber over a 48 h period. Sections (1 
cm) taken from the catheters were placed onto agar plates that had been seeded with 
Pr. mirabilis. After incubation, clear zones of inhibition were visible around each of 
the sections on the bacterial lawn, indicating that the biocide had impregnated the 
silicone along the whole length of the catheter.
Experiments in laboratory models infected with Pr. mirabilis demonstrated that when 
the retention balloons of all-silicone, silicone-coated latex and hydrogel-coated latex 
catheters were inflated with water, the artificial urine in the bladder chamber became 
alkaline and the catheters blocked with crystalline biofilm after mean times of 26 h 
(all-silicone), 19 h (silicone-coated latex) and 23 h (hydrogel-coated latex). In contrast 
when the balloons were inflated with triclosan (10 mg/ml in 5% w/v PEG), the pH of 
the urine remained acid, all the catheters drained freely for the seven day experimental 
period and little sign of encrustation was found on the catheters. Subsequent 
experiments showed that concentrations of triclosan ranging from 0.5 -  10 mg/ml in a 
variety of solvents were effective in preventing catheter blockage. The strategy was 
also effective in models supplied with pooled human urine. In additional experiments 
it was established that the triclosan solution had no adverse effects on the physical 
properties of the balloons over an eight week test period.
Experiments investigating the concentration of triclosan required in the artificial urine 
supplying the bladder models to inhibit further development of an established biofilm 
revealed that concentrations of 10 pg/ml triclosan or higher were needed. Introducing 
triclosan into the balloon of catheters where encrustation by Pr. mirabilis had already 
begun had no significant effect on delaying catheter blockage. This suggested that if 
the strategy is to be effective in patients who are “blockers”, it will be necessary to 
change catheters and then inflate the new catheter with the triclosan solution.
Inflating the catheter balloon with triclosan significantly reduced the numbers of 
viable cells in the biofilm on catheters in models inoculated with Pr. mirabilis, 
Escherichia coliy Klebsiella pneumoniae, Morganella morganii, Providencia stuartii, 
Serratia marcescens, Staphylococcus aureus and Enterococcus faecalis but not 
Pseudomonas aeruginosa. Despite being capable of producing the urease enzyme, the 
pH of control and test models inoculated with Ser. marcescens, S. aureus, K. 
pneumoniae, Ps. aeruginosa and M. morganii remained acidic over the 48 h test 
period.
Under laboratory conditions, it was possible to select for Pr. mirabilis mutants with 
increased resistance to triclosan, however no cross-resistance to antibiotics was 
observed. The triclosan strategy was ineffective at controlling catheter encrustation in 
models inoculated with mutants with MICs of 40 pg/ml. Therefore should clinical 
trials based in this strategy go ahead, the sensitivities of urinary tract organisms to 
triclosan should be monitored carefully.
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A bstrac t
This strategy does not disrupt the integrity of the closed drainage system, and 
delivering the antibacterial agent straight to the bladder could avoid the selection of 
antibacterial-resistant gut flora caused by oral drug administration. The results from 
this study suggest that if this novel strategy for controlling catheter encrustation could 
be transferred successfully from the laboratory to the clinic, it could improve the 
quality of life and well-being of many elderly and disabled people who are currently 
enduring the complications associated with long-term indwelling bladder 
catheterisation.
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1. INTRODUCTION
1.1. Managing bladder dysfunction
The physiology underlying the functioning of a healthy bladder is a complex 
integrated process relying on muscular, neurological and psychological responses 
(Sarkar and Ritch, 2000). When the bladder fills, it expands spontaneously until the 
volume of urine reaches close to its maximum capacity, at which point healthy 
individuals can empty their bladders at will. Most o f us take the mechanisms 
governing this process for granted, but for a variety of different reasons drainage of 
urine from the bladder often requires medical intervention.
Failure to pass urine results in painful bladder distension which if not dealt with can 
be life threatening. Urinary incontinence causes social and hygiene problems and in 
immobile patients can lead to bedsores, skin infections and septicaemia (Kunin, 
1987c). Patients who have undergone prostatectomies, other lower urinary tract 
operations and some gynaecological operations often require bladder management for 
a few days to facilitate surgical repair (Slade and Gillespie, 1985). Others patients 
requiring bladder management include those with temporary anatomical or 
physiological bladder obstructions or those who are severely ill or comatosed (Kunin, 
1987c). Long-term incontinence in the elderly, in patients who have suffered strokes 
and in patients with spinal cord injuries or neurological diseases also necessitates the 
use of a bladder drainage system.
A report by the Royal College of Physicians (1995) estimated that 25% of patients in 
residential homes and 40% of patients in nursing homes suffer urinary incontinence. It 
was also estimated that 10 - 20% of women and 7 - 10% of men over the age of 65 
living at home had urinary incontinence. A literature review by Minassian et al.
(2003) of 35 studies revealed that the median prevalence of urinary incontinence, 
ranging from mild to severe was 27.6% in females and 10.5% in males. Many 
incontinent people are ashamed of their lack o f bladder control, and this in turn affects 
their psychological health and social interaction (Busby-Whitehead and Johnson,
1999). The severity o f the problems associated with incontinence is underlined by the 
fact that elderly people consider urinary incontinence to be one of the most 
embarrassing disabilities (Wilde, 2003; Sarkar and Ritch, 2000).
There are essentially four choices o f bladder drainage systems (Slade and Gillespie, 
1985).
1 Management of incontinence by external devices. This involves the use of 
absorbent pads and pants, or condom sheaths that empty into a drainage tube that 
can manage incontinence in men.
2 Suprapubic catheterisation This involves draining urine from the bladder by 
inserting a catheter directly through the anterior abdominal wall into the bladder. 
Although suprapubic catheterisation has its advocates, and is preferred as an 
alternative to indwelling urethral catheters for patients with urethral stricture or 
fistula, it is not as popular as other methods of bladder management (Stickler and 
Zimakoff, 1994).
3. Intermittent or self-intermittent urethral catheterisation. These bladder 
management techniques involve using urethral catheters intermittently. At 
intervals the catheter is inserted into the bladder, the urine drained and the catheter 
removed. People have been using intermittent catheterisation to drain urine from 
the bladder for centuries. Their earliest use was recorded in the third millennium 
BC, when catheters made from different metals were passed into the bladder
intermittently via the urethra to drain urine (Pomfiret, 2000). The same principle is 
still in use today, and some patients can easily be taught to perform this procedure. 
If a patient is unable to self-catheterise, a nurse or carer can catheterise the patients 
at regular intervals. In a retrospective study of 75 patients who performed 
intermittent self-catheterisation for a mean of seven years, 92% of patients with 
neuropathic bladder dysfunction were continent (Wyndaele and Maes, 1990).
4. Continuous urethral catheterisation. Urethral catheterisation involves inserting a 
catheter into the bladder via the urethra (Figure 1). By leaving the catheter in 
place, urine is continually drained from the bladder. Indwelling urethral catheters 
(IUCs) used in this way are an essential part o f modem medical care, and are used 
extensively in hospitals, care facilities and by patients at home.
A prevalence study o f catheterised patients in Maryland nursing homes revealed that 
0.4% used intermittent catheterisation, 0.6% used a suprapubic catheter, 1.3% used 
external collection devices and that IUCs were used by 8.7% o f patients (Warren et 
al.y 1989). Nine per cent o f residents in nursing homes in the UK have urinary 
catheters, with an equal male: female split (McNulty et al. 2003). Zimakoff et al. 
(1993) reported that in Denmark 13.2% of hospitalised patients, 4.9% of nursing home 
residents and 3.9% of patients receiving home care had IUCs. About 10% of all 
hospitalised patients will receive an IUC, making urinary catheters the most 
commonly implanted medical devices (Kunin, 1987c; Darouiche, 2001)
The bladder remains collapsed with long-term indwelling catheter drainage, and as a 
result of chronic infection often becomes contracted with unhealthy mucosa and 
phosphatic debris capable of causing catheter blockage (Slade and Gillespie, 1985).
Abdominal Wall
Uterus
Bladder
Urethral Catheter
Rectum
Figure 1: Diagram of the catheterised urinary tract.
These complications can be overcome using intermittent catheterisation or intermittent 
drainage with a catheter valve, both of which keep the bladder functioning normally. 
A multi-centre clinical evaluation o f the performance of seven different catheter 
valves revealed that using the most expensive valve, 100% of patients reported the 
valve as good or acceptable (Fader et al., 1997). Woods (1999) discovered that there 
was a 50/50 split in the number of patients who liked and disliked the valve as an 
alternative to conventional drainage. From their study they conclude that instead of 
trying to find which drainage system is ‘best’, it would be more beneficial to 
encourage patients to use both methods for them to decide which best suits them. Self- 
intermittent catheterisation and catheter valves rely on patients having sufficient 
manual dexterity to be able to insert the catheter or open and close the valves. Since 
catheter drainage bags do not have to be used with either of these methods, they are 
more discreet and can dramatically improve certain patients’ quality of life.
Many different urethral catheters are available varying in length, balloon size, base 
material and surface coating Catheters can be made of all-silicone, polyurethane, 
polyvinyl chloride, latex or latex coated with silicone, teflon, hydrogel or silver 
hydrogel. The Foley catheter designed by Dr. Frederick Foley in 1934 is the most 
commonly used IUC and its basic design has remained unchanged for seventy years. 
This catheter features a balloon that is inflated with sterile water to secure the catheter 
in the bladder. The standard Foley catheter therefore has two interior channels, one for 
draining the urine and the other for inflating the retention balloon.
The suggested catheter balloon size is 5 - 10 ml, the use of larger balloons is 
discouraged because they can cause bladder spasm and more trauma to the urethral
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mucosa during catheter removal (Slade and Gillespie, 1985; Woollons, 1996; Pomfret,
2000). The external diameter o f a catheter is measured in Charrier (Ch) or French 
gauge (F) units, which are equivalent to 0.33 mm. Sizes ranging from six to 24 are 
available. These measurements give no information about the diameter of the internal 
drainage lumen, which can vary enormously (Morris et al.y 1997), depending on 
catheter design, material, and coatings. It is recommended that the smallest diameter 
catheter that provides adequate drainage be used (usually 1 2 - 1 4  Ch) to minimise 
urethral irritation and trauma (Pomfret, 2000; Woollons, 1996). Foley catheters are 
available in three lengths, male (standard), female and paediatric. Female patients are 
often catheterised with male catheters, when shorter catheters would be less 
conspicuous and reduce drainage problems associated with catheter kinking and 
looping (Pomfret, 2000; Woollons, 1996).
1.2. Infections associated with the use of IUCs
Although IUCs constitute a convenient way o f draining urine from the dysfunctional 
bladder, they can actually be hazardous to the very people that they are designed to 
treat. A Foley catheter in situ in the bladder provides a convenient bridge for bacteria 
to move from the outside world into the sterile bladder. In recent years it has also 
become apparent that the catheter itself constitutes an attractive site for urinary tract 
pathogens to colonize and proliferate
Bacterial attachment to bladder cells causes an apoptotic-like innate host defence 
mechanism that results in exfoliation of colonized host cells (Mulvey et al. 1998). In 
contrast, catheter materials have no inherent defence mechanisms. In healthy 
individuals, the periodic emptying of the bladder also flushes out small numbers of
organisms colonizing the urinary tract, preventing their entry into the bladder. The use 
of IUCs undermines this process. Small residual volumes of urine collect in the 
bladder below the level o f the catheter eye-holes due to their positioning above the 
catheter balloon (Slade and Gillespie, 1985). This urinary stasis enables any bacteria 
that enter the catheterised urinary tract to thrive. Stark and Maki (1984) demonstrated 
that isolation of any microorganisms from an intraluminal specimen, even when 
microbial counts were initially in the lowest detectable range almost invariably 
increased to more than 105 cfu/ml within three days.
There are three main ways bacteria can enter the catheterised bladder: (1) during 
catheter insertion, (2) through the catheter’s internal lumen, or (3) along the catheter- 
urethral mucosal interface (Warren, 1991). Although bacteria can be pushed into the 
bladder during catheter insertion, when strict sterile techniques are employed, this 
mechanism does not account for much more than approximately 2% of catheter- 
associated urinary tract infections (CA-UTI) (Nickel, 1991).
Dukes (1928) was concerned that patients on IUCs after excision of the rectum for 
cancer inevitably and rapidly developed UTIs. It was suspected that infection rates 
would decrease if urine draining through the catheter emptied into a closed system 
instead of an open container. This was proven when a closed drainage system 
prevented infection in virtually all patients during the postoperative period. 
Surprisingly the significance of this finding went unnoticed for over 30 years. Miller 
et al. (1960a) showed that in patients undergoing short-term catheterisation for acute 
retention of urine, the incidence of UTI was much higher with open catheter drainage 
(73%) than with closed aseptic drainage (10%). Use of the closed drainage system
with disinfection of the urethra and urethral instruments had similar results in 
preventing urinary infection after prostatectomies, they dropped from 83% to 11% 
(Miller et at. 1960b). The use o f disposable, plastic, sterile closed-drainage systems in 
676 hospitalised patients that were catheterised for one to 39 days kept patients’ urine 
sterile from the time of catheter insertion until the time of catheter removal, or until 
the patients were discharged from hospital in 77% of patients (Kunin and 
McCormack, 1966).
The advent o f the closed drainage system is said to be the most important 
development in preventing CA-UTIs, and has greatly limited the intraluminal entry of 
organisms (Warren, 1991). However, opening the closed system either by 
disconnecting the catheter and drainage bag, or whilst emptying the drainage bag can 
introduce bacteria into the catheterised urinary tract. These organisms can ascend 
intraluminally from both these sites into the bladder.
Even with a strict closed catheter regime, bacteria can move from the highly 
contaminated urethral meatus by migration towards the bladder along the outside of 
the catheter, or by capillary action in the thin mucosal film coating the external 
catheter surface (Maki and Tambyah, 2001). This is known as the peri-urethral route, 
and is the predominant entry point when strict closed drainage systems are 
maintained. Kass and Schneiderman (1957) inoculated the peri-urethral epithelium of 
three catheterised patients with Serratia marcescens, and within three days Ser. 
marcescens was recovered from the urine o f all these patients. Garibaldi et al. (1980) 
showed that patients with positive meatal cultures were significantly more likely to 
acquire bacteriuria than patients with negative ones. The percentage of positive meatal
cultures was 72% for female patients compared with 30% of male patients. In patients 
with positive meatal cultures who acquired bacteriuria, the causative organism in 85% 
of cases was the same bacterial species previously isolated from the urethral meatus.
The role o f prior rectal or urethral bacterial colonization in the pathogenesis of CA- 
UTI was investigated in a prospective study by Daifuku and Stamm (1984). In patients 
catheterised for at least three days, urethral colonization with the same infecting strain 
preceding bacteriuria was observed in 12 of 18 infections in women and five of 17 in 
men, whilst rectal colonization with the same infecting strain isolated prior to 
bacteriuria occurred in 14 of 18 infections in women and five of 17 in men. This work 
confirmed that entry of bacteria into the catheterised urinary tract often occurs via the 
peri-urethral route, and more so in female patients due to the close proximity of the 
urethra to the rectum. Garibaldi et al. (1980) noted that catheterised patients who are; 
female, over 50 years old, not receiving antibiotics and who have conditions not 
treated by surgery have an increased risk o f acquiring bacteriuria.
Using an animal model to ascertain the relative importance of the intraluminal versus 
the extraluminal route of CA-UTI, Nickel et al. (1985b) reported that contamination 
of the drainage spout or disconnection of the drainage system resulted in bacteriuria 
within two days. If however the closed drainage system was maintained, the 
extraluminal route assumed more importance, although this pathway was much 
slower. The study established that bacteria moved through the catheterised urinary 
tract by forming thick biofilms that extend proximally from the drainage bag to the 
bladder.
It is widely recognised that CA-UTI represent a significant proportion of all hospital 
and community acquired infections. UTIs account for 14.5% of all community- 
acquired infections and 30.3% of all nosocomial infections, making them the most 
prevalent hospital-acquired infections (Meers et al., 1981). This survey by Meers et al.
(1981) found that 8.6% of hospitalised patients were catheterised, and that over one in 
five o f these patients were infected. Warren et al. (1989) studied the prevalence of 
urethral catheterisation in Maryland nursing homes, and combined this information 
with data obtained from studies on the incidence of bacteriuria in long term 
catheterised patients. They concluded that bacteriuria associated with the use of IUCs 
was the most common infection in American health care facilities. Even with the 
strictest implementation of the closed drainage system and the best catheter care, 
Garibaldi et al. (1974) found there to be an 8.1% cumulative daily risk of acquiring 
bacteriuria whilst an 1UC was in place, and that after 10 days half of all catheterised 
patients were bacteriuric. All long-term catheterised patients (over 28 days) inevitably 
develop bacteriuria (Slade and Gillespie, 1985; Stickler and Zimakoff, 1994).
In the first week of catheterisation infection is usually due to a single bacterial species, 
including Escherichia call which accounts for a quarter o f all nosocomial UTIs, 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus mirabilis, coagulase 
negative staphylococci, enterococci or Candida species (Warren, 2001; Jarvis and 
Martone, 1992; Stark and Maki, 1984). There is an increased likelihood of the patient 
being colonized by multiple bacterial species’ the longer the catheter remains in place. 
A prospective study o f patients with chronic IUCs revealed that bacteriuria was 
polymicrobial with up to five different bacterial species in 77% of all weekly urine 
specimens (Warren et al., 1982). Clayton et al. (1982) found that in long-term
catheterised patients, the mean number of organisms cultured from each urine sample 
was 3.6, and that single organisms were rarely isolated.
1.3. Complications associated with catheter associated urinary tract infection
Bacteriuria in catheterised patients is generally asymptomatic. Compared to non- 
catheterised individuals however, these patients are at a higher risk of developing a 
range of other complications. A one-year prospective study by Kunin et al. (1992) of 
1540 nursing home patients demonstrated a stepwise increase in mortality with 
duration of catheterisation. Patients who were catheterised for over 76% of their days 
in the nursing home were three times more likely to die within an year than matched 
non-catheterised patients. The frequency and duration of hospitalisation, as well as 
antibiotic usage was also three times higher for catheterised patients. This is consistent 
with a previous prospective study o f a similar size among hospitalised patients, which 
concluded that acquiring a UTI whilst an IUC was in place was associated with 
approximately a three fold increase in mortality (Platt et al., 1982).
A variety o f different complications can afflict catheterised patients. Complications 
associated with bacteriuria in catheterised patients fall into two categories, the first 
affects short- and long-term catheterised patients and includes symptomatic UTIs i.e. 
fever, acute pyelonephritis and bacteraemia. The second more frequently afflicts long­
term catheterised patients and symptoms include: catheter obstruction, urinary tract 
stones, local periurinary infections, chronic pyelonephritis and for patients 
catheterised for extensive periods o f time, bladder cancer (Warren, 1996; Stickler and 
Zimakoff, 1994).
1.3.1. Bacteraemia
Bacteraemia is the presence of bacteria in the blood, and can occur in patients with 
infected urine after catheter insertion, removal or manipulation. E. coli is significantly 
more likely than other organisms to cause bacteraemia, although even other ‘non- 
uropathogens’ such as Providencia stuartii and Morganella morganu can do so as 
well (Warren, 1996). Only a small number o f patients with bacteraemia suffer frank, 
clinically evident septicaemia (Slade and Gillespie, 1985). CA-UTIs are responsible 
for 8% and 10.6% of all hospital-acquired bacteraemia in teaching and non-teaching 
hospitals respectively (Coello et al., 2003). Siegman-Irga et al. (1994) showed that 
patients with IUCs were twice as likely to have polymicrobial rather than 
monomicrobial episodes o f urinary tract associated bacteraemia. A study in a veterans 
extended care facility showed that the urinary tract was the source of over half the 
incidences o f bacteraemic illnesses (Rudman et al.y 1988). The overall mortality rate 
was 21%, increasing to 35% for polymicrobial bacteraemias. The study also 
highlighted that although chronically catheterised patients only represented 5% of the 
patient population, they accounted for 40% of the Gram-negative bacteraemic 
illnesses, with the majority of catheterised men suffering from one or more each year. 
Since 90% of the patients had fevers with their episodes of bacteraemic illnesses, 
Rudman et al. (1988) suggest that patients in high risk catheterised groups should 
have their temperature monitored daily to lower the case fatality rate. Sir Andrew 
Clark in 1883 used the term “catheter fever” to describe the bouts of febrile illness in 
men that were healthy prior to the use of catheters to alleviate prostatic obstruction. 
The prognosis for the patients suffering from “catheter fever” was not good, and 
invariably resulted in the death of the afflicted patients.
A study of catheterised men in the community revealed that nearly all patients had 
infected urine after four weeks, and that 20 out of 197 catheter changes resulted in 
bacteraemia (Jewes et al., 1988). Most patients, however, developed no clinical 
symptoms. These authors conclude that symptomatic bacteraemia may only be a very 
small proportion of the total bacteraemia associated with catheter use, and that even 
asymptomatic bacteraemia could lead to bacterial endocarditis in susceptible patients.
1.3.2. Pyelonephritis
Pyelonephritis is acute or chronic infection of the kidneys, and in catheterised patients 
it is usually caused by the ascent and invasion of bacteria from the bacteriuric bladder 
into the kidneys. In his editorial entitled “the case against the catheter” Beeson (1958) 
noted how the use o f catheters increased the risk of acquiring pyelonephritis, and that 
the decision to catheterise a patient should be made in the knowledge that it can result 
in this serious disease. Two out o f three febrile episodes in aged, long-term 
catheterised patients may arise from the urinary tract, and pyelonephritis is the source 
o f many of these episodes (Warren, 2001). Warren et al. (1988) conducted a 
prospective clinicopathological study, examining the urinary tracts of 75 
consecutively autopsied patients from a single Baltimore nursing home. The study 
revealed that 21 out o f 55 catheterised patients had acute renal inflammation 
compared to one out of 20 non-catheterised patients. This study also highlighted that 
acute cystitis was associated with renal inflammation, 14 out of 18 kidneys in patients 
with acute cystitis also had renal inflammation. The duration of catheterisation is 
significantly associated with increasing the prevalence of chronic pyelonephritis and 
chronic renal inflammation (Warren et al., 1994). A retrospective analysis of urologic 
complaints in male spinal injured patients revealed that those managed with an IUC
were significantly more likely to develop pyelonephritis than those who were not 
(Larsen et al., 1997).
1.3.3. Cancer o f the bladder
Studies of spinal cord injured (SCI) patients suggest that people who are catheterised 
for extended periods of time are at a higher risk of developing carcinoma of the 
bladder. One of the first to make this association was Melzak (1966), who showed that 
11 out o f 3800 patients at the national spinal injuries centre in Stoke-Mandeville 
Hospital (0.28%) developed bladder cancer. He noted that the only common factors 
amongst all patients that developed bladder cancer was a long-standing, chronic 
bladder infection and the presence of a long-term suprapubic or urethral indwelling 
catheter. More recent work has confirmed these findings. A retrospective population- 
based analysis o f invasive treatments for carcinoma of the bladder revealed that spinal 
injured patients with IUCs were more than twice as likely to develop bladder cancer 
than patients using any other form o f bladder management (West et al., 1999). In a 
study of 3670 patients with SCI, indwelling catheters were shown to be a significant 
independent risk factor for increasing the risk of mortality by bladder cancer (Groah et 
al., 2002) Bladder cancer occurred after 12 or more years of catheterisation and in 
patients as young as 29, the risk of developing bladder cancer in patients catheterised 
for more than 20 years was 398.1 per 100,000 person-years.
The precise mechanisms that contribute to the increased incidence of bladder cancers 
among SCI patients are unknown. One theory is that malignant transformation occurs 
following infection and chronic stimulation of the urothelium, which is brought about 
by the presence of the catheter (Akaza et al., 1984; West et al., 1999). A second
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possible explanation is based on the theory that nitrate-reducing bacteria 
contaminating urine can produce nitrosamines, which are notorious carcinogens. 
Studies on patients in a paraplegic ward (Tricker et al.y 1991; Stickler et al.t 1992) 
confirmed that nitrate-reducing bacteria commonly infect the urine of SCI patients and 
that nitrosamines can be detected in patients' urine. The urine from a control group 
from the same hospital was found to be sterile and contained no nitrosamines, 
supporting the hypothesis that endogenously formed nitrosamines may be a risk factor 
for bladder cancer.
1.3.4. Infection stones
The formation of stones in the bladder and kidneys is a common problem amongst 
catheterised patients. The incidence of bladder stones in SCI patients has decreased 
over the past 30 years, however, an estimated 15% of all individuals who suffered a 
spinal cord injury between 1985 and 1996 still developed a bladder stone (Chen et al.,
2001). This study highlighted that the risk ratios for initial stone formation was more 
than three times higher in patients with IUCs than for individuals managed by 
intermittent catheterisation, catheter free care and condom drainage. A similar study 
by Larsen et al. (1997) revealed that bladder and renal stones were three times more 
prevalent in catheterised than non-catheterised patients. DeVivo et al. (1984) 
established that SCI patients with a bladder stone at hospitalisation were 8.6 times 
more likely to develop renal stones before discharge than patients who were free of 
bladder stones.
These stones can vary from being solid highly mineralised bodies to dispersed 
aggregates of crystals in an organic matrix (Stickler and Zimakoff, 1994), and are
- 15 -
formed due to chronic infections by urease producing bacteria (Griffith et al., 1976). 
Microcolonies of urease producers are formed when the bacteria produce extracellular 
polymeric substances (EPS) that glue aggregates of bacteria together. These 
encapsulated microcolonies of urease producing bacteria, particularly of Pr. mirabilis, 
play a central part in the development o f these stones. Positively charged calcium and 
magnesium ions are attracted to the anionic polysaccharide capsule. The production of 
the urease enzyme by the bacteria splits urea to ammonia and carbon dioxide, 
elevating the pH. The localised alkaline environment causes precipitation of calcium 
phosphate (apatite) and magnesium ammonium phosphate (struvite) crystals in the 
urine and in the EPS encapsulating the microcolonies. Continued bacterial growth in 
the aggregate colonies, along with the production of urease and EPS provides an ideal 
environment for the formation and attraction of crystals that together produce an 
infection stone (Clapham et al., 1990).
Stone formations in the bladder are not usually life threatening, whereas renal stones 
can lead to dangerous complications such as chronic pyelonephritis and renal 
dysfunction. The bacteria in the stones are protected from adverse agents such as host 
factors and antibacterials by crystals and EPS. Bacteria from the stone can therefore 
easily re-infect the urine following antibacterial treatment regimes, and due to their 
high risk of recurrence, infection stones are often described as ‘stone cancer’ (Hedelin,
2002).
1.3.5. Catheter blockage
Catheter blockage due to encrustation is one o f the biggest problems associated with 
the use of IUCs. As in the production of infection stones, encrustation is formed by
the precipitation of calcium and magnesium phosphates. The encrustation leads to 
persistence of infection and causes irritation to the bladder mucosa. The mineralised 
deposits can block the catheter lumen or eye-hole resulting in either urinary 
incontinence or retention. Urinary incontinence due to urine by-passing the catheter 
complicates the nursing care o f the patient, and can lead to breakdown of the skin, 
bedsores and all the consequent problems. Urinary retention is painful and distressing 
and if it goes unnoticed, urinary reflux leads to ascending infection and the 
development o f pyelonephritis, which can lead to episodes of fever, sepsis and shock 
(Kunin, 1987c). When blockage occurs, removal of the mineralised catheter is the 
only option, and oflen causes trauma to the urethra and bladder mucosa. A recent 
clinical study revealed that 62% of patients suffering from recurrent catheter blockage 
had bladder stones (Sabbuba et al., 2004).
This problem is particularly distressing for community based patients and carers, 
where instant professional help is not available. Recurrent catheter blockage is also 
costly to health services, in terms of both time and resources, necessitating 
unscheduled visits and time-consuming procedures (Getliffe, 1990). The primary 
concern regarding catheter blockage, however, should always be the misery it causes 
the patient.
1.4. The control of catheter associated urinary tract infections
The maintenance of a closed drainage system is important in preventing UTI in the 
first week of catheterisation. Over the years several other methods trying to prevent 
the development o f CA-UTI have been attempted.
1.4.1. Disinfection of the drainage bag
Extensive research efforts in the 1980’s focused on disinfecting drainage bags with 
agents such as hydrogen peroxide, iodophors, chlorhexidine and trichioroisocyanuric 
acid (Stamm, 1991). The belief that eliminating bacteria in the drainage bag would 
lower the incidence of CA-UTI was, however, short-lived. Although these agents 
reduced contamination in the drainage bags, their effect on the overall rate of infection 
was minimal due to their infrequency as the source of infection. A study by Thompson 
et al. (1984) highlighted that only 7% of organisms contaminating the bag were also 
responsible for the bacteriuria. Gillespie et al. (1983) and Thompson et al. (1984) 
showed that disinfecting patients’ drainage bags with either chlorhexidine or hydrogen 
peroxide had no significant effect on the rate of bacteriuria compared to patients’ bags 
that were not disinfected.
1.4.2. Bladder washouts
Attempts to delay infection by irrigating the bladder with antimicrobial solutions 
appeared promising when they were first tested. Studies on the effect of intermittent 
irrigation showed that chlorhexidine and silver nitrate were effective in reducing the 
urinary bacterial counts o f patients with infected catheterised urinary tracts, but that 
saline and acetic acid solutions were not (Bruun and Digranes, 1978). Chlorhexidine 
and silver nitrate lowered the numbers of all organisms isolated prior to bladder 
irrigation. It was concluded that although the antibacterial efficacy of chlorhexidine 
was not as good as the silver nitrate, its use would be favoured due to the pain 
associated with irrigating the bladder with silver nitrate. It is worth noting that this 
was a very small clinical study, with less than 10 patients receiving treatment with 
each type of washout solution.
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Stickler et al. (1987) used a physical model of the catheterised bladder to assess the 
activity of povidone-iodine, phenoxyethanol, chlorhexidine, chlorhexidine 
supplemented with EDTA and tris, noxythiolin and neomycin as bladder instillation 
treatments for UT1 in catheterised patients. Single applications of these antibacterials 
for 30 min were not capable o f sterilising urine in the bladder infected singly with a 
range of six uropathogens. Phenoxyethanol was, however, effective at dealing with 
Pv. stuartii and Ps. aeruginosa. It was noted that daily washouts with these solutions 
would at best only produce a temporary decrease in the numbers of bacteria, which 
would have recovered back to their original numbers by the time for the next washout 
the following day. Similar work by King and Stickler (1991) established that only 
mandelic acid could eliminate a range of bacterial species commonly responsible for 
CA-UT1 under conditions simulating heavy infections.
A clinical trial demonstrated that instilling chlorhexidine or saline into the bladder was 
not effective in reducing bacteriuria in patients catheterised for 10 days or more 
(Davies et al.y 1987). Kennedy et al. (1992) showed that bladder washouts with Suby 
G (a 3.23% citric acid solution) and Solution R (a 6% citric acid solution) did not 
eliminate bacteria or have any effect on urease producing bacteria. A study in which 
106 hospital and district nurses were interviewed about their experiences with bladder 
washouts revealed that more than half were recommending chlorhexidine washouts 
for long term catheterised patients (Roe, 1989). This is despite the fact that no 
antiseptic, especially chlorhexidine can eradicate infections in long-term catheterised 
patients (Stickler and Thomas, 1980: Slade and Gillespie, 1985). Nearly half of the 
nurses had a non-rational reason to support the prescribing of these solutions, and 
some relied exclusively on manufacturers’ recommendations, which concerning the
use o f chlorhexidine as a washout solution is not supported by clinical and scientific 
evidence (Roe, 1989). There is still confusion about when bladder washouts should be 
performed and their effectiveness (Evans and Godfrey, 2000). Although bladder 
washouts may benefit patients whose catheters block regularly, for patients whose 
catheters drain freely their use is unnecessary and it is best to maintain the closed 
drainage system (Roe, 1989).
1.4.3. Cleansing
The importance of infections stemming from the colonization of the peri-urethral 
pathway in CA-UTI has been confirmed, and is especially significant in female 
patients (Garibaldi et al., 1980). It was therefore logical to assume that cleansing or 
using antibacterial ointments on this area would prevent bacterial meatal entry. 
However, Burke et al. (1981) showed that daily meatal cleansing with soap and water 
or with a povidone-iodine solution followed by the application of povidone-iodine 
ointment was ineffective at lowering rates o f bacteriuria, and actually increased rates 
in a subset o f high-risk female patients. The use of a poly-antibiotic ointment twice 
daily was shown to decrease bacteriuria by 1% compared to the control group, 
indicating that meatal care with such ointments confer little benefit (Burke et al., 
1983).
1.4.4. Systemic and oral administration of antibiotics
Antibiotics are not generally prescribed to control CA-UTI, and there is a consensus 
that patients with asymptomatic bacteriuria should not be treated with antibiotics. 
Their administration should be to those patients showing clinical symptoms of 
infection (Warren, 1991). Britt et al. (1977) evaluated the effectiveness of short-term
systemic antibiotic prophylaxis in controlling catheter-associated bacteriuria in 
women undergoing gynecological operations. They discovered that nine out of 100 
women in the placebo group developed bacteriuria compared to three out of 96 
receiving the antibiotics. However, the benefit of receiving the antibiotics was short 
lived since at the time of discharge from the hospital, both these groups had similar 
rates o f positive cultures. It is now accepted that administration of antibiotics only 
produces short-term benefits, and that after only a few days the sensitive uropathogens 
are replaced by resistant ones (Garibaldi et al, 1974; Clayton et al., 1982; Kunin, 
1987c; Warren, 1996). It must also be noted that if bacteria growing on catheters have 
formed biofilms, although antibiotics eliminate microorganisms in the urine, bacteria 
in the biofilm remain viable and can cause re-infection after the antibiotic course had 
concluded (Nickel, 1991). The routine use of antibiotics is therefore limited by their 
lack o f effectiveness and the possible emergence of resistance (Garibaldi et al. 1974; 
Stamm, 1991; Warren 1996). The use o f prophylactic antibiotics should only be 
considered as a preventative method in high-risk patients for short-term periods of 
catheterisation (Britt et al, 1977; Stamm, 1991).
1.4.5. The incorporation of antimicrobials into the catheter
The search for an 1UC that would prevent infection led to antimicrobial agents being 
used to coat or impregnate catheters. An ideal antimicrobial agent should therefore; 
have a broad spectrum of antimicrobial activity, persist for the lifetime of the catheter, 
not be altered by contact with body fluids and not select for drug resistant organisms 
(Stickler, 2000).
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The wide antimicrobial spectrum of silver against nosocomial pathogens, along with 
its ability to satisfy many o f the above criteria led to several manufacturers coating 
urethral catheters with silver oxide or metallic silver coated surfaces. Gabriel et al. 
(1996) showed that primary adherence o f E. colt was reduced 25% - 50% using 
hydrogel silver-coated compared to hydrogel-coated latex catheters. It must be noted, 
however, that this study only monitored the adherence of bacteria to the catheters over 
a very short time period (2 h).
Clinical studies on silver-modified catheters have provided inconsistent results. A 
large randomised clinical trial failed to demonstrate the efficacy of silver impregnated 
IUCs in preventing CA-UTI (Riley et al., 1995). This study showed that not only did 
the silver catheters increase the incidence of bacteriuria in men, they also significantly 
increased the rate o f staphylococcal bacteriuria. Bologna et al. (1999) noted a trend 
towards a reduction in UTI with the use o f hydrogel-silver coated catheters, although 
the results were not significantly different from those not coated with silver. Liedberg 
and Lundeberg (1990) showed that there was a significant decrease in UTI when 
silver alloy coated catheters were used in short-term catheterised patients (six days or 
less)
A meta-analysis of eight clinical trials performed by Saint et al. (1998) compared 
whether silver-coated IUC were likely to lead to lower rates o f UTI than standard 
catheters. Their results revealed that silver alloy catheters were significantly more 
effective in preventing bacteriuria, whereas silver oxide catheters were not. Saint et al. 
(1998), along with others (Schierholz et al. (1999) and Niel-Weise et al. (2002)) note 
that the findings o f this study should be interpreted with caution. The clinical trials
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were all subject to different interventions and were performed on different study 
populations, the results using the silver alloy catheters were all carried out by the same 
institution and the analysis only compared bacteriuria, and not the clinical outcome. A 
review by Niel-Weise et al. (2002) highlighted a lack of high standard trials related to 
the effectiveness o f silver coatings on IUCs, and concluded that because of this, there 
is insufficient evidence to recommend the use of these devices.
The conflicting results regarding the use of silver-coated catheters indicate that they 
may give minimal protection against CA-UTI. There is no evidence that they are 
effective in preventing infection in patients undergoing long-term catheterisation. At 
best they may delay bacteriuria in short-term catheterised patients. This said, there are 
different methods of introducing silver into the catheterised urinary tract that may 
prove more effective. A silver iontophoretic catheter with two silver wires connected 
to an electric power source has been shown to have a broad spectrum of activity 
against Gram-negative and positive bacteria (Raad et al., 1996). A lecithin, silver 
citrate and liquid silicone mixture has also been shown to be more effective at 
preventing intraluminal ascent of bacteria than other silver coatings (Kumon et al.
2001 ).
Early work impregnating catheters with antibiotics showed no efficacy in preventing 
CA-UTI (Butler and Kunin, 1968). The possible outcome of impregnating catheters 
with antibiotics could be particularly hazardous. The release of sub-inhibitory 
concentrations of antibiotics from the catheter, together with the presence of high 
numbers o f different bacterial species in the catheterised urinary tract could lead to the 
selection of bacteria with decreased antibiotic sensitivities, aggravating the problems
of CA-UTI and drug resistance. Notwithstanding these concerns, antibiotic 
impregnated catheters continue to be developed.
The antimicrobial activity and durability of minocycline and rifampin impregnated 
catheters were tested in spinal injured patients for a maximum of two weeks. On 
removal of the catheters, sections were cut from the devices and tested for 
antibacterial activity against lawns o f bacteria. Zones o f inhibition were observed 
against 10 tested uropathogenic species including Ps. aeruginosa and Pr. mirabilis 
(Darouiche et al. 1997). A clinical trial evaluating the short-term efficacy of these 
catheters revealed that patients who received the antimicrobial impregnated catheters 
had significantly lower rates o f Gram-positive bacteriuria compared to the control 
group, but similar rates of Gram-negative bacteriuria and candiduria (Darouiche et al., 
1999b). Testing organisms isolated before and after the insertion of minocycline and 
rifampin impregnated central venous catheters (CVCs) revealed similar antibiotic 
sensitivities (Darouiche et al, 1999a). Although this indicates that bacterial strains 
with decreased susceptibilities had not developed, the use of such catheters should be 
coupled with a continued surveillance programme that monitors resistance.
Darouiche et al. (1997) and Darouiche et al. (1999b) both comment that using 
combinations of antimicrobials with different modes of action may prevent the 
development o f bacterial resistance. Tambe et al. (2001), however, discovered a 10- to 
16-fold increase in minimum inhibitory concentration (MIC) after 10-20  subcultures 
through sub-inhibitory concentrations o f the combination of minocycline and 
rifampicin, but noted that resistant bacteria had not yet emerged in the clinical setting.
An in vitro study evaluated the activity of nitrofurazone-coated urinary catheters 
against six species o f susceptible and multidrug resistant (MDR) bacteria (Johnson et 
al., 1999). Using an agar diffusion assay it was established that the nitrofurazone- 
coated catheters showed comparable inhibition zones with susceptible and MDR 
strains for each species tested except for vancomycin resistant Enterococcus faecium. 
A limited number o f bacterial species were tested in this study, and some very 
important urinary tract pathogens including Ps. aeruginosa and Pr. mirabilis, species 
intrinsically resistant to nitrofurazone, were not tested. The complications associated 
with Pr. mirabilis indicate that the impact o f these catheters on long-term catheter care 
will be negligible.
Reid et al. (1994) using an in vitro assay demonstrated that pre-treatment of silicone- 
coated latex catheters with ciprofloxacin significantly reduced adhesion and survival 
o f a clinical isolate o f Ps. aeruginosa. Stickler et al. (1994) confirmed that pre- 
treatment o f sections o f silicone-coated latex catheters with ciprofloxacin inhibited 
bacterial colonization of suspensions o f cells in buffer, although cells in urine 
colonized both control and ciprofloxacin treated catheter sections equally well. 
Subsequent experiments in physical models o f the bladder demonstrated that within 
48 h Ps. aeruginosa, Pv. stuartii, Pr. mirabilis and E. coli were all capable of 
colonizing control and treated catheter sections.
Using an agar inhibition method, the antimicrobial efficacy of Foley catheters (latex 
and silicone) impregnated with 1) chlorhexidine and silver sulfadiazine (CXS) and 2) 
chlorhexidine, silver sulfadiazine and triclosan (CXST) were compared to the silver 
hydrogel-coated latex catheter and nitrofurazone-coated silicone catheters (Gaonkar et
al, 2003). The CXS and CXST catheters both had an increased spectrum of 
antimicrobial activity compared to the silver- and nitrofurazone-coated catheters. This 
group also devised a novel in vitro urinary tract model to study the ability of these 
catheters to prevent extraluminal migration of bacteria into the bladder. Overall, the 
CXST catheters exhibited a broader antimicrobial spectrum and significantly 
increased the duration o f antimicrobial activity compared to the silver- and 
nitrofurazone-coated catheters (Gaonkar et al., 2003). The group concluded that the 
greater efficacy of the CXST catheters compared to the CXS catheters might be due to 
the synergistic effects o f all the different agents. It is surprising, however, that they 
did not test the migration of Pr. mirabilis along the various antibacterial catheters or 
suggest that triclosan alone could be responsible for the increased efficacy. The 
extrapolation that zone of inhibition size could predict the clinical efficacy of a 
catheter in some of the above experiments is dangerous (Stickler, 2000), and should 
generally only be used as a starting point on which to base further investigations.
Reid (1999) made a suggestion that oral administration of antibiotics could be a way 
of coating the surfaces of medical devices. Reid et al., (2001) showed that oral 
administration of ciprofloxacin and ofloxacin in 40 patients led to the antibiotics being 
adsorbed onto their ureteral stents. This method should be approached with caution as 
such indiscriminate and overuse o f antibiotics would surely provide the perfect 
environment for the selection of bacteria with decreased antibiotic sensitivities, 
exacerbating and not controlling the problem of CA-UTI.
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1.4.6. Other measures for controlling CA-UTI
The selection of resistant organisms after the introduction of antiseptic agents should 
be considered carefully. Stickler and Thomas (1980) tested the sensitivity of over 800 
isolates o f Gram-negative bacteria to different antiseptic agents, and revealed that 
approximately 10% of isolates exhibited a degree of resistance to cationic agents. 
These resistant organisms were Proteus, Providencia or Pseudomomas species, and 
were also generally resistant to five to seven antibiotics. The resistant strains were 
mostly isolated from patients where chlorhexidine washes were used to clean the 
urethral meatus prior to catheter insertion, chlorhexidine creams were used to facilitate 
catheter insertion and in some cases chlorhexidine was added to the drainage bags. 
From these results it was concluded that antiseptic policies that rely on the intensive 
use of cationic antiseptics such as chlorhexidine could well result in the selection of 
bacterial flora that are notoriously drug resistant. Clinical evidence supporting this 
warning soon followed.
Instilling chlorhexidine or saline into the bladder was not effective in reducing 
bacteriuria in patients catheterised for 10 days or more, and there was an increase in 
patients with Proteus bacteriuria (Davies et al., 1987). Out of 24 patients, six had 
Proteus bacteriuria pre-washout but this increased to 11 patients after completing a 
course of chlorhexidine instillations. Dance et al. (1987) report on an outbreak of UTI 
between 1980 and 1985 involving strains o f Pr. mirabilis resistant to gentamicin and 
several other antibiotics that affected 90 patients in Southampton. This outbreak 
occurred shortly after the introduction of extensive chlorhexidine use into the catheter 
care policies. It is possible that overuse of chlorhexidine impregnated catheters could 
result in a similar scenario. Gaonkar et al. (2003) note that “choosing antimicrobials
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with a lower risk of inducing microbial resistance for incorporation into medical 
devices is critical”.
There is little doubt that many patients are catheterised unnecessarily (Saint et al., 
2000; Gokula et al. 2004). A study by Saint et al. (2000) revealed that physicians and 
medical students were often unaware that their in-patients had IUCs. It was also noted 
that when catheters were used inappropriately, they were ‘forgotten’ about more 
frequently than the appropriately used ones, and if physicians are unaware that a 
catheter is in place they are unlikely to order its removal. Currently there are no 
effective measures for preventing CA-UTI, the best way to decrease the incidence of 
infection associated with these devices is to avoid their use, or reduce the length of 
time they remain in situ.
1.5. Bacterial biofilms
Costerton et al. (1995) defined biofilms as “matrix-enclosed populations adherent to 
each other and/or to surfaces or interfaces”. In aquatic environments bacteria prefer to 
grow on surfaces rather than in suspension. For this reason larger numbers of bacteria 
are found as sessile biofilm communities than as single planktonic cells. Biofilms can 
be found in all aquatic environments from streams to sewers, and food fermenters to 
ship hulls. Advances in modem medicine have led to the increased use of medical 
devices and prostheses over the past decades, which continue to grow 7% per annum 
(Ried et al., 1995). Persistent microbial infection, however, is one of the leading 
causes of failure of these devices, and biofilms are typically central to the microbial 
pathogenesis of these troublesome infections (Donlan and Costerton, 2002).
Microorgansims undergo profound changes as they transform from planktonic 
organisms to surface attached communities. These changes produce new phenotypic 
characteristics for cells growing in biofllms and occur in response to environmental 
factors (O’Toole et al., 2000). The catheterised urinary tract provides an ideal 
environment for biofilm formation, with infected urine flowing over the catheter 
surface for prolonged periods of time. Clinical and laboratory studies have revealed 
that biofilms form readily on catheter surfaces. Nickel et al. (1989) used scanning 
electron microscopy (SEM) and transmission electron microscopy (TEM) to show that 
the biofilm mode of growth is a predominant factor in the pathogenesis and 
persistence of CA-UTI. Ohkawa et al. (1990) using SEM revealed the presence of 
biofilms on the catheters of 13 out of 14 patients catheterised for 14 days or more. 
Ganderton et al. (1992) found biofilms on 44 out of 50 catheters that had been 
indwelling for three to 83 days. Extensive biofilm formation has also been observed 
on catheters removed from physical models o f the catheterised urinary tract within 24 
h o f heavy inoculation with Pr. mirabilis (Stickler et al., 2003).
The first step in biofilm formation is bacterial attachment to a surface. The surfaces of 
implanted devices are coated with glycoproteinaceous conditioning films from the 
surrounding body fluids containing fibronectin, fibrinogen and other proteins almost 
immediately after they are inserted. The components o f the conditioning films provide 
receptor sites for bacterial adhesion (Gristina, 1987). The conditioning film plays an 
important role in influencing subsequent adsorption and attraction of microbes to the 
medical devices (Lappin-Scott and Bass, 2001). Ohkawa et al. (1990) collected IUCs 
from patients that were catheterised for short periods of time. The studies revealed 
fibrin on the surface of catheters removed from the patients within three days. They
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concluded that this material originated from host cells injured during catheter 
insertions, and that this film was important in gluing microorganisms and crystals 
from the urine onto the catheter. The protein pattern of conditioning films on 
encrusted and non-encrusted ureteral stents have different electrophoresis profiles 
(Santin et al.y 1999). Western blots revealed that adsorption of Tamm-Horsfall protein 
and a  1-microglobulin were limited to non-encrusted devices.
Microbial cells in the vicinity of a medical device by direct contamination, 
transcutaneous spread or by seeding from infected bodily fluids that flow over the 
surface o f the device, are drawn to the surface by physical forces such as hydrophobic 
interactions and electrostatic attractions (Stickler and McLean, 1995). When a 
bacterium is in very close proximity to the surface, short-range chemical interactions 
(ionic, hydrogen and covalent bonding) may occur (Gristina, 1987). Specific 
adhesions mediated by fimbriae are not strong. Firm adhesion requires the non­
specific interaction of the elastic polymers o f the extracellular polymeric substances 
(EPS) layer, even when the fimbriae dictate the site of eventual adhesion with specific 
receptors (Costerton, 1999).
The attached bacterial cells must synthesise new EPS in order to ‘cement’ their 
adhesion and progress from reversible attachment to the irreversible adhesion phase of 
biofilm formation (Costerton, 1999). Cell division then produces sister cells within the 
EPS, initiating the development o f adherent microcolonies (Costerton et al., 1987). 
Depending on the bacterial species and the level of nutrients in the surrounding media, 
the microcolonies will contain 10 - 25% cells and 75 - 90% EPS (Costerton, 1999). 
Glycocalyx, slime, capsule and sheath are all terms referring to EPS associated with
individual or cell aggregates, and biofilms (Characklis and Cooksey, 1983). The 
glycocalyx is defined as “tangled fibres of polysaccharides or branching sugars” 
(Costerton et al., 1978). However, in microbial adhesion and biofilm formation in 
general, other macromolecules besides polysaccharides and sugars are found within 
the organic matrix, including glycoproteins, proteins and nucleic acid (Characklis and 
Cooksey, 1983). The organic matrix will therefore be referred to as EPS. Cell division 
within these microcolonies and recruitment o f bacteria from the planktonic phase 
eventually results in extensive surface colonization. Nickel et al. (1992) showed that 
bacteria could migrate along a catheter surface against gravity and the flow of urine. 
Their study showed that after an initial “log phase” characterised by biofilm build up 
at the site of contamination, there is a “creep phase” characterised by biofilm 
movement.
Biofilms are not continuous layers o f bacteria and EPS as once thought. Direct 
observations of living biofilms, particularly by confocal laser microscopy and other 
non-invasive physical methods have revealed that they are elaborate and complex 
structures. Caldwell et al. (1992a) and Caldwell et al. (1992b) showed how confocal 
laser microscopy used in conjunction with 3-D image analysis could create computer 
reconstructions of 3-D biofilms, allowing their development to be visualised directly. 
Biofilms may be comprised of a single or multiple bacterial species. Costerton et al. 
(1995) described how many microcolonies develop into mushroom like structures, and 
that most cells are at the top of the mushroom, whilst there are very few down the 
‘stalk’. These microcolonies are arranged both horizontally in thin biofilms, and 
vertically in thick biofilms. Water-filled channels were also observed throughout the 
biofilms that could take nutrients into, and take waste out of the biofilm. It was noted,
however, that it is yet to be established whether such elaborate microcolonies and 
fluid channels are found in all biofllms.
Recent evidence has suggested that biofilm development might be regulated at the 
level o f population-dependent gene expression controlled by cell-to-cell signalling 
molecules (O’Toole et al., 2000). Acylated homoserine lactones (AHLs) are signal 
molecules that mediate population density-dependent (quorum sensing) gene 
expression in many Gram-negative bacteria (Fuqua et al., 1996). Davies et al. (1998) 
showed that a mutation blocking the generation of the quorum sensing signalling 
molecules in Ps. aeruginosa prevented the formation of a normally differentiated 
biofilm, producing thin biofilms o f densely packed cells. Stickler et al. (1998a) were 
the first to demonstrate that AHLs were produced by biofllms in the clinical setting. It 
was shown that Ps. aeruginosa biofilms that had developed in urinary catheters in vivo 
produced AHLs. Once the biofllm has reached a critical mass, a dynamic equilibrium 
is achieved when the outermost layer o f the biofilm begins to generate planktonic 
organisms (Dunne, 2002). Using digital time-lapse microscopy imaging (DTLM) 
Lappin-Scott and Bass (2001) were able to show that loss of bacteria and small 
clusters o f bacteria via erosion was a continuous process, as opposed to sloughing of 
large microcolonies. The organisms that are released from the biofllm are then free to 
colonize new surfaces (Dunne, 2002).
The biofllm mode of growth protects bacteria against antimicrobial agents and host 
defence mechanisms making them difficult to control and eradicate. Clinical 
observations have revealed that within the protection of the biofllm, bacteria that are 
sensitive to an antimicrobial agent in standard tests survive urinary concentrations of
antibiotics generated by conventional treatments. Nickel et al. (1985a) demonstrated 
that whilst a Ps. aeruginosa planktonic culture had tobramycin MIC of less than 1 
fig/ml and a MBC of 50 pg/ml, the same strain growing as a thick biofilm on the 
surface of a latex catheter could survive exposure up to 1000 pg/ml. This 
concentration is at least five times higher than can be clinically achieved in the 
patients’ urine. The failure of antibacterial washout solutions to clear established 
bladder infections can also be attributed to the increased resistance of bacteria 
growing in biofllms (Stickler et al.y 1987). Biofllm formation on surfaces is regarded 
as a universal bacterial strategy for both survival and optimal positioning with regard 
to available nutrients (Costerton et al., 1987).
Although it is now accepted that bacteria in biofllms are generally more resistant to 
antibacterials than their planktonic counterparts, susceptibility tests of microorganisms 
using planktonic growth conditions are still used to predict their efficacy against 
biofilm bacteria. This is particularly true for medical devices, when antimicrobial 
therapy is based on antibiotic sensitivity data obtained using planktonic organisms in 
nutritionally rich media (Dunne, 2002). In reality these growth conditions could not be 
further from the conditions found in biofllms on medical devices. Anwar et al. (1990) 
suggested that a new more realistic in vitro test should be developed to study the dose 
and frequency of antibacterial agents required to treat infections involving medical 
devices. Costerton et al. (1987) considered that tests using planktonic cultures for 
biofilm . related problems yield useful information, such as their efficacy against 
planktonic cells that detach from the biofilm, or that negative results rules out their 
usefulness for treating biofllms. If the objective o f an antimicrobial treatment is to 
treat biofllms however, the agent must be tested against bacteria in biofilms.
1.6. The resistance of bacterial biofllms
Bacteria in all sorts o f biofllms share one common characteristic,- their ability to resist 
antimicrobial activity. When biofilms are formed on medical devices this 
characteristic extends to their ability to evade host defence mechanisms. Although 
current evidence does not exclude the possibility that conventional resistance 
mechanisms such as efflux pumps are expressed in biofllms, it is necessary to look 
beyond them to understand biofilm resistance (Stewart and Costerton, 2001). The 
protection conferred to bacteria in biofllms is due to a multi-cellular mode of growth. 
Several hypotheses have been proposed to try and explain the mechanisms responsible 
for the increased resistance shown by bacteria in biofllms (Donlan and Costerton,
2002).
A biofilm’s most distinguishing feature is its ability to produce an exopolysaccharide 
matrix. For years the main hypothesis regarding the resistance of biofllms centred on 
the ability o f the matrix to protect cells embedded in the biofllm by slowing down or 
preventing penetration of antimicrobials into the biofilm. Some research has shown 
that the biofllm can affect the diffusion of antimicrobial agents, for example Hoyle et 
al. (1992) showed that Ps. aeruginosa biofllms retarded the diffusion of piperacillin. 
Using a microelectrode, de Beer et al. (1994) demonstrated that only one fifth of the 
chlorine concentration in the bulk of the liquid penetrated the biofilms of Ps. 
aeruginosa and K. pneumoniae. The chlorine penetration profile of the biofllm also 
suggested that the chlorine was being consumed within the matrix. Other work 
however, has shown that the biofllm poses no barrier to the diffusion of other 
antimicrobial agents. Vancomycin and rifampicin are both able to diffuse through 
Staphylococcus epidermidis biofllms (Dunne et al., 1993). However, although
rifampicin can penetrate S. epidermidis biofilms, it fails to effectively kill the bacteria 
in the biofilm (Zheng and Stewart, 2002). These authors suggest that the slow growth 
of the bacteria in the biofilm may be responsible for this protection. Hydrogen 
peroxide can penetrate thin but not thick biofilms of Ps. aeruginosa (Cochran et al.,
2000). The increased resistance o f thin biofilms to hydrogen peroxide compared to 
planktonic cells must therefore be attributed to another resistance mechanism.
Inactivation of antimicrobial compounds could have a significant effect on their 
ability to kill bacteria in biofilms. Catalases have been shown to protect Ps. 
aeruginosa biofilms by preventing full penetration of hydrogen peroxide (Stewart et 
al., 2000). Anderl et al. (2000) tested the penetration of ciprofloxacin and ampicillin 
into K. pneumoniae biofilms. Ciprofloxacin was shown to penetrate the biofilms 
quickly, whilst ampicillin failed to do so. Ampicillin penetrated the biofllms created 
by a (3-lactamase deficient K. pneumoniae mutant, but failed to kill the bacteria within 
the biofilm. Bagge et al. (2004) monitored (3-lactamase expression in Ps. aeruginosa 
biofilms exposed to antibiotics, p-lactamase expression was induced in the whole 
biofllm when exposed to high concentrations of imipenem, but only at the peripheries 
o f the microcolonies at sub-MIC concentrations. Only the bacteria at the peripheries 
o f the microcolonies were induced to form p-lactamases when exposed to ceftazidime, 
even at high concentrations. These experiments confirm that P-lactamase production 
in biofllms can increase in response to antibiotic exposure and show the heterogeneity 
o f P-lactamase induction in growing biofllms.
These conflicting results indicate that the ability and extent to which antimicrobial 
agents penetrate a biofllm depends on the type of antimicrobial agent and the target
organism in the biofilm. It appears that slowing down or inhibiting antimicrobial 
penetration alone cannot explain the inherent resistance of bacteria in biofilms to 
antimicrobials.
Bacteria growing as biofllms are expected to experience an altered chemical 
environment depending on their position within the biofllm. Studies monitoring the 
oxygen content of biofllms have revealed that the outer layer o f the biofllm can 
completely consume the available oxygen, leading to an anaerobic environment within 
the deep layers o f the biofllm (de Beer et al., 1994). Some form of micro-scale 
nutrient gradient is also expected within the biofllm, and the concentrations of 
substrates present are mirrored by that o f metabolic products (Stewart and Costerton,
2001). It has been suggested that physiological changes (slower growth rates or 
activation of a starved state) in response to altered chemical environment, nutrient 
limitation or accumulation of inhibitory waste products may be responsible for the 
increased resistance of bacterial biofllms. Most antibacterial agents are more active 
against rapidly growing cells. Penicillin and ampicillin will not kill non-growing cells, 
whilst other p-lactams, cephalosporins, aminoglycosides and fluoroquinolones can kill 
non-growing cells, but not as effectively as rapidly growing ones (Lewis, 2001). 
Noting that planktonic stationary phase K. pneumoniae cultures were not killed by 
ampicillin or ciprofloxacin, especially in experiments with medium lacking carbon 
and nitrogen sources, Anderl et al. (2004) suggested that tolerance of biofilm bacteria 
may be explained by at least some cells in the biofilm being in stationary phase due to 
nutrient limitation. Their suggestion was supported by their experiments showing that 
glucose could not penetrate the entire biofilm and that oxygen only penetrated the 
upper biofilm level. This study showed that whilst the specific growth rate for
planktonic bacteria was 0.59 h '1, it was only 0.032 h '1 for biofilm bacteria. These 
results suggested that local nutrient limitation within the biofllm that causes bacteria 
to enter stationary phase results in bacteria less susceptible to antibiotics.
Several studies have examined the effect o f growth rates on the sensitivity of biofllm 
cells to antibacterial agents. Eng et al. (1991) controlled bacterial growth rates by 
limiting nutrient availability and showed that only the fluoroquinolones (ciprofloxacin 
and ofloxacin) were bactericidal against stationary phase Gram-negative organisms. 
The other antibiotics tested included gentamicin, nafcillin, cefotaxime, piperacillin, 
imipenem, meropenem and rifampicin. However, an increase in nutrients, and 
subsequent rise in growth rates resulted in the increased activity of multiple classes of 
antimicrobial agents. The susceptibility o f Ps. aeruginosa and E. coli in chemostat 
grown cultures (planktonic cells) to ciprofloxacin has been shown to be directly 
related to the growth rates, with increased growth rates leading to increased bacterial 
sensitivities (Evans et al., 1991). Increasing the growth rates in biofilms of non­
mucoid strains of Ps. aeruginosa increased their susceptibility to ciprofloxacin, but 
had a minimal effect on the suceptibilities o f mucoid strains of Ps. aeruginosa. 
Further studies revealed the increased susceptibility of S. epidermidis biofilms and 
planktonic cultures to ciprofloxacin and tobramycin at higher growth rates (Duguid et 
al.y 1992a; Duguid et al., 1992b).
Desai et al. (1998) compared the resistance of planktonic and biofilm cultures of 
Bulkholderia cepacia to ciprofloxacin and cefazidime at different stages during 
exponential growth. Bacteria growing as biofilms were about 15-times more resistant 
to the antibiotics than the equivalent planktonic bacterial cultures, and resistance to
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the antibiotics increased progressively during exponential growth phase. The dramatic 
change in resistance before a measurable reduction in growth indicates that the 
changes in resistance are attributed to factors other than changes in growth rates. 
These authors suggested that the increased resistance might be attributed to a 
mechanism that detects a change in environmental conditions, and then initiates the 
increased resistance.
A more recent hypothesis regarding the increased resistance of biofllms involves the 
concept that a sub-population of biofllm cells differentiate into a spore-like state, 
which are highly protected. This is an attractive concept as it could explain why 
biofllms are resistant to such a wide range o f antimicrobials (Stewart, 2001). This 
hypothesis unlike the previous ones is not activated by diffusion limitation 
(antimicrobials or nutrients) and is supported by experiments performed by Cochran et 
al. (2000). These authors remarked that since thin biofllms of Ps. aeruginosa were 
still resistant to hydrogen peroxide and minocycline, that the resistance could not be 
attributed to transport problems through the biofllms, and they suggested that the 
resistance o f these biofllms was due to an inherent phenotypic change that occurs on 
cell attachment to a surface. Further work by Brooun et al. (2000), showed a “plateau” 
on a biofilm killing plot o f quinolones against Ps. aeruginosa biofllms. They 
suggested that although most cells were killed by the quinolones, a resistant sub­
population persisted despite continued exposure to the antibiotic. Since this 
mechanism is genetically encoded, it could reveal new targets for novel anti-biofilm 
approaches (Cochran et al., 2000).
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Reviewing the different mechanisms of biofllm resistance, Mah and O’Toole (2001) 
concluded that no one answer will do in response to the question of why cells growing 
in a biofllm mode o f growth have an increase resistance to antibacterial agents. It is 
most likely that several mechanisms are responsible, and that they are dependent on 
the species o f bacteria in the biofllm and the type of antimicrobial agent.
1.7. Catheter blockage and crystalline bacterial biofllm formation
One o f the most serious complications involving the long-term use of IUCs is the 
formation of encrustation on the catheter balloon and luminal surfaces. Kohler- 
Ockmore and Feneley (1996) carried out a two-year prospective study investigating 
the complications associated with the long-term use of IUCs. For the 457 patients that 
were being monitored, 506 emergency referrals were recorded in the first six months 
of the study period. O f these complications, 149 were referred for emergency hospital 
treatment and 60% of these complications were due to catheter blockage. A more 
detailed 12-week study o f 54 patients in the second year revealed that 48% 
experienced catheter blockage. Getliffe (1990) and Getliffe (1994) reported that 54% 
and 43% of long-term catheterised patients in the community suffered from recurrent 
encrustation and blockage. A retrospective study of 69 long-term catheterised nursing 
home patients revealed that only 18% of catheters were replaced according to the 
once-a-month protocol, and in 54% of cases the catheters needed to be changed before 
this time because of catheter obstruction (Cools and Van der Meer, 1986). Most of the 
obstructed catheters had to be replaced in the second or third week of catheterisation. 
Mobley and Warren (1987) over a one-year period studied 32 catheterised women 
who had silicone-coated latex catheters in place for 100 days or more, 23 patients 
experienced at least one catheter obstruction (a total of 67 blockages).
Kunin et al. (1987a) used the terms “blocker” and “non-blocker” to broadly 
distinguish these two groups of patients. The “blockers” were patients that formed 
sufficient catheter encrustation to alter the flow of urine through the catheter within 
the first two weeks of insertion, whilst the urine flow through the catheter of “non- 
blockers” was not affected by encrustation. Kunin et al. (1987b) found this clinical 
distinction useful in deciding what catheter material to use in both patient groups. The 
“non-blockers”, who constituted half the patient population, did well regardless of the 
catheter material, whilst there was significantly less encrustation with silicone 
catheters than silicone- and teflon-coated latex catheters for the “blockers” after a 14- 
day trial period. To gain further insight into this phenomenon, Kunin (1989) studied 
patients that were grouped as “blockers”, “intermediates” and “non-blockers”. There 
were no significant differences among the groups for age, activities of daily living, 
mental status, use of antibiotics, clinical manifestations of urinary infection or 
incidence o f fever. “Blockers” excreted urine that was significantly more alkaline, and 
that contained less magnesium, urea and phosphate. Pr. mirabilis and Pv. stuartii 
colonized the urine of “blockers” significantly more often than “non-blockers”. 
Patients tended to remain as “blockers” or “non-blockers” consistently over time. 
Mobley and Warren (1987) also found that Pr. mirabilis, but not the other urease- 
positive species was significantly associated with catheter obstruction. Similarly, 
bacteriological testing of catheters removed from patients undergoing long-term 
bladder management by Stickler et al. (1993) revealed that the most extensive 
encrustation was present on catheters colonized by pure cultures of Pr. mirabilis, 
whilst significant crystalline material was absent in non -Proteus biofilms.
Introduction
Production o f  the urease enzyme is central to the development o f  catheter encrustation 
(Mobley et al., 1995). Infections o f  the urinary tract with urease producers, 
particularly Pr. mirabilis, hydrolyse the urea in the urine increasing urinary ammonia, 
bicarbonate, carbonate and alkalinity (Griffith et al., 1978).
UREASE
CO(NH2)2------------ ► 2NH3 + C 02
h 2o
Further hydrolysis yields:
2NH3 + 2H20  « ► 2N H /+20H
C 0 2 +H20   ----► H2C 03 j ► H+ + HC03  ----► 2H+ + C 03
The resulting alkalinity produces an environment in which magnesium and calcium 
phosphates are insoluble. Crystals o f  struvite (magnesium ammonium phosphate) and 
hydroxy apatite (a form o f  calcium phosphate) appear in the urine. Using jack bean 
urease, Hedelin et al. (1985) were able to show that crystallisation o f calcium 
phosphates precedes the crystallisation o f  struvite. Studying encrustation on catheters 
taken from patients at a chronic care facility, Bruce et al. (1974) cultured Proteus 
from seven o f  the 14 patients, and in six o f  these seven patients high levels o f calcium, 
phosphorus and magnesium were found in the catheter encrustation.
A SEM study o f  32 encrusted urinary catheters showed that the encrustation consisted 
o f  blocky struvite crystals surrounded by very small amorphous crystallites o f  
hydroxyapatite (Cox et al., 1989a). The study showed that layers o f  tightly packed 
bacteria were visible underneath the minerals, and that crystals were often engulfed in
a bacterial layer. This process not only binds the crystals of both minerals together, it 
helps bind the continually forming crystalline deposits to the catheter surface. Cox et 
al. (1989a) therefore proposed that the sequence of events leading to the encrustation 
o f catheters comprises o f five steps: (1) colonization of the catheter surface by a 
urease producer, (2) bacterial production of the urease enzyme, (3) hydrolysis of urea 
by the urease enzyme to form ammonia, (4) the urine becomes alkaline and (5) 
struvite and hydroxyapatite crystals are deposited. A better understanding of biofilm 
formation by urease producing bacteria and the use of chemical analysis and electron 
microscopy has confirmed that catheter encrustations are mineralised bacterial 
biofilms.
Flow cell studies with Pr. mirabilis have shown that cells attach to the glass slides 
either singly or as small clumps, where they grow slowly and multiply (McLean et al.y 
1991). Deposition o f organic matter onto the glass slides was shown to immediately 
precede struvite crystallisation. The struvite crystals were shown to form within the 
Pr. mirabilis biofilm, and the bioiflm afforded a significant degree of protection to 
these crystals against dissolution under conditions o f increased flow rates. Studies by 
Ohkawa et al. (1990) noted that microorganisms and crystals were attached onto the 
catheter surface of IUCs of patients that had been catheterised for a week or more, the 
study also highlighted an intimate association between the bacteria and struvite 
crystals. In-vitro experiments have also shown the importance of the EPS to stabilise 
crystal growth (Clapham et al., 1990). These experiments showed that crystals formed 
in the EPS have growth habits that reflect a higher supersaturation than those formed 
in the surrounding urine, i.e. that the bacterial presence in the biofllm provides an 
environment which facilitates struvite crystal growth.
Winters et al. (1995) using physical models o f the catheterised bladder showed that 
heavy infection with Pr. mirabilis could encrust and block urinary catheters within 48 
h. This work also showed that bacteria and crystals that form in the urine can adhere 
to the catheter, and that continued colonization and bacterial growth on the catheter 
and crystal surfaces produced an alkaline mineralised biofilm. SEM of freeze- 
fractured cross sections of the catheters showed that the encrustation completely 
occluded the lumen. X-ray microanalysis revealed that the material in and around the 
cell-like structures was calcium, phosphates and oxygen together with a small amount 
of magnesium. Further experiments using the models showed that urease positive M  
morganii, K. pneumoniae and Pv. stuartii failed to raise the urinary pH and form 
crystalline bacterial biofllms (Stickler et al., 1998b). In contrast Pr. mirabilis, Pr. 
vulgaris and Pv. rettgeri increased the urinary pH from 6.1 to 8.3 - 8.6, and extensive 
catheter encrustation was observed within 24 h. It was concluded that while many 
bacterial species can form biofllms on catheters, only organisms that generate alkaline 
urinary conditions could produce crystalline biofllms capable of causing catheter 
blockage. The urease enzyme produced by M. morganii and K. pneumoniae hydrolyse 
urea around ten times slower than the enzyme produced by Pr. mirabilis (Jones and 
Mobley, 1987). In addition, the urease enzyme of K. pneumoniae is induced by 
nitrogen starvation, whilst the urease enzyme of Pr. mirabilis is induced by urea to 
levels o f up to 25-fold over those of non-induced cultures (Mobley et al., 1995).
Studies, o f urinary samples from catheterised patients in a long-term rehabilitation 
hospital revealed that all samples yielded bacterial growth, and that Pr. mirabilis was 
the most commonly isolated organism (in 51% of all samples) (Hedelin et al., 1984). 
Analysis of the encrustation from the patients’ catheters showed that in addition to the
calcium and magnesium phosphates, smaller amounts of oxalate, urate and protein 
were present. Studies following 11 patients with long-term IUCs for a prolonged 
period of time revealed that urinary pH was related to the persistent presence of Pr. 
mirabilis, and that precipitation of phosphates on catheters was linked to the urinary 
pH (Hedelin et al., 1991). The critical pH in this study was around 6.8, patients with a 
mean urinary pH below this had minute amounts o f catheter encrustation, whilst 
above this pH, considerable catheter encrustation was observed but with marked 
individual variation. Proteus species once present in the catheterised urinary tract 
tends to persist to initiate a vicious circle o f crystalline biofilm formation and local 
irritation (Hedelin, 2002).
Morris et al. (1997) tested 18 different types of catheters, including those coated with 
hydrogel or silver. Using a laboratory model o f the catheterised urinary tract it was 
shown that none of the catheters were capable of resisting encrustation by Pr. 
mirabilis biofllms. Electron micrographs established that the catheter blockage was 
due to crystalline bacterial biofllm formation, and that the blockage generally occurred 
in the first few centimetres below the eye-hole. This was confirmed by calcium and 
magnesium analysis that revealed the encrustation was mainly on the 10 cm of 
catheter below the eye-hole.
1.8. Proteus mirabilis
Pr. mirabilis is a motile Gram-negative bacterium commonly found in the intestines 
o f humans and animals, in soil and in polluted water (Coker et al., 2000). It is not a 
common cause of UTI in normal healthy hosts, however, in patients who have urinary 
tracts compromised by functional or anatomical abnormalities or chronic
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instrumentation it becomes an important cause of morbidity (Mobley et al., 1995). 
Clinical studies have revealed the high incidence of complications associated with 
infections by this bacterium in long-term catheterised patients (Mobley and Warren, 
1987; Kunin, 1989; Stickler et al., 1993). Developing a catheter care regime which 
eliminated Pr. mirabilis would significantly reduce the complications associated with 
long-term catheter use.
Pr. mirabilis exists as short ( 2 - 4  pm) motile rods in liquid medium. However, it 
undergoes dramatic changes in response to growth on a solid surface, exhibiting a 
form o f multicellular behaviour termed swarming. A short period after Proteus cells 
are inoculated onto suitable agar plates, the short vegetative rods at the colony’s edge 
differentiate into long (20 -  80 pm) swarmer cells. The swarmer cells rapidly move 
away from the colony margin in a co-ordinate manner until they stop and revert back 
into the shorter vegetative cells by cell division, in a process termed consolidation. 
These vegetative cells grow normally for a certain period of time before the cells at 
the edge of the colony swarm again (Allison et al., 1992). It is these periodic cycles of 
swarming and consolidation that produce concentric ring patterns on certain agar 
media.
Clinical studies have suggested that bacteria contaminating the urethral meatus can 
migrate along the external surface of the catheter into the bladder (Garibaldi et al., 
1980; Stamm, 1991). In-vitro testing has revealed that clinical strains of Pr. mirabilis 
can migrate over urethral catheters at a rate o f up to 10 cm per day (Stickler and 
Hughes, 1999). Migration was significantly more rapid over hydrogel-coated latex 
catheters than over all-silicone or silicone-coated latex catheters. Similar experiments
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by Sabbuba et al. (2002) later revealed that Pr. vulgaris could also successfully swarm 
over all four types o f catheters tested. Testing the mobility of Pr. mirabilis in the 
presence of other species revealed that it was capable of transporting non-motile 
species such as K. pneumoniae and S. aureus over the catheter surface.
Stickler and Hughes (1999) using scanning electron microscopy revealed that Pr. 
mirabilis moves along the catheter surface as discrete rafts of typically elongated 
swarmer cells. By developing a new vapour fixation technique for preparing samples 
to observe under SEM, Jones et al. (2004) were able to show that adjacent swarmer 
cells formed helical connections by interweaving flagellar filaments. It was suggested 
that this highly ordered structural formation might contribute to the stability of the 
multicellular rafts, facilitate communication between swarmer cells, and may play an 
important role in organising the migration of the rafts. The importance of these 
connections were emphasised by the failure of mutants lacking the helical connections 
to swarm successfully.
As well as the production of urease and the ability to swarm, other Pr. mirabilis 
virulence factors include adherence to host mucosal surfaces, damage and invasion of 
host tissues, evasion of the host immune system and iron acquisition (Coker et al., 
2000). Allison et al. (1992) reported that Pr. mirabilis co-ordinately synthesised 
proteins required for swarming (flagellin) and virulence (haemolysin, urease and 
proteases) during cycles o f cellular differentiation and migration. The virulence 
factors are linked to the predilection of Pr. mirabilis for infections of the upper 
urinary tract.
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1.9. The control of catheter encrustation
A range of methods have been devised to try and control the problem of catheter 
blockage. Simply replacing a blocked catheter commonly results in rapid encrustation 
o f the new catheter, gaining the patients a reputation as a “blocker” (Kunin, 1987c). 
However, nursing staff responsible for catheter management are often uncertain about 
the best way to manage encrusted catheters due to a lack of data about which method 
if any is best, and clinical experience with the poor performance of current treatments 
(Capewell and Morris, 1993).
1.9.1. Fluid intake and diet
The rationale of increasing a catheterised patients fluid intake is to reduce the 
concentration of urinary components such as calcium, magnesium and phosphates. A 
prospective study of 47 community patients with long-term catheters revealed that 
“blockers” were characterised by high urinary pH and ammonium concentration, 
although the study did not detect any significant differences in fluid intake or urinary 
osmolarity between patients categorised as “blockers” and “non-blockers” (Getliffe, 
1994). Getliffe (2003) noted this was probably due to the fact that even very dilute 
urine still contains sufficient quantities of urinary components to produce a crystalline 
biofllm under alkaline conditions. Morris and Stickler (2001) carried out experiments 
in models of the catheterised urinary tract infected with Pr. mirabilis. By manipulating 
the concentration of artificial urine that was being supplied to the models, they 
showed that under conditions simulating increased fluid intake the deposition of 
crystalline biofilm on the catheters was significantly reduced.
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Burr and Nuseibeh (1993) concluded from a study of 44 spine-injured catheterised 
patients that the main factors contributing to catheter blockage are bacterial urease 
activity and urinary calcium concentrations. They also noted that elevation of urinary 
pH following ingestion of effervescent preparations (such as those containing sodium 
carbonate), drug or diet induced increases in urinary calcium or magnesium excretion 
and inadequate fluid intake were contributing factors. Findings by Getliffe (1994) also 
showed that patients termed “blockers” consumed more dietary-flbre than “non- 
blockers”.
Although there is evidence from surveys and laboratory experiments that increasing 
fluid intake will result in more urinary calcium and magnesium remaining in solution, 
it is extremely difficult to persuade many catheterised patients (especially the elderly) 
to drink more. Perhaps it would be more persuasive if evidence was available from a 
controlled clinical trial which showed that increasing fluid intake reduced catheter 
encrustation.
1.9.2. Dietary acidification of the patient’s urine
Attempts have been made to acidify patient’s urine through the ingestion of acidifying 
agents such as ascorbic acid. McDonald and Murphy (1959) demonstrated that 
ascorbic acid could significantly lower the urinary pH in patients receiving a daily 
total of 2.5g ascorbic acid administered in doses every 4 h. Further studies by Travis 
et al. (1965) showed that orally administered ascorbic acid even in higher doses than 
in the previous experiment failed to consistently lower the urinary pH below 5.5 when 
given four times daily. From this they concluded that if ascorbic acid was to be used,
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large amounts should be given to patients, and that it should be administered at 4 h 
intervals day and night.
Murphy et al. (1965) analysed the results from urine cultures made at their hospital 
over a three-year period. The authors noted that giving ascorbic acid orally every 4 h 
in patients with Proteus infected urine failed to have a significant acidifying effect. 
They noted that this contrast to results in uninfected urine must be attributed to the 
alkalinising effect of ureases produced by infecting organisms.
In-vitro experiments were performed to determine whether acidifying the urine could 
prevent a rise in pH when the urease enzyme was present in the urine (Bibby and 
Hukins, 1993). It was found that under these conditions, the assumptions of Le 
Chatelier’s principle fitted, whereby a decrease in the pH resulting from acidification 
was countered by further urea being converted into ammonia. It was determined that 
to prevent the rise in pH resulting from complete conversion of urea in a day supply of 
urine would require 2.7 L of mono-basic acid at a reasonable concentration. Bibby and 
Hukins (1993) concluded that prevention of catheter encrustation by acidifying the 
patient's urine was not feasible without the elimination of the urease-producing 
bacteria.
The rationale behind encouraging patients to drink cranberry juice is based on its 
possible, bacterial anti-adherence effects. In-vitro studies (Sobota, 1984) showed that 
urine obtained from healthy mice and humans, who had been drinking cranberry juice, 
inhibited the adherence of E. coli onto uroepithelial cells. In a later paper (Schmidt 
and Sobota, 1988) this anti adherence activity was also demonstrated against clinical
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isolates o f Proteus, Klebsiella, Enterobacter and Pseudomonas. Morris and Stickler 
(2001) used their laboratory model of the catheterised bladder to examine whether 
drinking cranberry juice produces urine that inhibits the development of crystalline Pr. 
mirabilis biofllm on catheters. They reported that there was significantly less 
encrustation (P = 0.007) on catheters from models receiving urine from volunteers 
who had drunk 2 x 500 ml o f water, than on catheters incubated with models supplied 
with urine pooled from individuals who had drunk 2 x 500 ml of cranberry juice. The 
amount of encrustation on the two groups of catheters however, were substantially 
less (P = 0.001) than on catheters incubated in models supplied with urine from 
volunteers who had not supplemented their normal fluid intake. They concluded that 
the important factor in preventing catheter encrustation is a high fluid intake. To date, 
there is no clinical evidence supporting the use of cranberry juice as a preventative 
measure for controlling catheter encrustation.
1.9.3. Bladder washouts
Bladder washout solutions are frequently used in attempt to prevent catheter 
encrustation. Neutral solutions such as chlorhexidine or saline are not effective at 
preventing catheter encrustation (Getliffe, 2003). Getliffe et al. (2000) using in-vitro 
models o f the catheterised bladder showed that Suby G was effective at dissolving 
catheter encrustation. It must be noted however, that Jack bean urease and not urease 
producing bacteria were used in this study. A randomised cross over study was 
conducted to study three bladder-washout solutions -saline, Suby G and Solution R 
(Kennedy et al., 1992). The study revealed that neither of the washout solutions 
administered twice weekly for three weeks had a demonstrable effect in preventing 
crystal formation or catheter ensrustation, nor was there a significant difference in
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catheter encrustation between acidic washout solutions and the neutral saline washout 
solution. Treatment with the acidic washout solutions resulted in a high frequency of 
red cells in the urine, suggesting that these solutions adversely affect the bladder 
endothelium.
1.9.4. Catheter coatings
In-vitro experiments comparing encrustation on latex catheters coated with modified 
hydrogel to all-silicone and silicone elastomer-coated catheters revealed that there was 
no significant difference in the quantities o f encrusting deposits formed on the three 
materials (Cox et al., 1989b). In-vitro tests with 18 different catheters including those 
coated with hydrogel or silver revealed that they were all susceptible to catheter 
blockage by encrustation (Morris et al., 1997). Currently there is no experimental or 
clinical evidence to suggest that any of the catheters on the market can successfully 
resist colonization by crystalline Pr. mirabilis biofllms.
1.9.5. Urease inhibitors
Bibby and Hukins (1993) noted how difficult preventing the rise in urinary pH was in 
the presence of the urease enzyme. Several studies have focused on inhibiting this 
enzyme as a way of controlling catheter encrustation. The urease inhibitor 
acetohydroxamic acid (AHA) when administered orally, is absorbed into the 
gastrointestinal tract and excreted in the urine. When AHA was administered to 23 
patients, with renal calculi and urinary infection by urease producing organisms, it 
successfully reduced urinary ammonia and alkalinity in each patient (Griffith et al., 
1978). Williams et al. (1984) studied the effects of AHA on the growth of struvite 
stones in the urinary tract. Their findings revealed that AHA effectively inhibits stone
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growth in patients infected with urea-splitting bacteria. Bums and Gauthier (1984) 
administered AHA to five patients that required frequent catheter changes because of 
severe encrustation and catheter blockage. It was shown that AHA significantly 
decreased the amount o f encrustation on the catheters, and that all patients required 
less-frequent catheter changes during therapy. The reported complications associated 
with the administration of AHA vary from study to study; Bums and Gauthier (1984) 
reported only minimal adverse effects, Griffith et al. (1978) state that a dose of 1 g of 
AHA daily was well tolerated whilst Williams et al. (1984) reported that patients 
receiving AHA had increased adverse effects such as tremulousness and deep vein 
phlebothrombosis. Investigating the ability o f urease inhibitors to control catheter 
encrustation by Pr. mirabilis in a physical model of the catheterised urinary tract, 
Morris and Stickler (1998) observed that AHA (1 mg/ml) and flurofamide (1 pg/ml) 
restricted the increase in urinary pH from 9.1 to 7.6. These urease inhibitors also 
significantly reduced the deposition of calcium and magnesium salts onto the catheter. 
As flurofamide is a more potent inhibitor of the Pr. mirabilis urease enzyme, much 
lower doses are required to prevent catheter encrustation. If the safety of flurofamide 
could be confirmed it may have clinical applications in controlling catheter 
encrustation. Efforts to find more potent urease inhibitors have focused on 
synthesising a range of different dipeptidyl hyroxamic acids, and testing their activity 
against Pr. mirabilis ureases (Odake et al., 1992). The use o f non-antibacterial agents 
such as urease inhibitors to control catheter encrustation is an attractive prospect as it 
rules out the possibility of generating problematic resistant mutations.
1.9.6. What else can be done ?
In their study of community patients with long-term IUCs, Getliffe (1994) noticed a 
prevailing tendency towards only replacing a catheter when it blocks, resulting in 
“crisis care” of patients classed as “blockers”. Evans and Godfrey (2000) suggest that 
every effort should be made to try avoiding this type of “crisis management”, and that 
nurses should attempt to predict when individual patients’ catheters are going to 
block. Keeping a record o f an individual’s blockage pattern over three to five catheter 
episodes identifies a characteristic pattern o f catheter life (Norberg et al., 1983). This 
information could help develop individual planned re-catheterisation programmes, 
changing the catheters before they were likely to block. This type of monitoring 
programme would reduce the distress catheter blockage causes to patients and ease the 
pressure on the health services with the need for fewer urgent unscheduled catheter 
changes. Evans and Godfrey (2000) also suggest that testing the patients’ urinary pH 
may assist in predicting the catheter life for individual patients.
1.10. A novel method for controlling catheter encrustation
Bibby et al. (1995) were the first to suggest that the catheter retention balloon could 
be filled with an antimicrobial solution instead of water as a novel way of controlling 
catheter encrustation. They suggested that the delivery of the antimicrobial agent 
could be achieved by diffusion through the balloon. Using a simple in-vitro model 
with an all-silicone Foley catheter inflated with a mandelic acid solution, they showed 
that low concentrations of this agent could pass through the catheter balloon into the 
surrounding liquid for up to four weeks. The concentration of the antimicrobial agent 
in the catheter balloon could be monitored. If it fell below a level at which it was 
effective, it could easily be replaced or replenished without disrupting the closed
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drainage system. Another benefit of this approach was that it did not require any 
modifications to catheters currently used. Oral antibiotic intake destabilises the gut 
flora and can result in overgrowth o f certain organisms or colonization by resistant 
organisms (Levy, 2000). Treatment of CA-UTI by delivering antibacterial agents 
directly into the bladder could avoid altering the gut flora by oral administration of 
drugs.
Mandelic acid has previously been used to perform bladder washouts, but 
unfortunately it is not very active against Pr. mirabilis. A search of the literature 
revealed that Pr. mirabilis was very sensitive to the biocide triclosan. Studies 
investigating the concentration of triclosan required to inhibit growth and swarming of 
42 animal isolates of Pr. mirabilis and Pr. vulgaris were performed by Firehammer 
(1987). These revealed that growth of all but one isolate was inhibited by less than 1 
pg/ml in broth and on agar, and that swarming was inhibited at concentrations two- to 
four-fold less than the MIC. Reported MICs o f triclosan against national collection of 
type cultures (NCTC) of Pr. mirabilis are 0.3 pg/ml (Bhargava and Leonard, 1996). 
Catheter isolates of Pr. mirabilis have also been shown to be very sensitive (MIC, 0.5 
pg/ml) to triclosan (Stickler, 2002).
The phenylether or chlorinated bisphenol, triclosan (2,4,4 '-trichloro-2 '- 
hydroxydiphenyl ether), is a synthetic antimicrobial agent. It has a broad spectrum of 
activity encompassing many, but not all types of Gram-positive and Gram-negative 
non-sporulating bacteria, and some fungi and viruses (Bhargava and Leonard, 1996; 
Jones et al., 2000; Schwiezer, 2001). Triclosan is added to toothpastes and 
mouthwashes to prevent or reduce plaque (Fine et al., 1998), and is used in personal
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care products such as deodorants, soaps and handwashes. It has been incorporated into 
fabrics and plastics such as surgical drapes, children’s toys and cutting boards, and 
searches o f patent databases reveal further unique applications for triclosan- 
impregnated material, ranging from antimicrobial concrete to triclosan impregnated 
bowling ball inserts (Schweizer, 2001). Triclosan’s safety has been established 
through extensive acute and long-term toxicity, carcinogenicity, reproduction and 
teratology studies (Bahrgava and Leonard, 1996).
Figure 2: Chemical structure of triclosan.
In-vitro studies evaluating triclosan-impregnated sutures revealed that they were 
effective at preventing microbial adherence of selected nosocomial pathogens, which 
may reduce the risk of superficial incisional site infections in at-risk surgical 
populations (Edmiston et al., 2004). Continuous ambulatory peritoneal dialysis 
catheters impregnated with triclosan, chlorhexidine and silver sulfadiazine tested in 
rats were shown to be highly effective at lowering bacterial colonization at the 
catheter exit point compared to control catheters (Kim et al., 2002). Using in-vitro 
experiments, Gaonkar et al., (2003) established that urinary catheter-tubing 
impregnated with triclosan, chlorhexidine and silver sulfadiazine exhibited a broad- 
spectrum of antimicrobial resistance.
Cl
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1.11. Aims of study
In view of its overriding importance in the process of encrustation and blockage of 
urinary catheters, it was decided to develop a strategy for the control of the problem 
which specifically targeted Pr. mirabilis. The strategy was based on the biocide 
triclosan, which has particular activity against Pr. mirabilis. It also involved a novel 
approach to introducing the active agent into the catheterised bladder which did not 
involve disturbing the integrity of the closed drainage system.
AIMS:
• To establish whether Pr. mirabilis strains isolated from the catheterised urinary 
tract are fully sensitive to triclosan.
•  To determine the minimal bactericidal concentrations for triclosan of clinical Pr. 
mirabilis isolates growing in urine.
• To investigate what concentrations of triclosan can be delivered through the 
retention balloon of catheters.
• To determine if filling the catheter retention balloon with triclosan will delay or 
prevent catheter blockage by crystalline Pr. mirabilis biofilms.
• To ascertain what concentrations of triclosan are required in the urine to eliminate 
established Pr. mirabilis biofilms from catheters.
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To investigate whether resistant cells emerge when populations of Pr. mirabilis 
are exposed to triclosan, and if so, whether the triclosan resistant cells exhibit 
cross-resistance to antibiotics.
To examine how the triclosan strategy influences the development of catheter 
biofilm communities by a variety o f species that cause CA-UTI.
2. MATERIALS AND METHODS
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2.1. Chemicals
Most chemicals used in this study, unless otherwise stated, were purchased from 
Fisher Scientific Ltd. (Loughborough, UK). The triclosan and triclosan formulations 
were obtained from CIBA speciality chemicals (Basel, Switzerland).
2.2. Culture media
The agar media used in this study were purchased from Oxoid (Basingstoke, UK). 
Cysteine-Lactose Electrolyte Deficient (CLED) Agar was used to culture a range of 
urinary pathogens. CLED Agar inhibits the swarming of most Pr. mirabilis strains 
(Figure 3a). Colistin Inositol (Cl) Agar (Clayton, 1984) was used for the enumeration 
of strains of Pr. mirabilis that swarmed on CLED Agar. Cl Agar is made up using 28 
g/L Nutrient Agar, 10 g/L myo-inositol (Sigma chemical company, Poole, UK), 0.02 
g/L bromothymol blue (Sigma) and 0.01 g/L colistin methanesulfonate (Sigma). 
Nutrient Agar was used for viable cell counting of Klebsiella pneumoniae cultures. 
Tryptone Soya Agar (TSA) was used to demonstrate the swarming of Pr. mirabilis 
(Figure 3b) and in the method for determining the minimum inhibitory concentrations 
(MIC) of triclosan to test organisms. Iso-sensitest Agar was used for the antibiotic 
sensitivity testing. Urea Agar, a nutrient agar containing 2% (v/w) urea was used to 
check for the production of the urease enzyme. When inoculated with urease- 
producing organisms the medium changes from straw-colour to bright pink (Figure 
3c). Non-urease producing organisms produce no colour change (Figure 3d).
Tryptone Soya Broth (TSB) was used to grow cultures for experimental purposes and 
to supplement the artificial urine.
Figure 3a: Pr. mirabilis culture on a CLED Agar plate.
Figure 3b: A Pr. mirabilis 4 h culture spot inoculated onto a TSA plate.
I
Figure 3c: Pr. mirabilis streaked onto a urea Agar plate
Figure 3d: E. coli streaked onto a urea Agar plate.
Figure 3. The appearance o f urinary tract pathogens on different agar.
23 . Preparation of artificial and human urine
The artificial urine used in this study was made up as described by Griffith et al. 
(1976). It was made up using the chemical quantities given in Table 1. Before the 
gelatine was added, the pH was adjusted to 6.10 with sodium hydroxide (3 M). Once 
the gelatine had dissolved, the artificial urine was filter sterilized using a 0.2 pm 
Sartorius (Goettingen, Germany) capsule filter. The TSB was prepared separately and 
aseptically added to the sterile artificial urine. The pH was measured with an Accumet 
basic AB15 pH meter.
To prepare sterile human urine, urine was collected from healthy human volunteers 
and pooled. It was filtered through cotton wool to remove general debris and then 
sterilized by filtration through a 0.8 pm capsule filter (Sartorius), and then through a 
0.2 pm capsule filter (Sartorius).
2.4. Bacteria
The bacteria used in this study were clinical isolates from the indwelling catheters of 
patients undergoing long-term catheterisation. They were kindly supplied by Dr. N. 
Morris, Dr. N. Sabbuba, Dr. S. Jones, Dr M. Suller and Miss S. Macleod of Cardiff 
School of Biosciences. In each case, identities o f isolates were confirmed by Gram- 
staining and then using the appropriate BBL1M crystal identification kits (Becton 
Dickinson, Oxford, UK). The E. coli reference strain (NCTC 10418) was used as a 
control organism in the antibiotic sensitivity testing. Isolates were stored at -80°C in 
cryogenic vials containing 5% glycerol.
Chemical Chemicalformula
Grams per 
litre
Sodium sulphate Na2SC>4 2.3
Calcium chloride dihydrate CaCl2 .2H20 0.65
Magnesium chloride MgCl2 .6H20 0.651
Sodium chloride NaCl 4.6
Trisodium citrate Na3C6H5 07.2H20 0.65
Sodium oxalate (COONa) 2 0 . 0 2
Potassium dihydrogen orthophosphate k h 2p o 4 2 . 8
Potassium chloride KC1 1 . 6
Ammonium chloride NH4 CI 1
Urea 25
pH to 6.10 using sodium hydroxide (NaOH)
Gelatine 5
Filter sterilize
Tryptone soya broth (TSB) 1
Table 1: The chemical quantities required for preparing artificial urine.
2.4.1. Viable bacterial cell counts
The method described by Miles and Misra (1938) was used to determine the number 
of viable bacterial cells present in cultures and cell suspensions. Serial dilutions of the 
bacterial suspensions were made in quarter strength Ringer’s solution (Oxoid). 
Triplicate aliquots (10 pi) were dropped onto pre-dried CLED Agar plates that had 
been divided into different sections for each dilution. Each set of dilutions was 
prepared in triplicate and inoculated onto different plates.
2.4.2. Preparation of bacterial lawns for testing antibacterial activity of catheter 
sections
Young log phase cultures o f Pr. mirabilis B2 grown in TSB for 4 h at 37°C were used 
as the inocula. Aliquots (100 pi) were dropped onto plates of TSA. Bacterial lawns 
were prepared by spreading the culture using a glass rod and allowing them to dry in a 
laminar flow cabinet. Catheters were cut into sections of 1 cm, every other 1 cm 
section of the catheter was used and the other discarded. The test sections were cut 
further into 0.5 cm sections, one of these 0.5 cm section was left whole whilst the 
other was cut in half lengthwise, leaving the catheter inflation line in one half but not 
the other (Figure 4). Since it was not possible to cut the latex based catheters 
lengthwise, two whole 0.5 cm sections were used. The catheter sections were then 
placed onto the bacterial lawns and incubated overnight at 37°C. The following day 
the plates were checked for any zones of inhibition around the catheter sections.
2.5. Catheters
During the experimental work size 14 Ch all-silicone, silicone-coated latex or 
hydrogel-coated latex (Biocath) catheters were used. All catheters were purchased
These sections 
were placed onto a 
bacterial lawn on 
TSA.
The zone o f  inhibition was measured as the diameter o f  the zone around the catheter 
section that had been left intact, measuring across the lumen through the inflation line.
Figure 4: Testing the antibacterial activity of catheter sections.
from Bard Ltd. (Crawley, UK). In the bladder model experiments the catheters were 
connected to 2000 ml urine drainage bags (Bard).
2.6. Methods used for testing the sensitivity of bacteria to triclosan and 
antibiotics
2.6.1. The MIC of triclosan in agar
The MICs of triclosan against a range of bacterial species isolated from the 
catheterised urinary tract were determined in agar. Stock solutions of triclosan were 
prepared in dimethyl sulfoxide (DMSO), and were added to molten TSA to produce 
plates containing different triclosan concentrations. Plates containing TSA alone and 
TSA containing the maximum DMSO concentration were used as controls. All MICs 
were performed in triplicate.
In the case o f the clinical isolates of Pr. mirabilis, tests were performed using cultures 
of the test organisms in 100 ml TSB that had been incubated at 37°C for 4 h with 
gentle aeration. These cultures were diluted 1:100 with TSB and triplicate aliquots (10 
pi) were dropped onto agar plates containing different concentrations of triclosan and 
the control plates (three plates o f each). The plates were dried and incubated at 37°C 
for 18 h. Uninoculated control plates of each concentration were also incubated. The 
following day the plates were examined for any signs of growth and swarming. The 
MIC was determined as the lowest concentration of triclosan in the agar that 
prevented bacterial growth. The use of TSA also allowed the determination of the 
minimum inhibitory swarming concentration (MISC) of triclosan against Pr. 
mirabilis.
Alternatively aliquots (1 pi) o f overnight cultures of test organisms in TSB (10 ml) 
were applied to agar plates using the Denley multipoint inoculator (Denley 
instruments Ltd., Billinghurst, UK). This allowed several strains to be inoculated onto 
one agar plate, allowing a high throughput of strains and species. Each strain was 
inoculated onto three plates for each concentration of triclosan and control plates. The 
plates were incubated for 18 h and examined for growth the following day. This 
method was used to test the MIC of the triclosan resistant mutants of Pr. mirabilis and 
for the clinical isolates o f eight other species o f bacteria.
2.6.2. The MIC of triclosan in artificial urine
Triclosan stock solutions were prepared in DMSO at 1000 times the final 
concentrations required in the artificial urine. Aliquots (10 pi) o f these stock solutions 
were added to artificial urine (10 ml) in sterile glass universal containers and mixed. 
Inocula (10 pi) of the test organisms that had been grown overnight in TSB at 37°C 
were added to each concentration of triclosan, mixed and incubated with gentle 
shaking at 37°C in an orbital shaker for 6 h. Control cultures were set up where the Pr. 
mirabilis cultures were used to inoculate 10 ml artificial urine and 10 ml artificial 
urine containing 10 pi DMSO. For each batch of tests, uninoculated tubes containing 
10 ml artificial urine and 10 ml artificial urine and DMSO were also placed in the 
incubator as controls. Following the 6 h incubation period, the cultures were observed 
for turbidity as a sign of bacterial growth. The pHs of the cultures were also recorded. 
The MIC of triclosan was recorded as the lowest concentration of triclosan that 
inhibited growth.
2.6.3. Determination of the bactericidal activity of triclosan
Tests were performed in order to determine the bactericidal efficacy of triclosan. To 
standardise the bacterial inoculum in this procedure, calibration curves of optical 
density against viable cell counts were prepared. This was achieved by harvesting 
bacterial growth from an overnight culture grown on a CLED Agar plate and re- 
suspending the cells in 10 ml sterile de-ionized water. This suspension was diluted 
stepwise 1:1 with sterile de-ionized water down to 1:16. The optical density of each of 
these dilutions, including the neat sample was measured at 500 nm, and viable cell 
counts on CLED Agar were also performed on each suspension. This was done in 
triplicate for each strain examined in the bactericidal tests (Appendix 1). The resulting 
calibration curves were used to prepare standardised inocula of 1 x 109 cfu/ml for use 
in the bactericidal tests.
The method used for the bactericidal tests was based on the British Standard EN 1276. 
The standard suspensions (1 ml) of the test organisms were used to inoculate solutions 
(9 ml) in glass vessels containing various concentrations of triclosan in de-ionized 
water, and all resulting in a final DMSO concentration of 1%. The suspensions were 
mixed and incubated at ambient temperature. At various time intervals, samples (1 ml) 
were removed and added to the neutraliser (9ml). The neutraliser used for triclosan 
contained 1.5% (w/v) lecithin and 5% (v/v) Tween 80 (polysorbate 80) (Suller and 
Russell, 1999). Control suspensions where the standard inoculum (1 ml) was added to 
de-ionized water (9 ml) were run in parallel with each test. Samples were taken from 
the control suspensions at the same time intervals as from the test suspensions.
2.6.4. Neutralisation of triclosan
The efficacy of the neutraliser was confirmed using a method based on that described 
by Langsrud and Sundheim (1998). Incubation mixtures were prepared containing the 
neutraliser (8 ml), triclosan (100 pi o f a 10 mg/ml solution in DMSO) and sterile de­
ionized water (900 pi). Inocula of Pr. mirabilis B2 cells (1 ml of overnight TSB 
cultures grown at 37°C) were added to the triclosan and neutraliser mixtures. After 5 
min contact time at ambient temperature, samples were removed to enumerate the 
numbers o f viable cells. Two controls were run parallel to this experiment, a positive 
control where sterile de-ionized water (100 pi) was added to the mixture instead of the 
triclosan solution, and a negative control where sterile de-ionized water was added 
instead of the neutraliser.
To examine the possible toxicity of the neutraliser and of the 1% DMSO used in these 
tests and in the bactericidal testing procedure, tests based on the method by Messager 
et al. (2001) were performed. Overnight TSB cultures (1 ml) grown at 37°C were 
added to the neutraliser (9 ml) and to mixtures containing a final concentration of 1% 
DMSO. Following a 15 min contact time, viable counts were performed. Controls 
using 9 ml sterile de-ionized water instead of the neutraliser or the DMSO solution 
enabled the bacterial reduction to be calculated. These tests were carried out on all 
strains that came into contact with the neutraliser or with 1% DMSO.
2.6.5 ThoMICs of antibiotics to test strains
The MICs of ampicillin, ciprofloxacin, gentamicin, nalidixic acid, nitrofurantoin, 
trimethoprim, cefalexin and norfloxacin to a range of test organisms were determined 
using E-test strips (AB Biodisk, Sweden). The methods used were based on those used
by Brown and Brown (1991). Agar plates with a depth of 4 ± 0.5 mm were prepared 
by pouring 15 ml of molten Iso-sensitest Agar into petri dishes. The inoculum was 
prepared by suspending bacterial colonies from an overnight agar plate into sterile de­
ionized water. To achieve the correct turbidity, the suspension was visually compared 
to a 0.5 McFarland standard. A swab was dipped into the inoculum suspension and the 
excess was removed. This swab was then used to streak the entire surface of the Iso- 
sensitest Agar plates three times (rotating the plate 90 degrees each time to distribute 
the inoculum evenly). The plates were allowed to dry completely before applying the 
E-test strips with forceps. One strip was placed on each agar plate and the plates were 
incubated for 18 h at 37°C. The MIC value was determined by observing where the 
edge of the inhibition ellipse intersected the side of the strip. Any swarming by 
Proteus in the inhibition ellipse was ignored. The MIC of the reference strain E. coli 
NCTC 10418 to the test antibiotics was also determined using this method.
2.7. The bladder model
2.7.1. The bladder model set u p
The in vitro bladder model set-up was used to study the ability of a range of urinary 
tract pathogens to form biofilms on urinary catheters, and to observe what effect 
introducing triclosan into the catheterised urinary tract had on their development. 
The model o f the catheterised bladder was described by Stickler et al. (1999), and 
consists of a glass chamber (the bladder) that is maintained at 37°C by a water jacket. 
Water at 37°C was supplied to the outer jacket from a circulating water bath. The 
models were sterilised by autoclaving (121°C for 15 min), and a Foley catheter was 
inserted aseptically into each model through a section of tubing (the urethra) attached
to the glass outlet at the base of the model. To reduce the chance of contamination the 
catheters were inserted into the models in a laminar flow cabinet. The catheters are 
secured into position by inflating the catheter balloon with 10 ml of sterile water. The 
catheters were then connected to drainage bags that collect the urine draining through 
the catheters from the model (Figure 5).
Sterile artificial urine stored in sterile aspirators was supplied to the bladder models 
via sterile silicone tubing by a peristaltic pump (503U, Watson and Marlow, 
Falmouth, UK) to maintain a constant flow of urine into the bladder. A residual 
volume of 20 ml was pumped into the bladder models (just below the level of the 
catheter eyelet) and the pump supplying the urine was switched off. The models were 
then inoculated with a 4 h log-phase culture in artificial urine (10 ml), and the culture 
left for 1 h to establish itself in the system before resuming the supply of urine at a 
rate o f 0.5 ml per minute. The viable cell count and pH of the inoculating culture was 
determined. The viable cell count and pH was also taken from the residual urine in the 
bladder when the catheter blocked, or at the end of the experiment if the catheter did 
not block. Unless otherwise stated models were fitted with size 14 Ch catheters and 
experiments were replicated three times.
2.7.2 Electron microscopy
2.7.2.1. Low vacuum scanning electron microscopy
Low vacuum scanning electron microscopy (LV-SEM) was used to visualise the 
extent of encrustation on the catheter eye-hole and in its inner-lumen. Six 1 cm 
sections (Figure 6) were cut from catheters that had been carefully taken out of the 
bladder models. These samples needed no further preparation and were placed onto
Bladder models
37°C Water bath
Catheter
Balloon
Aspirators containing 
artificial urine
Catheter
Drainage bags
Figure 5: The bladder model set-up. The models consist o f a glass chamber maintained at 37°C by a water jacket. Urine stored in the aspirators is 
pumped into the model and then drains through a catheter inserted into the base o f the chamber. The urine draining through the catheter collects in 
drainage bags linked to the catheters. Figure adapted from Stickler et al. (1999).
Figure 6: Positions o f the six catheter sections used for electron 
microscope analysis.
black carbon disks stuck onto a metal stub. The sections were then viewed under the 
JEOL JSM 52001v SEM on low vacuum mode (3%) at 20 kv. The first section was 
examined looking down through the eye-hole and the remaining sections were 
observed looking down through the lumen.
2.1.22. Critical point drying and high vacuum scanning electron microscopy 
The same catheter sections as in Figure 6 were used, but the 1 cm sections were also 
cut in half longitudinally. The catheter sections were fixed either with or without 
ruthenium hexaammine trichloride (RHT). All the electron microscopy reagents were 
purchased from Agar scientific (Stansted, UK), except for the RHT, which was 
obtained from Johnson Matthey Materials Technology Ltd., Hertfordshire, UK.
Fixing without RHT
The 0.1 M Sdrensen phosphate buffer was made by adding 95 ml of 0.1 M disodium 
hydrogen orthophosphate to 5 ml of 0.1 M potassium dihydrogen orthophosphate. The 
sections were fixed in 2.5% glutaraldehyde in 0.1 M Sorensen phosphate buffer (pH 
8.5) at room temperature for 1 h. Samples were then washed in the 0.1 M Sdrensen 
phosphate buffer and stored in fresh buffer overnight at 4°C. The samples were then 
post-fixed by immersion for 30 min at room temperature in 1% osmium tetroxide in 
0.1 M Sdrensen phosphate buffer. Special care was taken when handling osmium as it 
can fix corneas and skin. It was used in the fume hood and gloves were worn at all 
times. The osmium was pipetted off and the specimens were washed twice in de­
ionized water for a total of 15 min before being dehydrated in a graded series of 
ethanol solutions (70 - 100%). The samples were placed firstly in 70% ethanol then 
90% ethanol and twice in 100% ethanol each for 10 - 15 min. Once the dehydration
process was complete the samples were critically point dried using liquid carbon 
dioxide (Balzers CPD 030 critical point dryer). The specimens were finally mounted 
with carbon cement onto aluminium stubs and left to dry overnight in a dessicator. 
The samples were gold-coated (Edwards splutter coater S150B) and examined using 
the JEOL XL20 scanning electron microscope.
Fixing with RHT
The primary fixation step for this experiment was carried out in 2.5% glutaraldehyde 
in 0.05 M sodium cacodylate buffer and RHT (0.14 g of RHT was added into 20 ml of 
the fixative 1 h before it was needed, to allow the pH to stabilise) and left overnight at 
room temperature. The fixative was then washed off with 0.05 M sodium cacodylate 
buffer. The samples were then processed in the same way as fixing without RHT from 
the post fixing with osmium tetroxide step.
2.7.3. Calcium and magnesium analysis o f the catheter biofilm by atomic absorption 
spectroscopy
This method was used to determine the extent o f encrustation on catheters removed 
from the bladder models. After removing the balloon the catheter was cut into 2 cm 
sections and placed into 100 ml of 4% (v/v) nitric acid in double de-ionized water. 
This sample was then sonicated at 35 khz for 5 min to facilitate the dissolution of the 
crystals embedded in the biofilm, and samples were kept refrigerated at 4°C until the 
samples could be analysed. To carry out the analysis, the nitric acid from the bottles 
containing the catheter sections was diluted 1:10, 1:50, 1:100, 1:200 and 1:400 using 
4% nitric acid to bring the concentration into the readable range of the 
spectrophotometer. These samples were then analysed using the atomic absorption
spectrophotometer (aa/ae Spectrophotometer, Thermoelectron, UK). The readable 
ranges were between 0.5 ppm and 2 ppm for calcium (at 422.7 nm) and between 0.05 
ppm and 0.4 ppm for magnesium (at 285.2 nm). Prior to sample analysis, the 
spectrophotometer was calibrated within these ranges with standards purchased from 
Spectrosol (BDH Chemicals Ltd., Poole, UK). These 1000 ppm standards were 
diluted with 1% (v/v) nitric acid. This enabled the assay of the calcium and 
magnesium accumulating on each catheter to be determined.
2.8. Triclosan extraction from artificial urine and chemical analysis
Dr. Carsten Muller of Cardiff School of Biosciences designed the experimental 
procedure for this method to determine the concentration of triclosan in artificial urine 
samples. The chemicals used for this test were AnalaR grade chemicals purchased 
from BDH. 50 ml of each artificial urine sample was acidified with eight drops of 
concentrated hydrochloric acid. The sample was then poured into a 100 ml separating 
funnel and extracted twice with dichloromethane (10 ml). This method involved 
shaking the separating flask containing the artificial urine sample and the 
dichloromethane fifty times, and then leaving the flask for 20 min to allow the organic 
and inorganic layers to separate out. The triclosan preferentially dissolves in the 
dichloromethane, hence the bottom layer containing the triclosan in dichloromethane 
was then taken off and kept. The sample remaining in the funnel was extracted again 
in the same way with dichloromethane. The combined bottom layers of 
dichloromethane containing triclosan were dried with anhydrous sodium sulphate, - 
the salt was added until the anhydrous salt appeared in the extract. The sample was 
decanted into a 50 cm3 round-bottomed flask and dried down on a rotary evaporator. 
The sample remaining in the round-bottomed flask was re-suspended twice in 0.5 ml
of high-pressure liquid chromatography (HPLC) solvent (70% acetonitrile (HPLC 
quality)). This 1 ml sample was then run on HPLC. The control was 10 pg/ml 
triclosan in absolute ethanol. The HPLC machine (Dionex AGP) was used with a 
Spectra-physics auto-sampler (AS3500) and a Spectra-physics 100 UV detector at 279 
nm. A Phenomenex lichrosphere (5uRP-8e, 250 x 4mm) column was used and was 
fitted with a Phenomenex 0DS security cartridge, which prevented the column getting 
damaged. The data was collected and interpreted using HPLC technologies prime 
chromatography software.
As chemicals are detected by HPLC, the chromatograph displays a peak. Each peak 
on a chromatograph indicates the presence of a chemical in the sample and is labelled 
with a retention time (the retention time for triclosan in this experiment was around 
5 .75). The retention time is the time it takes for a chemical to come out of the HPLC 
column. The triclosan control samples were clearly identified on the HPLC 
chromatograph by a clean peak. By standardising the HPLC parameters, the retention 
time for the peak of a given chemical compound is kept the same. Therefore, by 
comparing the area underneath the peak of the control triclosan samples to the test 
samples at the same retention time, it was possible to quantify the concentration of 
triclosan in the unknown samples. To calculate the percentage efficiency of the 
extraction, two artificial urine samples were spiked to contain 1 pg/ml of triclosan and 
were put through the above procedure. By working out the percentage efficiency of 
the extraction, the results for the amount of triclosan in each sample could be 
corrected.
2.9. Physical properties of catheter balloons
The physical properties of catheter balloons that had been inflated with water and 
triclosan solutions were tested. Catheters were inflated with water, a triclosan solution 
and the solvent used in the triclosan solution. Catheter balloons were submerged in 
water and kept in a dark cupboard. The catheters were observed daily for any signs of 
change in the balloon morphology and the water in which the balloons were soaking 
was changed weekly. After eight weeks, the catheter balloons were deflated and a 
section o f each catheter balloon was stretched using the Lloyds testing instrument 
(LRK10) (Figure 7). This allowed a comparison between the load (N) that each 
section could take, its tear strength (N/mm) and its percentage elongation. Even small 
samples of balloon material are very hard to break, hence a nick (half way across the 
balloon test section) was placed half way down the sample to facilitate tearing.
2.10. Isolation of mutants with increased resistance to triclosan
Two methods were employed to attempt to isolate Pr. mirabilis mutants with 
decreased susceptibilities to triclosan.
2.10.1. The disk diffusion method
Sterile paper disks (Whatman, Kent, UK) were soaked in super-MIC concentrations of 
0.5, 1, 2, 5 and 10 pg/ml triclosan in 1% DMSO for 5 min. The disk soaking solutions 
were prepared by diluting triclosan stock solutions in DMSO that had been prepared at 
100 times the desired experimental concentration 1:100 with sterile de-ionized water. 
The disks were placed onto TSA plates swabbed with a 4 h culture of Pr. mirabilis. 
Following a pre-diffusion period of 1 h, the plates were sealed with nescofilm and
The catheter balloon 
before stretching.
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Figure 7: The LRK10 Lloyds testing instrument. This instrument 
was used to test the physical properties o f  the catheter balloons.
incubated at 37°C for up to five days. Plates were examined daily for resistant 
colonies growing within the inhibition zone around the disks.
2.10.2. The heavy inoculum method
100 pi of a 4 h TSB culture was swabbed onto TSA plates containing super-MIC 
concentrations of 0.5, 1, 2, 5 and 10 pg/ml triclosan (all contained less than 1% 
DMSO). Plates were left for one hour before they were sealed and incubated at 37°C 
for up to five days. Plates were examined daily for any resistant colonies.
Any apparently resistant organisms produced using these methods were sub-cultured 
onto TSA plates. Frozen stocks of each mutant were also prepared (in cryogenic vials 
containing 5% glycerol). To prevent the loss of resistance in these mutants, these 
frozen cultures and plates contained 0.1 pg/ml of triclosan until the stability of the 
resistance was confirmed.
2.10.3. Determining the stability of the resistant mutants
To determine whether the bacterial resistance was stable, mutant strains were cultured 
in the absence of triclosan. If the resistance is stable, the MIC will not decrease when 
sub-cultured in the absence of the selective pressure. Following the initial plate to 
broth (10 ml TSB) sub-culture, 14 overnight broth-to-broth sub-cultures were 
performed, testing the MIC after the 1st, 3rd, 7th, 11th and 15th sub-culture (Figure 8). 
After every sub-culture, each TSB culture was plated out onto TSA and CLED Agar 
to check the culture’s purity. At the end of the experiment, the identity of a selection 
o f mutants was confirmed using the BBL™ crystal identification kits.
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Figure 8: Method for determining the stability of the mutants. Following the initial plate to broth sub-culture, 14 
overnight broth-to-broth sub-cultures were performed, testing the MIC after the 1st, 3rd, 7th, 11th and 15th sub-culture.
2.11. Statistical analysis
Unless otherwise stated experiments were performed in triplicate. When reporting the 
mean of the data, the standard error (SE) of the mean was also indicated. The error 
bars on the Figures indicate the standard error of the mean for that particular data 
point. ANOVA (analysis of variance) comparing the mean of the data, carried out at 
95% confidence interval was the statistical test of choice for all the experiments. This 
was carried out using Minitab® release 13 software (Minitab Inc. PA, USA). To allow 
ANOVA to be performed the data was analysed with the Minitab programme to 
confirm a normal distribution of the residuals and the equal variances of the data. If 
any of these assumptions were violated and the data could not be transformed to fit 
them, the Kruskal Wallis test (which compares the median of the data) was performed 
at 95% confidence interval.
3. RESULTS
3.1. The sensitivity of Pr. mirabilis to triclosan
Clinical and laboratory studies have clearly identified Pr. mirabilis as the organism 
mainly responsible for the encrustation and blockage of catheters (Mobley and 
Warren, 1987; Kunin, 1989; Stickler et al.t 1993). If this organism is to be a primary 
target for novel strategies to control the complication of catheter encrustation, then it 
is important to investigate the sensitivity of strains that are currently forming 
crystalline biofilms on patients’ catheters to triclosan.
Firehammer (1987) reported that low concentrations of triclosan (< 1 pg/ml) inhibited 
the growth of animal isolates of Pr. mirabilis and that swarming was prevented at sub- 
MIC concentrations. More recently Stickler (2002) confirmed that several Pr. 
mirabilis isolates from encrusted catheters were also sensitive to triclosan (MIC, 0.5 
pg/ml). The aim of this section was to examine the activity of triclosan on catheter 
isolates o f Pr. mirabilis in more detail.
The MIC and MISC of a collection of Pr. mirabilis strains that had been isolated from 
encrusted urinary catheters were determined and the results are given in Table 2. 
These data confirm the sensitivity of Pr. mirabilis catheter isolates to triclosan, the 
MISC of the isolates being between 0.1 and 0.2 pg/ml and the MIC between 0.1 and 
0.3 pg/ml.
The tube dilution technique was used to examine the bacteriostatic activity of triclosan 
against Pr. mirabilis in artificial urine. A typical set of results is illustrated in Figure 9. 
The MICs in artificial urine of Pr. mirabilis B2, NP6, NP14, NP37, NP43 and NP55 
ranged from 0.05-0.2 pg/ml, confirming the sensitivity of Pr. mirabilis to triclosan in
. mirabilis 
strain
Minimum inhibitory swarming 
 concentration (Mg/ml)
Minimum inhibitory 
concentration (pg/ml)
NP 1 0.1 0.2
NP 6 0.1 0.1
NP 14 0.2 0.2
NP 15 0.1 0 .2 -0.3
NP 16 0.1 0.2
NP 17 0.1 0.2
NP 30 0.1 0.2
NP 33 0.1 0.2
NP 35 0.1 0.2
NP 36 0.1 0.2
NP 37 0.1 0.1
NP 38 0.2 0.2
NP 41 0.1 0.2
NP 43 0.1 0.2
NP 44 0.2 0.2
NP 45 0.1 0.2
NP 47 0.1 0.2
NP 50 0.1 0.1 - 0.2
NP 52 0.1 0.2
NP 55 0.1 0.2
B 2 0.1 0.2
NSM 6 0.1 0.2
NSM 42 0.1 0.2
E.coli (NCTC 
10148) N/A 0.2
Tabic 2: The MIC and MISC of triclosan in agar of 23 Pr. mirabilis isolates from patient's 
catheters. The MIC value o f triclosan against the E. coli reference strain (NCTC 10418) is also 
included The results are based on experiments replicated three times.
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Figure 9: A Pr. mirabilis B2 artificial urine culture series containing different concentrations of triclosan.
artificial urine. The pH of each culture was measured after the incubation period, the 
results are presented in Figure 10. It can be seen that the mean pH for each of the six 
strains exposed to 0.2 pg/ml triclosan was still acidic after incubation. These mean 
values were all significantly (P < 0.05) lower than the pH of the control cultures for all 
six Pr. mirabilis strains.
The next step was to determine the effect of triclosan on bacterial growth and pH in 
pooled human urine. The growth of Pr. mirabilis B2 in pooled human urine was 
followed, monitoring the viable cell count and the pH over a period of time in the 
presence and absence of triclosan. Experiments were performed adding triclosan 
either at stationary phase or at mid-log phase.
Aliquots (2 ml) of an overnight culture of Pr. mirabilis B2 grown in 100 ml TSB were 
used to inoculate sterile pooled human urine (200 ml). Triclosan stock solutions were 
prepared at 200 times the final required concentration in DMSO. These were added to 
give final triclosan concentrations in the urine o f 0.1, 1, 10 and 100 pg/ml, and all 
resulting in a final DMSO concentration of 0.5%. A human urine control containing 
no triclosan and a 0.5% DMSO control were also tested. Prior to incubation at 37°C in 
an orbital shaker, the flasks were shaken and a sample was taken to determine the 
viable cell count and the pH. Samples were taken every hour to monitor the pH and 
the viable cell counts. Before performing the viable cell counts, the samples were 
neutralised by placing 1 ml into 9 ml of the neutraliser for 5 min. Experiments 
determining the efficacy and non-toxicity o f the neutraliser are reported later in this 
section.
NP55
NP43
NP37
NP14
The mean pH of the 
uninoculated artificial 
urine control after 
incubation was: 
6.17 ±0.05
■ 0.2ug/ml triclosan
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■ 0.01ug/ml triclosan
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Figure 10: The effect of different triclosan concentrations on the pH values of artificial urine culture series’ inoculated with Pr.
mirabilis. Artificial urine culture series’ were set up containing different concentrations of triclosan, and inoculated with one o f six different 
Pr. mirabilis strains. These results show the pH values of the cultures after a 6 h incubation period. The results are a mean of three 
experiments. The black arrow indicates the mean pH of the uninoculated artificial urine controls after incubation.
Figure 11 shows the data from the experiment adding triclosan at t = 0 h (stationary 
phase). The results show that the control and DMSO control cultures produce 
characteristic sigmoidal curves, and that both these control cultures reached stationary 
phase by the end of the experiment. The results indicate that a very low concentration 
of triclosan (0.1 pg/ml) delays log phase growth and that 1 jig/ml prevents entry into 
log phase. It can be seen that triclosan at 10 pg/ml and 100 pg/ml is bactericidal in 
urine, the activity of the 100 pg/ml being more rapid. After the 8 h period, there was 
no significant difference (P > 0.05) between the viable cell count of the control, 
DMSO control and 0.1 pg/ml triclosan cultures. There were significantly lower (P < 
0.05) numbers of viable cells in the cultures containing 1, 10 and 100 pg/ml triclosan 
compared to the controls and the culture containing 0.1 pg/ml of triclosan.
The effect of adding triclosan at stationary phase on the pH of the pooled human urine 
cultures is shown in Figure 12. The results indicate that triclosan can control the pH of 
urine cultures of Pr. mirabilis. 0.1 pg/ml triclosan in the cultures delays the rise in pH 
but at 8 h the pH was not significantly different (P > 0.05) from the controls. The pH 
of the three higher triclosan concentrations was significantly lower (P < 0.05) than the 
controls at t = 8 h.
The results from the experiment above showed that cultures of the test strain were at 
mid-log phase growth at t = 2.5 h after inoculation. To determine the effect of 
triclosan on log phase growing cells, the same triclosan concentrations used in the 
previous experiment were tested against cultures at this time point. Aliquots (2 ml) of 
an overnight culture of Pr. mirabilis B2 grown in 100 ml TSB were added to sterile 
pooled human urine (200 ml). These cultures were shaken and a sample was taken to
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Figure 11: The effect of different triclosan concentrations on stationary phase Pr. mirabilis B2 
cultures in pooled human urine. Human urine cultures containing different concentrations o f  
triclosan were prepared and inoculated with Pr. mirabilis B2 at t = 0 h. Each data point is a mean 
value from three experiments.
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Figure 12: The effect of different triclosan concentrations on the pH of stationary phase Pr. mirabilis B2 cultures in human 
urine. Human urine cultures containing different concentrations of triclosan were prepared and inoculated with Pr. mirabilis B2 at t 
= 0 h. Each data point is a mean value from three experiments.
determine the viable cell count and the pH (at t = 0 h) before the cultures were placed 
in the 37°C orbital shaker. Samples were taken and analysed hourly throughout the 
experiment. In addition a sample was taken immediately after adding the triclosan or 
DMSO at t = 2.5 h.
The results o f adding triclosan to mid-log phase cultures o f Pr. mirabilis in pooled 
human urine are presented in Figure 13. Bacteria growing in log phase were more 
sensitive to very low concentrations of triclosan than those in stationary phase. 0.1 
pg/ml significantly lowered (P < 0.05) the viable cell count at t = 8 h compared to the 
controls. Adding the triclosan at mid-log phase however, produced no significant 
difference (P > 0.05) between the pH of the control and test cultures (Figure 14).
The experiments in human urine confirm that low concentrations (0.1 - 1 pg/ml) of 
triclosan inhibits bacterial growth, but that much higher concentrations (10 - 100 
pg/ml) are required to kill the bacteria. To investigate this further, suspension tests 
were performed to assess the bactericidal efficacy of triclosan. In preliminary tests the 
efficacy of the neutralising agent was confirmed by exposing Pr. mirabilis B2 to 100 
pg/ml triclosan with and without the 5% Tween 80 and 1.5% lecithin for 5 min, and to 
a control vessel containing water. Viable cell counts were performed on these cultures 
and the results presented in Table 3. There was no significant difference (P = 0.919) 
between the viable cell count of the cultures in water and those in 100 pg/ml triclosan 
in neutraliser, confirming that 5% Tween 80 and 1.5% lecithin can effectively quench 
bactericidal activity of triclosan at the concentration tested.
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Figure 13: The effect o f different triclosan concentrations on log phase growing Pr. mirabilis B2 
in pooled human urine. Human urine cultures inoculated with Pr. mirabilis B2 at t = 0 h were 
prepared. Different concentrations o f triclosan were added to these cultures at t = 2.5 h. Each data 
point is a mean value from three experiments.
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Figure 14: The effect of different triclosan concentrations on the pH of log phase growing Pr. mirabilis B2 cultures in human 
urine. Human urine cultures inoculated with Pr. mirabilis B2 at t = 0 h were prepared. Different concentrations of triclosan were 
added to these cultures at t = 2.5 h. Each data point is a mean value from three experiments.
Viable cell count of test suspensions (Logio (cfu/ml + 1))
Pr. mirabilis B2 in water Pr. mirabilis B2 in 100 pg/ml triclosan in water
Pr. mirabilis B2 in 100 
pg/ml triclosan and 
neutraliser
8.81 ± 0 .10 0 ±  0 8.78 ±0.12
Table 3: The efficacy of the neutraliser containing 5% Tween 80 and 1.5% lecithin 
at quenching the bactericidal activity o f 100 jig/ml triclosan. The data shows viable 
cell count results (Logio (cfu/ml + 1)) o f  Pr. mirabilis B2 cultures after a 5 min contact 
time with water (positive control), 100 pg/ml triclosan (negative control) or 100 pg/ml 
triclosan and neutraliser (test). The results are based on experiments replicated three 
times. Statistical analysis (ANOVA) revealed there was no significant difference (P = 
0.919) between the viable cell count o f  the cultures in water and those in 100 pg/ml 
triclosan and the neutraliser.
The effect of the neutraliser and the 1% DMSO used in the suspension tests was 
determined for all strains that were to be analysed using this method. Analysis of the 
data presented in Table 4 shows there was no significant difference (P > 0.05) 
between the control cultures and the neutraliser and DMSO treated cultures. These 
results confirm that the 1% DMSO and the neutraliser were non-toxic to all the strains 
tested.
In suspension tests the contact time between the antiseptic solution and the bacterial 
inoculum is normally 5 min. A general accepted requirement for an effective 
antiseptic is that in suspension tests a logio reduction in bacterial concentration equal 
to or greater than five is produced i.e. at least 99.999% of bacterial cells are killed (BS 
EN 1276 1997; Reybrouck, 1998). The maximum concentration used in the 
suspension tests in this study was 100 jig/ml triclosan. Since none of the Pr. mirabilis 
strains tested produced a five-log reduction in viable cell counts in 5 min with this 
concentration, contact times of 30 and 60 min were also included in the experiments. 
The suspension test results with five different Pr. mirabilis strains are given in Figure 
15. The mean logio reduction in viable cell count increases with time for all five 
strains, but there is considerable variability in the logio reduction between strains.
Species
Viable cell count of test suspension 
(Logio cfu/ml ± standard error)
Control Neutraliser DMSO
Pr. mirabilis B2 8.30 ± 0.06 8.25 ± 0.07 8.29 ± 0.07
Pr. mirabilis B2 mutant 
strain. M44 8.37 ± 0.06 8.42 ± 0.05 8.40 ± 0.05
Pr. mirabilis B2 mutant 
strain. M48 8.68 ± 0.04 8.65 ± 0.02 8.67 ± 0.02
Pr. mirabilis B2 mutant 
strain. M55 8.15 ±0.03 8.15 ±0.02 8.13 ±0.03
E.coli NSM 16 8.61 ±0.10 8.60 ± 0.04 8.54 ±0.08
K. pneumoniae CC 36 8.10 ±0.03 8.09 ± 0.02 8.13 ±0.05
Pv. stuartii NSM 14 8.48 ±0.21 8.46 ± 0.23 8.47 ± 0.20
Ent. faecalis CC 39 7.99 ± 0.03 7.98 ± 0.07 7.97 ±0.01
Ser. marcescens CC 13 8.35 ± 0.04 8.34 ± 0.03 8.36 ± 0.05
M. morganii MS 2 8.68 ±0.13 8.67 ±0.12 8.69 ±0.14
S. aureus NSM 5 8.25 ± 0.03 8.20 ± 0.06 8.24 ± 0.06
Ps. aeruginosa NSM 57 8.20 ± 0.03 8.22 ± 0.02 8.21 ±0.04
Pr. mirabilis NSM 6 8.19 ±0.06 8.20 ± 0.02 8.16 ±0.08
Pr. mirabilis NSM 42 8.41 ±0.15 8.39 ±0.13 8.37 ±0.17
Pr. mirabilis NP 55 8.72 ±0.13 8.70 ±0.11 8.71 ±0.11
Pr. mirabilis NP 37 8.49 ± 0.09 8.44 ± 0.08 8.47 ± 0.06
Table 4: The viable cell count (Logio cfu/ml) of test suspensions of different organisms after 
15-minutes contact time with water (control), neutraliser and 1% DMSO. Analysis o f the data 
presented in this table showed there was no significant difference (P > 0.05) between the control 
suspensions and the neutraliser or DMSO treated suspensions. This data confirms the non-toxicity 
of the neutraliser and o f 1% DMSO. The results are a mean of three experiments.
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Figure 15: Log,0 (cfu/ml) reduction for five strains of Pr. mirabilis after three contact times with 100 pg/ml triclosan.
Suspension tests were performed to determine the bactericidal efficacy of triclosan against five stains of Pr. mirabilis. The Pr. 
mirabilis strains were exposed to 100 pg/ml triclosan for 5, 30 and 60 min. Results are a mean of values obtained from three 
experiments.
3.2. Experiments to determine the feasibility of using the catheter retention 
balloon as a novel wav of introducing triclosan into the catheterised urinary tract
Potentially the catheter balloon provides a large reservoir for agents that might act as 
inhibitors o f the encrustation process. If it is to be exploited in this way however, the 
agent would have to be able to diffuse through the balloon at a controlled rate that 
would sustain active concentrations in the bladder urine for periods of up to 12 weeks. 
Since the activity of triclosan against catheter isolates of Pr. mirabilis was confirmed 
in section 3.1, the next step was to determine whether this agent could diffuse through 
the catheter balloon into the urine of the catheterised urinary tract.
3.2.1. Does triclosan diffuse through catheter balloons into urine?
Bladder models were set up with all-silicone catheters but were not inoculated. Two 
models were set up each time; the balloon of the test catheter was inflated with 10 
mg/ml triclosan in 5% polyethylene-glycol (PEG) (Sigma) whilst the control balloon 
was filled with sterile water. After the models were set up, the pump was switched off 
for 1 h to simulate the establishment period. The pump was then switched on and the 
models were left to run for 48 h. The collection bag linked to the triclosan test models 
was emptied every 4 h during the day and the first thing the following morning, i.e. at 
time = 4, 8, 24, 28, 32, and 48 h. The urine samples from the collection bags were kept 
at room temperature and the triclosan was extracted with dichloromethane as soon as 
possible after the samples were taken.
At time = 48 h, samples were taken from the collection bags linked to the control 
catheters. These samples along with two fresh artificial urine samples were put through 
the same extraction procedure as those samples suspected of containing triclosan.
These controls ensured that there was nothing in the artificial urine or in the catheter 
polymer that would give a background reading from the high pressure liquid 
chromatography (HPLC) close to the triclosan peak. After extraction of triclosan from 
each of the artificial urine samples, HPLC was used to determine the amount of 
triclosan in each of the samples (Section 2.8). This experiment was replicated twice.
The concentration of triclosan in the artificial urine samples taken from collection bags 
of catheters inflated with 10 mg/ml triclosan in 5% PEG over a 48 h period are shown 
in Figure 16. The results from the spiked artificial urine samples determined that the 
percentage efficacy of the extraction process was 81.3%, the results in Figure 16 have 
been corrected to take this into account. No triclosan was detected in the control 
artificial urine or in the samples taken from the control models fitted with catheters 
inflated with sterile water.
3.2.2. Does triclosan impregnate the catheters?
After establishing that triclosan could pass though the balloons of all-silicone 
catheters, further bladder models were set up to determine if catheters would become 
impregnated with triclosan. Bladder models were run in the same way as in section
3.2.1, using all-silicone catheters and both types o f latex based catheters. Models were 
not inoculated and were left to run for 48 h. At the end of the experiment the catheters 
were taken out of the models and the test catheters that had been inflated with triclosan 
had their balloons flushed out. This was done by inflating and deflating the catheter 
balloon with fresh sterile water 10 times. To determine if the triclosan had impregnated 
the catheter material, test and control catheter sections were placed onto Pr. mirabilis 
B2 bacterial lawns (section 2.4.2).
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Figure 16: The concentration of triclosan (pg/ml) in the artificial urine samples taken from bladder 
models fitted with all-silicone catheters inflated with 10 mg/ml triclosan in 5%PEG over a 48 h period.
These values have been corrected to take into account the efficacy o f the extraction process.
Each impregnated all-silicone catheter section produced a zone of inhibition, indicating 
that triclosan impregnated the length of the all-silicone catheters. In contrast, only the 
top section from directly beneath the balloon of the triclosan impregnated hydrogel- 
coated latex catheter produced a zone of inhibition, and the silicone-coated latex 
catheter produced no zone of inhibition (Figure 17). No zone of inhibition was visible 
around any of the control catheters.
3 .2 .3. The effect of triclosan in 5% PEG on the physical properties of catheter balloons 
This experiment was carried out to determine how triclosan and 5% PEG might affect 
the physical properties of the catheter balloons. Three all-silicone catheters were 
placed into a 1 L Duran bottle and their balloons were inflated with 10 mg/ml triclosan 
in 5% PEG. The bottle was then filled with de-ionized water, submerging the catheter 
balloons. Two control experiments were also set up in separate bottles where three all­
silicone catheter balloons were filled with either de-ionized water or 5% PEG before 
the Duran bottles were again filled with de-ionized water. The effect of triclosan and 
5% PEG on both types of latex-based catheters was monitored in the same way. The 
bottles were placed in a dark cupboard and observed daily for any signs of change in 
the balloon morphology. The water in the bottles was changed weekly and the 
experiment was monitored for eight weeks.
There was no visible change to any of the catheter balloons after they had been inflated 
with 10 mg/ml triclosan in 5% PEG, 5% PEG or sterile water and soaked in water for 
eight weeks. All the catheter balloons could be deflated at the end of the experiment. 
The physical properties of the balloons were analysed using the Lloyds testing 
instrument. This instrument works by placing samples of materials into tight grips.
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Figure 17: The mean zone of inhibition size (cm) produced by 0.5 cm sections taken down the length of three 
different catheter types that had been inflated with triclosan in the bladder models for 48 h. Catheter sections 
were placed onto Pr. mirabilis B2 bacterial lawns. Section 1 was directly bellow the catheter balloon, sections 2 -  
15 were taken every other 1 cm down the length o f  the catheter. The results are a mean o f  values obtained from 
three experiments.
These grips that are linked to a computer system pull the sample until it tears, giving 
information about the physical properties of the material. The balloons of the latex 
based catheters were too strong to be tested using this instrument, but the balloons of 
the three sets of test all-silicone catheters along with a control catheter balloon taken 
straight from the packaging were tested. The balloon material was very hard to break, 
hence a nick (half way across the balloon test section) was placed half way down each 
sample to facilitate tearing. There was no significant difference (P > 0.05) in the load 
(N) applied to each section at the time of tearing (Figure 18a), the percentage it could 
be extended (Figure 18b) or the strength needed to tear the sections (N/mm) (Figure 
18c) between the four groups tested. These results indicate that triclosan and PEG do 
not have a detrimental effect on the physical properties of catheter balloons.
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Figure 18a: Load (Newtons) applied to catheter sections at breakage.
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Figure 18b: Percentage extension results.
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Figure 18c: Tear strength (N/mm) results.
Figure 18: The effect of triclosan on the physical properties of all-silicone (AS) 
catheter balloons. Load (N), percentage extension and tear strength (N/mm) results from 
all-silicone catheter balloons taken straight from the packaging, and from balloons that 
were submerged in water for eight weeks filled with either water, 5% PEG or 10 mg/ml 
triclosan in 5% PEG. The results are a mean o f values obtained from three experiments.
3.3. The effect of introducing triclosan into the catheterised urinary tract on the 
development of crystalline bacterial biofilm formation bv Pr. mirabilis in in-vitro 
models of the catheterised bladder
The aim of experiments reported in this section was to use the bladder models infected 
with Pr. mirabilis to determine whether catheters that had their retention balloons 
inflated with triclosan, or catheters that were impregnated with triclosan could resist 
encrustation by crystalline biofilm.
3.3.1. Does filling the retention balloon with triclosan solutions inhibit the 
development of crystalline Pr. mirabilis biofilms on catheters?
Bladder models were set up with the catheter retention balloons inflated with a range 
of concentrations of triclosan in 5% PEG. For each set of experiments a control model 
that had its balloon inflated with water was also set up. The triclosan test 
concentrations were 10 pg/ml, 100 pg/ml, 500 jug/ml, 1 mg/ml and 10 mg/ml. To 
determine how the 5% PEG might affect catheter encrustation, models were also set 
up with 5% PEG in the balloon. The models were inoculated with Pr. mirabilis B2 
and run until blockage or for a maximum of seven days. This experiment was carried 
out using all-silicone catheters; hydrogel-coated latex and silicone elastomer-coated 
latex catheters.
Four ready-made triclosan solutions were obtained from CIBA, each containing 1% 
triclosan.
1. Cremol Ritter Douche.
2. Procutol Wash lotion.
3. Henkel Ecolab skinsan scrub.
-85-
4. Dial complete foaming hand wash.
The ability of these commercially available triclosan formulations to prevent 
encrustation in all-silicone catheters was also tested using the bladder models. Control 
catheters were inflated with water, and were run alongside test catheters whose 
balloons were inflated with one of the ready-made triclosan formulations. Models 
were run until blockage or for a maximum of seven days, and experiments were 
performed in triplicate.
Figures 19a, 20a and 21a show the time to blockage results for the three different 
catheter types inflated with different concentrations of triclosan in 5% PEG and 
inoculated with Pr. mirabilis B2. Only two (Henkel Ecolab skinsan scrub and Dial 
complete foaming hand wash) out of the four pre-made CIBA formulations were 
tested as the others were too viscous to inflate the retention balloon. The 5% PEG in 
the balloon produced no significant difference (P > 0.05) in the time to blockage for 
the three catheter types compared to the controls. 10 and 100 pg/ml triclosan in 5% 
PEG in the catheter balloon significantly increased (P < 0.05) the time to blockage of 
the all-silicone catheters and latex-based catheters respectively compared to the 
control models. Some of the higher concentrations of triclosan tested enabled the 
catheters to drain freely for the duration of the seven day experiment. The 
concentrations required to prevent blockage of the latex-based catheters for seven 
days were higher than with the all-silicone catheters. Using the two CIBA 
formulations to inflate the catheter balloon also allowed the all-silicone catheters to 
drain freely for seven days.
2160
o 140
—120
§>100 tfO
80
60
40
20
0
DID NOT BLOCK
“  ' 4 I
<f
Mean time 
to
blockage 
of control 
models:
26.32 ± 
2.47 h
Figure 19a: Time to blockage results.
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Figure 19c: Log,0 (cfu/ml + 1) in the residual urine.
Figure 19: Time to blockage, pH and viable cell count results from models fitted with all­
silicone catheters inflated with the CIBA formulations or different concentrations of 
triclosan in 5% PEG after blockage or after seven days. Models were inoculated with Pr. 
mirabilis B2. The red arrows indicate the results o f the control models. Each value is a mean 
from triplicate experiments.
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Figure 20: Time to blockage, pH and viable cell count results from models fitted with 
hydrogel-coated latex catheters inflated w ith different concentrations of triclosan in 5% 
PEG after blockage or after seven days. Models were inoculated with Pr. mirabilis B2. The 
red arrows indicate the results o f the control models. Each value is a mean from triplicate 
experiments.
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Figure 21a: Time to blockage results.
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Figure 21c: Log,0 (cfu/ml +1) in the residual urine.
Figure 21: Time to blockage, pH and viable cell count results from models fitted with 
silicone-coated latex catheters inflated with different concentrations of triclosan in 5% 
PEG after blockage or after seven days. Models were inoculated with Pr. mirabilis B2. The 
red arrows indicate the results o f the control models.
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Figures 19b+c, 20b+c and 21b+c show that triclosan in the catheter balloon can 
control the pH and viable cell count of the residual urine. 1 and 10 mg/ml triclosan in 
the balloons of the latex-based catheters kept the pH and viable cell count from the 
residual urine at seven days significantly lower (P < 0.05) than the control models 
after blockage. 500 pg/ml triclosan and higher had the same effect in all-silicone 
catheters. Figure 22a shows the cloudy residual urine in the control all-silicone 
catheter model at 24 h, in contrast the residual urine of the model that had its balloon 
inflated with 10 mg/ml triclosan in 5% PEG was clear at 24 h, and remained like this 
until the end of the seven day experiment.
LV-SEM was carried out on control and test catheters that had their balloons inflated 
with 10 mg/ml triclosan in 5% PEG for each of the three catheter types. Figures 23, 24 
and 25 show heavy encrustation down the length of all three control catheters, whilst 
there is little evidence of encrustation on the catheters that had their balloons inflated 
with 10 mg/ml triclosan in 5% PEG (Figures 26,27 and 28).
The ability of triclosan to control encrustation by other strains of Pr. mirabilis was 
also tested in the bladder models. All-silicone catheters were run in the same way as in 
the above experiment, with the test catheter balloons inflated with 10 mg/ml triclosan 
in 5% PEG and the control catheters with water. The models were inoculated with Pr. 
mirabilis strains NSM 6, NSM 42, NP 37 and NP 55. The results were consistent with 
those obtained above, the triclosan prevented catheter blockage in the models for 
seven days (Figure 29a), and significantly (P < 0.05) lowered the pH and viable cell 
count o f the test models compared to the controls (Figures 29b+c).
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Control Triclosan
Figure 22a: The residual urine o f models supplied with artificial urine and Fitted with catheters 
inflated with 10 mg/ml triclosan in 5% PEG or water 24 h after inoculation with Pr. mirabilis.
TriclosanControl
Figure 22b: The residual urine o f  models supplied with pooled human urine and fitted with catheters 
inflated with 10 mg/ml triclosan in 5% PEG or water 24 h after inoculation with Pr. mirabilis
Figure 22: The effect of triclosan on the turbidity o f the residual urine in Pr. mirabilis 
infected bladder models supplied with artificial and human urine.
Figure 23: Electron micrographs of a blocked control all-silicone catheter taken from the bladder model.
6 pictures were taken along the length of the catheter. The positions of sections A-F are indicated in Figure 6.
Figure 24: Electron micrographs of a blocked control hydrogel-coated latex catheter taken from the bladder model.
6 pictures were taken along the length of the catheter. The positions of sections A-F are indicated in Figure 6.
Figure 25: Electron micrographs of a blocked control silicone-coated latex catheter taken from the bladder model.
6 pictures were along the length of the c a th e te r  The positions of sections A -F  are indicated in Figure 6.
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Figure 26: Electron micrographs of an all-silicone catheter that had its balloon inflated with 10 mg/ml triclosan in 5% PEG after
7 days in the bladder model. 6 pictures were taken along the length of the catheter. The positions of sections A-F are indicated in Figure 6.
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Figure 27: Electron micrographs of a hydrogel-coated latex catheter that had its balloon inflated with 10 mg/ml triclosan in 5% PEG after
7 days in the bladder model. 6 pictures were taken along the length of the catheter. The positions of sections A-F are indicated in Figure 6.
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Figure 28: Electron micrographs of a silicone-coated latex catheter that had its balloon inflated with 10 mg/ml triclosan in 5%
PEG after  7 days in the b lad d er m od el. 6 pictures were taken along the length o f the catheter The positions of sections A-F are indicated in Figure 6
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Figure 29c: Logl0 (cfu/ml +1) o f the residual urine.
Figure 29: Time to blockage, pH and viable cell count results from test and control 
models fitted with all-silicone catheters and inoculated with four different Pr. mirabilis 
strains. Catheters in control models were inflated with water, catheters in test models were 
inflated with 10 mg/ml triclosan in 5%  PEG. The results are a mean o f  triplicate 
experiments.
3.3.2. The effect of inflating the catheter balloon with a triclosan solution on catheter
encrustation when bladder models were supplied with human urine 
To determine whether triclosan would have the same effect of preventing crystalline 
bacterial biofilm formation when supplied with pooled human urine, bladder models 
were set up with test catheters inflated with 10 mg/ml triclosan in 5% PEG and control 
catheters inflated with water. Models were infected with Pr. mirabilis B2, supplied 
with sterile pooled human urine and were run until blockage or for a maximum of 48 
h. This limited time period is due to the difficulty in collecting and sterilizing large 
volumes of human urine. Catheters from three replicates were prepared for calcium 
and magnesium analysis when the catheters blocked or after 48 h, whilst an additional 
run was set-up to observe the catheters under LV-SEM.
None of the models blocked within the 48 h incubation period, but the residual urine 
of the control models that had their balloons inflated with water was very cloudy after 
48 h, whilst the urine in the test models that had their balloons inflated with 10 mg/ml 
triclosan in 5% PEG remained clear (Figure 22b). Triclosan significantly (P < 0.05) 
lowered the pH and viable cell counts of the residual urine (Figures 30a+b). Calcium 
and magnesium determination revealed there was significantly (P = 0.000) less 
encrustation on the triclosan treated catheters compared to the controls (Figure 30c), 
this was confirmed by the LV-SEM images showing heavy encrustation on the control 
catheter and little encrustation on the test catheter (Figure 31).
3 .3 .3. The ability of triclosan impregnated catheters to prevent blockage
From previous experiments (section 3.2.2) it became apparent that inflating the
catheter balloon with 10 mg/ml triclosan in 5% PEG in an uninoculated model can
Mean pH of pooled human urine at the beginning of the experiment = 6.64 ± 0.08
Control Triclosan
Figure 30a: The pH o f the residual urine in the models at 48 h.
Control Triclosan
Figure 30b: Log10 (cfu/ml + 1) o f  the residual urine at 48 h.
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Figure 30c: Amount o f calcium and magnesium (pg per catheter) recovered from the 
catheters at 48 h.
Control Triclosan
Figure 30: pH, viable cell count and calcium and magnesium results from test and 
control catheters taken from models supplied with human urine. Control catheters 
were inflated with water, test catheters were inflated with 10 mg/ml triclosan in 5% PEG. 
Experiments were run for a maximum o f 48 h. Results are a mean o f experiments 
replicated four times.
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Figure 31: Electron micrographs or control and triclosan treated catheters supplied with human urine and 
inoculated with Pr. mirabilis B2 after 48 h in the models. The positions o f sections A-D are indicated in Figure 6.
impregnate the length of all-silicone catheters. This method along with filling the 
catheters in their packaging with 10 mg/ml triclosan in 5% PEG was used to 
impregnate all-silicone catheters. After deflation, the catheter balloons were flushed 
out 10 times with sterile water. The impregnated catheters were then taken from the 
models or packaging, and placed in fresh models. A control model that had its balloon 
inflated with sterile water was also included. Each model was infected with Pr. 
mirabilis B2 and supplied with artificial urine until blockage or for a maximum of 
seven days. Catheters were impregnated for 24 h using the bladder model method, and 
for 1 min, 1 h and 24 h in their packaging.
None of the replicates from the catheters impregnated in the models for 24 h blocked 
within the seven day experimental period. The residual urine in the models remained 
clear throughout the experiment and no viable cells were cultured from the urine at the 
end of the experiment (Figure 32b). All the urine samples remained acidic (Figure 
32c) and LV-SEM revealed little encrustation on the catheter sections (Figure 33). 
Sections of these catheters were placed onto bacterial lawns at the end of the 
experiment, revealing zones of bacterial inhibition around sections down the length of 
the catheter (Figure 34).
The results of impregnating the catheters in the packaging were more variable than 
those impregnating the catheters in the models. One or two replicates for each 
impregnating time period blocked whilst the others drained freely for seven days 
(Figure 32a). The pH and viable cell count of the residual urine from the catheter 
impregnated in the model was significantly lower (P < 0.05) than from models fitted 
with catheters impregnated for 1 min in the packaging, but not significantly different
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Figure 32: Time to blockage, pH and viable cell count results from models fitted with 
all-silicone catheters impregnated for different time periods with triclosan in the models 
and in their packaging. Models were inoculated with Pr. mirabilis B2. The black arrows 
indicate the mean results o f the control models.
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Figure 33: Electron mircographs of an all-silicone catheter impregnated with triclosan inside the model for 24 h, that was then 
tested in Pr. mirabilis infected bladder models. These 6 pictures along the length o f the catheter were taken after 7 days in the model.
Figure 34a.
Figure 34b.
Figure 34c.
Figure 34: Images showing zones of inhibition from an all-silicone catheter that was 
impregnated with triclosan in the bladder model for 24 h, and was then tested in a Pr. mirabilis 
infected bladder model. The images show zones o f inhibition created on Pr. mirabilis lawns by 
sections taken from a catheter after seven days in the infected bladder model. The top image (a) 
shows the section from under the balloon, the central image (b) is o f a section from the middle o f the 
catheter, and the final image (c) is the section above where the catheter attaches to the drainage bag.
Figure 35: Scanning electron micrographs of a control all-silicone catheter at blockage fixed without RHT. Images A, B and D were taken from the catheter eye-hole. 
Images C and E were taken from the section directly beneath the catheter balloon and catheter eye-hole respectively. Image F was taken from a section half way down the 
length o f the catheter. Large numbers o f bacilli can be seen in images A, C and F, the ones in image C appear to be covered by a polysaccharide matrix. Image D shows how 
bacteria become trapped within rough surfaces. Large struvite crystals and small crystallites of hydroxy-apatite are visible in images B and E.
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Figure 36: Scanning electron micrographs of an all-silicone catheter inflated with 10 mg/ml triclosan in 5% PEG that drained freely in the model for 7 days and was 
fixed without RHT. These images are taken o f the catheter eye-hole and at intervals down the length of the catheter. Image A reveals little sign o f catheter encrustation, but 
highlights the surface irregularities resulting from engineering techniques used to create the eye-hole. Only very small groups of bacteria were visible, many of which 
appeared smaller than on the control catheter, and often appeared to be deformed.
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Figure 37: Scanning electron micrographs of an all-silicone catheter impregnated in the model for 24 h that then prevented catheter blockage in a Pr. mirabilis 
infected model for 7 days. The catheter was fixed without RHT. These images are taken of the catheter eye-hole and at intervals down the length o f the catheter. Only 
very small groups of bacteria were visible. Many of the bacteria appeared smaller than in the control catheter, and often appeared to be deformed.
Figure 38: Scanning electron micrographs of a control all-silicone catheter at blockage fixed with RHT. Large numbers of Pr. mirabilis could be seen colonizing the 
catheter eye-hole and the length o f the catheter. Bacteria can be seen surrounding and colonizing a large crystal in image A. Images B, C and D show high magnification 
images of the Pr. mirabilis cells. Image E shows a web like polysaccharide matrix binding groups of bacterial cells. A gluey polysaccharide matrix can be seen covering the 
bacteria in image F.
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Figure 39: Scanning electron micrographs of an all-silicone catheter inflated with 500 pg/ml triclosan in 5% PEG that drained freely in the model for 7 days and was 
fixed with RHT. These images are taken of the catheter eye-hole and at intervals down the length of the catheter. Image A reveals little sign of encrustation on the catheter eye­
hole. Very little crystal formation was observed down the length o f the catheter. Groups of bacterial cells were however visible but they appeared deformed and smaller than 
normal cells.
triclosan treated catheters (Figures 36, 37, 39), many of which appeared deformed. 
Hardly any crystalline material was observed on the triclosan test catheters.
3.3.5. The effect of introducing triclosan into the balloon on established Pr. mirabilis 
catheter biofilms
Bladder models were set up with all-silicone catheters, the balloons of both control 
and test models were filled with sterile water. 18 h after the models had been 
inoculated with Pr. mirabilis B2, the water inflating the catheter balloon of the test 
model was replaced with 10 mg/ml triclosan in 5% PEG. All models were then run 
until blockage or for a maximum of seven days.
The data obtained from three replicate experiments are presented in Figure 40. It is 
clear that exposing an 18 h biofilm to triclosan did not prevent subsequent blockage of 
the catheter. The control catheters blocked at a mean time of 30 h compared to the 90 
h of the treated catheters. So once the biofilm has started to develop on the catheter, 
the triclosan strategy is less effective. The pH of the urine in the test models was 
alkaline (mean pH = 8.2) and not significantly different (P = 0.513) from the pH of the 
urine in the control models. There was also little effect on the cells in urine suspension 
in the bladder models, there being no significant difference (P = 0.496) between the 
mean log viable cell count from urine of control and test models.
3.3.6. The concentration of triclosan required in the urine to inhibit an established 
biofilm from further development and subsequent catheter blockage
The aim of this experiment was to use the bladder models to allow a crystalline 
biofilm to form on all-silicone catheters, then to change the urine supply to one that
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Figure 40a: Time to blockage results.
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Figure 40c: The Log10 (cfu/ml) o f the residual urine.
Figure 40: The effect of introducing triclosan into catheter balloons where encrustation 
by Pr. mirabilis had already begun. Control catheters were inflated with water. 18 h after 
inoculation with Pr. mirabilis the water inflating the test catheter balloons was replaced with 
10 mg/ml triclosan in 5% PEG. The subsequent time to blockage, pH and viable cell count 
in the residual urine are shown. The results are means o f  triplicate experiments.
contained different concentrations of triclosan. This would determine the 
concentration of triclosan in the urine required to prevent further development of the 
biofilm. In previous experiments, size 14 Ch all-silicone catheters had been used, but 
as these blocked rapidly and did not allow much time between application of the 
triclosan and subsequent blockage of the control catheters (section 3.3.5), size 16 Ch 
catheters were used in this experiment. Preliminary experiments were set up running 
control models with these catheters for 16 and 20 h. LV-SEM performed on both these 
catheters (Figure 41) revealed that the eye-hole of the 20 h catheter looked very 
encrusted. Since there was an even crystalline biofilm along the length of the 16 h 
catheter but it did not look close to blocking, the urine supply in this experiment was 
changed to one containing triclosan after 16 h.
Seven models were set up for each test. Two control models where the urine supply 
was not changed, one that was taken down after 16 h and one that was run until 
blockage. For the four test models, artificial urine supplies were changed after 16 h to 
contain 0.1, 1, 10 and 100 jug/ml triclosan, all with a final DMSO concentration of 
1 %. A DMSO control was also set up where the urine supply was changed to one that 
contained 1% DMSO after 16 h.
To begin the experiment the seven models were set up all with catheters inflated with 
sterile water and all inoculated with Pr. mirabilis B2 grown in artificial urine (10 ml). 
Samples were taken from each of the models through the sampling ports at t = 15 h for 
viable cell counts and pH determinations. The tubing and artificial urine supply of the 
DMSO control and triclosan test models were changed at t = 16 h. One of the control 
models was also taken down at this time point, and the catheter was prepared for
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Figure 41: Electron micrographs down the length of size 16 Ch all-silicone catheters inflated with water that had been
in Pr. mirabilis B2 infected bladder models for 16 h and 20 h. The positions o f sections A-D are indicated in Figure 6.
calcium and magnesium analysis. Samples were taken through the sampling ports at t 
= 42 h and the models were left to run until blockage or for a maximum of 66 h. When 
the models blocked or at the end of the experiment, viable cell counts and pH 
determinations were performed on the residual urine. These catheters were also 
prepared for calcium and magnesium analysis.
All the control and DMSO control models blocked within the duration of the 
experiment. The models that had their artificial urine supply changed to contain 10 
and 100 pg/ml triclosan drained freely for 66 h. With 0.1 pg/ml triclosan in the 
artificial urine, two of the replicates blocked at 41 and 55 h whilst the other did not 
block. One of the replicates supplied with 1 jig/ml triclosan after 16 h blocked (at 50 
h) whilst the others drained freely until the end of the experiment.
The pH and viable cell count of each model was monitored at 15 h, 42 h, 66 h and at 
blockage, the data are presented in Figures 42 - 45. Analysis of the viable cell count 
and pH of the residual urine at t = 15 h revealed no significant difference (P > 0.05) 
between any of the seven groups. There was no significant difference (P > 0.05) 
between the time to blockage or the pH and viable cell counts of the control and 
DMSO control models at blockage. All the triclosan concentrations significantly 
lowered (P < 0.05) the pH of the residual urine at blockage or at 66 h compared to the 
control models at blockage, whilst 10 and 100 pg/ml triclosan were required to 
significantly lower (P < 0.05) the viable cell count of the urine compared to the 
controls.
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Figure 42: The viable cell count from the residual urine of models in which the urine 
supply was changed to contain different triclosan concentrations 16 h after the 
bladder models were inoculated with Pr. mirabilis B2. Red points indicate the time of 
catheter blockage. Models were run for a maximum o f 66 h.
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Figure 43: The viable cell count from the residual urine of models in which the urine 
supply was changed to contain different triclosan concentrations 16 h after the 
bladder models were inoculated with Pr. mirabilis B2. Red points indicate the time of 
catheter blockage. Models were run for a maximum o f 66 h.
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Figure 44: The pH from the residual urine of models in which the urine supply was 
changed to contain different triclosan concentrations 16 h after the bladder models were 
inoculated with Pr. mirabilis B2. Red points indicate the time of catheter blockage. Models 
were run for a maximum o f 66 h.
Artificial urine supply at 16 h changed to contain 1% DMSO.
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Figure 45: The pH from the residual urine of models in which the urine supply was changed 
to contain different triclosan concentrations 16 h after the bladder models were inoculated
w ith Pr. mirabilis B2. Red points indicate the time o f catheter blockage. Models were run for a 
maximum o f 66 h.
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An extra control model was set up and taken down at 16 h. This allowed a comparison 
between the amount of calcium and magnesium in the catheters taken down at 16 h 
and in the test catheters at blockage or at 66 h. Figure 46 shows the mean amount of 
calcium and magnesium on the catheters for each group tested. There was 
significantly (P < 0.05) more calcium and magnesium on the control, DMSO control, 
0.1 and 1 pg/ml triclosan catheters than on the catheters taken out at 16 h, but no 
significant difference (P > 0.05) between the 16 h catheters and those treated with 10 
and 100 jig/ml triclosan. The only two groups where the calcium and magnesium 
results were significantly lower (P < 0.05) than the control models at blockage were 
the control group taken down at 16 h and the catheters supplied with artificial urine 
containing 100 pg/ml triclosan. As the catheters in this experiment blocked at different 
times, the rate of catheter encrustation was also calculated. The results are presented 
in Figure 47. Statistical analysis revealed no significant difference (P > 0.05) between 
the rates o f encrustation of the control model taken down at 16 h and those of the 
control and DMSO control models that were run until blockage. The rate of 
encrustation of the models whose artificial urine supply was changed to contain 100 
pg/ml triclosan was significantly lower (P < 0.05) than that of the control models and 
those models supplied with 0.1 and 1 pg/ml triclosan.
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Figure 46: The amount of calcium and magnesium (fig per catheter) from catheters in which the urine supply was 
changed to contain different triclosan concentrations 16 h after the bladder models were inoculated with Pr. mirabilis
B2. Three control models were also set up, one was taken down at 16 h, one was run until blockage and the other was supplied 
with artificial urine containing 1% DMSO. The results are a mean o f  triplicate experiments.
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Figure 47: The rate of catheters encrustation (pg calcium and magnesium per catheter per hour) in models where the urine 
supply was changed to contain different concentrations of triclosan 16 h after the bladder models were inoculated with Pr.
mirabilis B2. Three control models were also set up, one was taken down at 16 h, one was run until blockage and the other was supplied 
with artificial urine containing 1% DMSO. The results are a mean o f triplicate experiments.
Resul t s
3.4. Formulation of the triclosan solution
A problem with the preparation of triclosan is its relative insolubility in water. The 
formulation containing 10 mg/ml triclosan in 5% PEG solution has to be heated and 
stirred to produce a white colloidal suspension, and needs to be continually stirred to 
keep it in suspension. It also proved difficult to sterilize this formulation by membrane 
filtration. If triclosan is to be used in the treatment of patients, it is important that the 
formulation is simple to produce, is stable and can be easily sterilized. For these 
reasons, other solvents were tried out to test their ability to dissolve triclosan. It was 
then necessary to establish what effect these solvents had on the catheter balloons and 
to determine if they would be as effective at preventing catheter blockage as the 
triclosan suspension in 5% PEG.
3.4.1. The ability of different solvents to dissolve triclosan and the feasibility of using 
them to inflate the catheter balloon
The first solvent tested was 70% ethanol. Triclosan dissolved quickly in this but the 
alcohol leached out of the catheter balloons within one week. Triclosan could also be 
dissolved without heat in castor oil and olive oil, but both these oils are very viscous. 
The castor oil would not go into the catheter balloons and it was difficult to get the 
olive oil into the balloons. Propylene glycol dissolved triclosan and could be used to 
inflate the balloons, but after a couple of days soaking the catheters in water, the 
balloons became swollen. The final test solution was sodium carbonate; 0.1 M sodium 
carbonate dissolved 3 mg/ml triclosan with stirring but no heat in under 1 h. This was 
the limit of solubility of the biocide in sodium carbonate. It produced a clear solution 
that could easily be used to inflate the all-silicone catheters and both types of latex 
based catheters.
3.4.2. The effect of 3 mg/ml triclosan in 0.1 M sodium carbonate on the catheter 
balloons
Using the method described in section 3.2.3, the effect of triclosan in 0.1 M sodium 
carbonate on the catheter balloon was determined. There were no visible changes to 
any of the catheter balloons inflated with 3 mg/ml triclosan in 0.1 M sodium 
carbonate, 0.1 M sodium carbonate or water after eight weeks soaking in water. All 
catheter balloons could still be deflated at the end of the experiment. The volume of 
liquid left in the catheter balloons after two months soaking in water was recorded and 
the data are presented in Figure 48. There was no significant difference (P > 0.05) 
between the volumes of liquid left in any of the three groups for both types of latex 
catheters. In the case of the all-silicone catheters there was significantly (P < 0. 05) 
more fluid in the 0.1 M sodium carbonate balloons (with and without triclosan) than in 
the catheters that had their balloons inflated with water.
3.4.3. The ability of triclosan in 0.1 M sodium carbonate used to inflate the catheter 
balloon at preventing encrustation bv Pr. mirabilis
Bladder models were set up fitted with all-silicone catheters. Control catheters were 
inflated with water whilst the test catheters were inflated with 10 pg/ml, 100 pg/ml, 
500 pg/ml, 1 mg/ml and 3 mg/ml triclosan all in 0.1 M sodium carbonate. A control 
catheter inflated with 0.1 M sodium carbonate was also tested. The models were 
inoculated with Pr. mirabilis B2 and run until blockage or for a maximum of seven 
days.
There was no significant difference (P > 0.05) between the time to blockage (Figure 
49a) or the pH and viable cell count (Figures 49b+c) from the residual urine of the
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Figure 49: Time to blockage, pH and viable cell count results from models fitted with all­
silicone catheters inflated with triclosan in sodium carbonate and inoculated with Pr.
mirabilis B2. The black arrows indicate the mean results o f the control models.
control and 0.1 M sodium carbonate control models at blockage. 1 and 3 mg/ml 
triclosan in 0.1 M sodium carbonate prevented catheter blockage for seven days, and 
the pH and viable cell count from the residual urine of these models after seven days 
were significantly lower (P < 0.05) than those from the control models at blockage. 
Figure 50 shows electron micrographs of sections down the length of the catheter that 
had its balloon inflated with 3 mg/ml triclosan in 0.1 M sodium carbonate after seven 
days in the model. One of the catheters that had their balloons inflated with 500 pg/ml 
triclosan in 0.1 M sodium carbonate blocked within the seven days, whilst the other 
two replicates drained freely for seven days. 100 pg/ml triclosan in the catheter 
balloon significantly (P < 0.05) increased the time to blockage compared to the 
controls.
3.4.4. The ability of triclosan suspensions in water to prevent catheter encrustation 
when used to inflate the catheter balloons
To determine how the 5% PEG and 0.1 M sodium carbonate solutions affect the 
ability of triclosan to prevent catheter encrustation, models were set up filling the 
catheter retention balloons with a triclosan suspension in water. To allow a 
comparison between the time to blockage of the catheters whose balloons were 
inflated with triclosan in water and those inflated with triclosan in 5% PEG and 0.1 M 
sodium carbonate, a concentration of 100 pg/ml triclosan was chosen to inflate the 
balloons. At this concentration all three types of catheters block (section 3.3.1), but 
the time to blockage of the catheters containing this concentration of triclosan is 
significantly longer than the controls (P < 0.05) for each catheter type (Figure 19a, 
20a, 21a). All three different types of catheters were tested with the 100 pg/ml 
suspension of triclosan in water, models were run until blockage. All-silicone
Figure 50: Electron micrographs of an all-silicone catheter that had its balloon inflated with 3 mg/ml triclosan in 0.1 M sodium carbonate
after 7 days in a Pr. mirabilis infected bladder model. 6 pictures were taken along the length o f the catheter. The positions o f sections A-F are
catheters were also set up inflating the catheter with a 10 mg/ml triclosan suspension 
in water. Models were run until blockage or for a maximum of seven days.
There was no significant difference (P > 0.05) between the time to blockage, pH or 
viable cell count in the residual urine (Figures 51) of all-silicone catheters using 100 
Ug/ml triclosan in suspension compared to the same concentration in 5% PEG or 0.1 
M sodium carbonate. The 10 mg/ml triclosan in aqueous suspension in all-silicone 
catheters allowed the urine to drain freely for seven days. There was no significant 
difference (P > 0.05) between the viable cell counts and pH from the residual urine of 
these models at seven days compared to those inflated with 10 mg/ml triclosan in 5% 
PEG or 3 mg/ml triclosan in 0.1 M sodium carbonate.
Using the hydrogel-coated latex catheters, there was no significant difference (P > 
0.05) in the time to blockage, pH or viable cell count between catheters inflated with 
100 pg/ml triclosan in aqueous suspension and the same concentration in 5% PEG. 
The pH and viable cell count from the residual urine of models fitted with the 
catheters inflated with 100 pg/ml triclosan in 5% PEG were significantly lower (P < 
0.05) than those inflated with triclosan in suspension for the silicone-coated latex 
catheters. The time to blockage for the silicone-coated latex catheters were also 
significantly (P < 0.05) increased using triclosan in 5% PEG.
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Figure 51: Time to blockage, pH and viable cell count results from models fitted with 
three different catheter types and inflated with 100 pg/ml triclosan in water or 5% PEG, 
the all-silicone catheter results with 100 ^ig/ml triclosan in 0.1M sodium carbonate are 
also included. All-silicone, Biocath (hydrogel-coated latex catheters) and silicone-elastomer 
(silicone-coated latex catheters) catheters were tested. Models were inoculated with Pr. 
mirabilis B2. Results are means o f  triplicate experiments.
3.5. The sensitivity of other urinary tract pathogens to triclosan
3.5.1. MICs of urinary tract pathogens to triclosan
A wide range of bacterial species can infect the catheterised urinary tract. The activity 
of triclosan was tested against eight of the more common species. Table 5 gives the 
MIC values of eight different urinary tract pathogens (clinical catheter isolates) to 
triclosan,- Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, 
Morganella morganii, Providencia stuartii, Serratia marcescens, Staphylococcus 
aureus and Enterococcus faecalis were all tested. Where possible five isolates of each 
species was tested. The maximum triclosan concentration used in the MIC tests was 
100 pg/ml, as this is the limit of its solubility in agar.
3 .5 .2. The bactericidal activity of triclosan against different urinary tract pathogens 
To determine the bactericidal activity o f triclosan against other urinary tract 
organisms, bactericidal tests were performed using one strain from each bacterial 
species tested in section 3.5.1 (the organisms used have been marked with in Table 
5). Figure 52a shows the mean logio reductions in the numbers of viable cells with 100 
pg/ml triclosan for six bacterial species over 5, 30 and 60 min. A mean logio reduction 
of less than one was achieved with 100 pg/ml triclosan over a 1 h period with E. coli, 
K. pneumoniae, Ser. marcescens and Ps. aeruginosa. Higher mean logio reductions 
were given by Pv. stuartii and M  morganii, but only the latter gave a mean logio 
reduction of higher than five in 1 h. S. aureus and Ent. faecalis were more sensitive to 
the lethal effects of triclosan, hence lower concentrations were tested all over a 5 min 
time period (Figure 52b). Mean logio viable bacterial cell count reductions of over five 
were achieved with 20 and 30 pg/ml triclosan for Ent. faecalis and S. aureus
Species Strain no. Triclosan MIC (pg/ml) Urease producer?
E. coli NSM 16* 0.2 X
N 123 0.2 X
N 55 0.3 \
N 39 0.2 X
SM 1 0.2 \
Pv. stuartii NSM 14* 0.3-0.4 X
NSM 40 0.2 \
NSM 58 0.2 X
NSM 71 0.2 X
NSM 24 0.2-0.3 X
K. pneumoniae SM 28 0.7 Y
NSM 48 0.3-0.4 Y
NSM 37 0.4-0.6 Y
NSM 41 0.5-0.6 Y
CC36* 0.5-0.8 Y
E nt faecalis N 21 7 X
N70 7 X
CC39* 7 X
CC40 7 X
CC43 7 X
S. aureus N 112 0.1 X
N 114 0.1 X
NSM 5* 0.4-0.6 Y
SM 9 0.2 X
NSM 8 0.1-0.2 X
Ser. marcescens NSM 63 >100 Y
N 53 >100 Y
CC 13* >100 Y
CC 42 >100 y
M. morganii NSM 63 >100 Y
NSM 21 >100 ✓
NSM 18 >100 Y
NSM 13 >100 Y
MS 2* >100 Y
Ps. aeruginosa NSM 10 >100 Y
NSM 20 >100 Y
NSM 46 >100 Y
NSM 57* >100 Y
NSM 62 >100 Y
Table 5: The MIC (pg/ml) of triclosan for eight different urinary tract pathogens. The
values were obtained from three replicate tests. Single strains o f each species marked with **' 
were tested in further experiments. The ability o f  each strain to produce the urease enzyme is 
also shown.
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Figure 52: The bactericidal effect of triclosan on urinary tract pathogens.
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respectively. Neat suspensions of Ent. faecalis only contained about 5 x 107 cfu/ml; 
hence this was used instead of the 1 x 109 cfu/ml standard inoculum in this 
experiment.
3.5.3. The ability of urinary tract pathogens to form biofilms on catheters and the 
effect of triclosan on their development
The aim of this experiment was to investigate the ability of a range of urinary tract 
pathogens to form biofilms on urinary catheters, and to observe what effect filling the 
balloon with triclosan had on their development. The bladder models were fitted with 
all-silicone catheters, and in each case, control catheters were inflated with water 
while the test catheters were inflated with 10 mg/ml triclosan in 5% PEG. Models 
were infected with a test organism (10 ml) grown for 4 h in artificial urine and were 
run for a maximum of 48 h. Biofilm formation was assessed by counting the number 
of viable cells attached to the catheter and by electron microscopy. To determine the 
number of viable cells attached onto the catheter, the catheters were removed from the 
models and the balloons of the triclosan catheters were flushed out 10 times with fresh 
sterile water. The catheter balloon was removed and the top of the catheter up to 5 cm 
below the balloon was cut into 1 cm sections. These sections were placed into 
neutraliser (10 ml), vortexed for 2 min and sonicated (at 35 khz) for 5 min. Viable cell 
counts were then performed to determine the numbers of bacteria that had been 
shaken off the catheter sections. This experiment was replicated four times, so that 
the catheters from one run could be observed under LV-SEM.
The same eight bacterial strains that were tested in section 3.5.2 were tested in the 
bladder models. Pr. mirabilis B2 was also run in the models for a maximum of 48 h
- 100-
with and without triclosan. None of the eight different bacterial species blocked the 
catheter within 48 h. All the Pr. mirabilis control models blocked within this time 
(mean 29 ± 9.24 h), but the triclosan models drained freely for 48 h.
The pH of the inoculating culture, and the pH of the residual urine from the control 
and test bladder models from each organism at 24 and 48 h are shown in Figure 53. 
The pHs of the inoculating cultures with Pr. mirabilis were all above 8.6 and the pH 
of the control models remained above 8 throughout the experiment until blockage. 
Triclosan significantly reduced the pH in the residual urine of the Pr. mirabilis 
infected models at 48 h compared to the pH o f the controls at blockage (P = 0.046). 
The pH values for all the other bacterial species remained acidic throughout the 
experiment, even with the urease-producing organisms. The pH of the residual urine 
for the triclosan treated Pv. stuartii was significantly lower than the control at 48 h (P 
= 0.017). There was no significant difference (P > 0.05) between the pH values of the 
test and control models at 24 or 48 h for any of the other bacterial species tested.
Figure 54 shows the logio (cfu/ml + 1) data of the inoculating culture and of the 
residual urine from the control and test bladder models from each organism at 24 and 
48 h. For the Pr. mirabilis, Pv. stuartii, E. coli, S. aureus, Ent. faecalis and K. 
pneumoniae there were significantly lower numbers (P < 0.05) of viable cells in the 
residual urine of the triclosan treated models compared to the controls at 24 and 48 h. 
There was no significant difference (P > 0.05) between the viable cell count from the 
residual urine of control and triclosan treated models inoculated with M. morganii, 
Ser. marcescens or Ps. aeruginosa at 24 or 48 h.
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The logio (cfu/ml +1) for the numbers of bacteria in the biofilm on the top sections of 
the control and test catheters inoculated with the eight different organisms after 48 h, 
the Pr. mirabilis triclosan catheter at 48 h and the Pr. mirabilis control catheter at 
blockage are shown in Figure 55. Triclosan significantly (P < 0.05) reduced the 
numbers of viable cells in the biofilm at the end of the experiment for all bacterial 
species except for Ps. aeruginosa.
Figures 56 + 57 show LV-SEM images of the control and triclosan test catheters 
inoculated with the Ps. aeruginosa and E. coli taken after 48 h in the models. The LV- 
SEM images of the catheters inoculated with the six other urinary tract pathogens are 
presented in Appendix 2.
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Figure 56: Electron micrographs of control and triclosan treated catheters inoculated with E. 
coli after 48 h. The positions o f sections A-D are indicated in Figure 6.
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Figure 57: Flectron micrographs of control and triclosan treated catheters inoculated with 
aeruginosa after 48 h. The positions o f sections A-D are indicated in Figure 6.
TRICLOSAN
3.6. An investigation of resistance to triclosan in Pr. mirabilis
Due to the increased concern regarding resistance in bacteria to biocides and 
antibiotics, the aim of this section was to examine whether exposure of Pr. mirabilis 
to triclosan could result in the emergence of strains with an increased resistance to the 
biocide.
3.6.1. Isolation of Pr. mirabilis mutants with increased triclosan MICs 
Two different methods of isolating mutants with elevated triclosan MICs were tested. 
The first method relied on isolating mutants from a zone of inhibition created by a 
triclosan soaked disk placed onto a bacterial lawn. All five Pr. mirabilis strains tested 
swarmed into these zones of inhibition, hence the isolation of mutants using this 
method was not possible. The second method involved spreading a heavy inoculum of 
the test strains onto plates containing super-MIC concentrations of triclosan (0 .5 -1 0  
pg/ml). 55 mutants were isolated using this method. Table 6 shows the MISC and 
MIC for each mutant isolated and it also gives details of the parent strains and the 
concentration at which each mutant was isolated.
A selection of 14 mutants were sub-cultured in the absence of triclosan for 15 days. 
Table 7 shows the MIC for each mutant tested after 1, 3, 7, 11 and 15 sub-cultures. 
There were no substantial decreases in the MIC of any mutants tested. Each of the 
mutant sub-cultures were streaked out onto TSA and CLED Agar and they revealed 
no signs of contamination. The purity of the cultures whose MICs rose considerably 
(M l2, 17, 19, 35, 40, 44, 55) were confirmed using the BBL crystal™ identification 
kits. This set of experiments confirmed the stability of the mutants.
Mutant
number
Parental
strain
Concentration o f triclosan 
at which the mutant was isolated
MIC
pg/ml
MSC
pg/ml
Ml NP43 0.5 pg/ml 5-40 0.8-10
M2 NP43 0.5 pg/ml 5 0.8-1
M3 NP43 0.5 pg/ml 60-80 10-20
M4 NP43 0.5 pg/ml 5 0.3-0.4
M5 NP43 0.5 pg/ml 0.5-5 0.1-0.3
M6 NP43 0.5 pg/ml 5 0.3-0.5
M7 NP43 0.5 pg/ml 5 0.3-0.5
M8 NP43 0.5 pg/ml 0.3-0.6 0.3
M9 NP43 1 pg/ml 40-60 20-40
M10 NP43 1 pg/ml 5 0.3-0.4
M il NP43 1 pg/ml 20-40 5-10
M12 NP43 1 pg/ml 40-60 20-40
M13 NP43 2 pg/ml 40-60 40
M14 NP43 2 pg/ml 2-5 0.6-1
M15 NP43 5 pg/ml 40 0.6-2
M16 NP43 5 pg/ml 40 10
M17 NP43 10 pg/ml 40-60 0.8-5
M18 NP14 0.5 pg/ml 0.3-0.4 0.2
M19 NP14 0.5 pg/ml 40-60 20-40
M20 NP14 0.5 pg/ml 0.4-0.5 0.3-0.4
M21 NP14 1 pg/ml 5 2-5
M22 NP14 1 pg/ml 0.3-0.4 0.2-0.3
M23 NP14 2 pg/ml 5-10 5
M24 NP14 2 pg/ml 5 2-5
M25 NP37 0.5 pg/ml 5-10 2
M26 NP37 0.5 pg/ml 20 10
M27 NP37 1 pg/ml 5-10 2-5
M28 NP37 1 pg/ml 5-10 2-5
M29 NP37 1 pg/ml 10 5
M30 NP37 2 pg/ml 5-10 2-5
M31 NP37 2 pg/ml 5 2-5
M32 NP55 0.5 pg/ml 5-10 5
M33 NP55 0.5 pg/ml 5-10 5
M34 NP55 0.5 pg/ml 5-10 5
M3 5 NP55 0.5 pg/ml 40 40
M37 NP55 0.5 pg/ml 5-10 2
M38 NP55 1 pg/ml 5-10 5
M39 NP55 1 pg/ml 20-60 20-40
M40 NP55 1 pg/ml 40-60 10-40
M41 NP55 2 pg/ml 0.2 0.1
M42 NP55 2 pg/ml 0.8-5 0.5-1
M43 NP55 2 pg/ml 5-40 1-20
M44 B2 0.5 pg/ml 40 10-20
M45 B2 0.5 pg/ml 2-5 0.4-0.6
M46 B2 0.5 pg/ml 2-5 0.4-0.6
M47 B2 0.5 pg/ml 2-5 0.2-0.4
M48 B2 0.5 pg/ml 2-5 0.8-2
M49 B2 0.5 pg/ml 0.5-5 0.2-0.5
M50 B2 0.5 pg/ml 5 0.8
M51 B2 0.5 pg/ml 0.3-0.8 0.2-0.4
M52 B2 2 pg/ml 20-60 20-40
M53 B2 2 pg/ml 40 10-40
M54 B2 2 pg/ml 0.2-0.3 0.1
M55 B2 5 pg/ml 40 20
Table 6: Table showing the parental strain o f each mutant, the concentration at 
which the mutants were isolated, their MIC and MISC. The results are from 
experiments performed in triplicate in agar.
MIC (pg/ml) after 1, 3, 7, 11 and 15 subcultures 
in the absence  of triclosan
Mutant no. MIC 1 MIC 3 MIC 7 MIC 11 MIC15
M 12 60 60 60 >100 >100
M 17 60 60 60 >100 100
M 19 40 40 40 100 80
M 21 5 5 5 10 5
M 23 5 10 10 20 10
M 26 20 20 20 20 10
M 29 5 5 5 5 5
M 31 5 5 2 2 2
M 35 40 40 40 >100 >100
M 40 100 >100 >100 >100 >100
M 42 5 5 10 10 5
M 44 40 40 60 100 >100
M 48 2 2 2 2 2
M 55 40 40 60 >100 >100
Table 7: The MIC of 14 Pr. mirabilis mutants after 1, 3, 7, 11 and 15 subcultures in the 
absence of triclosan. Since there were no considerable decreases in the MIC when the 
mutants were sub-cultured in the absence o f  a selective pressure, they were considered to be 
stable.
3 .6.2. Bactericidal activity o f triclosan against the mutants
Three of the mutants M44, M48 and M55 derived from Pr. mirabilis B2 were tested in 
further experiments. The mean logio viable cell count reductions for these mutants and 
their wild-type strains given by 100 pg/ml triclosan over three time periods are shown 
in Figure 58. Tables 8, 9 and 10 show the P-values from statistical analysis 
individually comparing each strain tested in the suspension tests throughout this 
project at 5, 30 and 60 min.
The MICs for M44, M48 and M55 in artificial urine were 5 - 8, 3 and 4 - 8  pg/ml 
respectively. These MICs are significantly higher (P < 0.05) than that of Pr. mirabilis 
B2 which was 0.2 pg/ml. Figure 59 shows the pH values from the cultures over a 
range of triclosan concentrations. Much higher triclosan concentrations were required 
to maintain acidic conditions in the artificial urine inoculated with the mutants 
compared to the parental strain. 0.2 pg/ml of triclosan kept the artificial urine culture 
inoculated with B2 acidic, whilst to keep the cultures inoculated with the mutants 
acidic, concentrations of 6, 3 and 8 pg/ml triclosan were required for M44, M48 and 
M55 respectively.
3.6.3. The ability of triclosan in the balloon to control catheter encrustation when the 
bladder models were inoculated with Pr. mirabilis triclosan resistant mutants 
Three mutants M44, M48 and M55 and their parental strain Pr. mirabilis B2 were run 
in the bladder models fitted with all-silicone catheters. Control models with sterile 
water in the balloon and test models with 10 mg/ml triclosan in 5% PEG in the 
balloon were set up for each mutant and the wild-type strain. Models were run until 
blockage or for a maximum of 48 h. Calcium and magnesium analysis was performed
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Figure 58: The bactericidal activity of triclosan against Pr. mirabilis B2 and three of its mutant strains after different contact times 
with 100 jig/ml triclosan. The mean values are from experiments performed in triplicate.
NP 55 NSM 6 B 2 NSM 42 NP 37 M 44 M 48 M 55 E. coli Prov Kleb Ser Morg Ps
NP 55 0.570 0.546 0.514 0.389 0.980 0.382 0.880 0.001 0.976 0.023 0.001 0.979 0.023
NSM 6 0.570 0.299 0.719 0.490 0.688 0.160 0.813 0.001 0.643 0.028 0.001 0.591 0.002
B 2 0.546 0.299 0.317 0.048 0.300 0.716 0.250 0.000 0.342 0.003 0.000 0.400 0.000
NSM 42 0.514 0.719 0.317 0.579 0.680 0.189 0.790 0.002 0.640 0.044 0.001 0.508 0.004
NP 37 0.389 0.490 0.048 0.579 0.Q62 0.005 0.126 0.000 0.061 0.001 0.000 0.213 0.000
M 44 0.980 0.688 0.300 0.680 0.062 0.071 0.784 0.000 0.900 0.001 0.000 0.995 0.000
M 48 0.382 0.160 0.716 0.189 0.005 0.071 0.065 0.000 0.092 0.000 0.000 0.195 0.000
M 55 0.880 0.813 0.250 0.790 0.126 0.784 0.065 0.000 0.705 0.002 0.000 0.857 0.000
E. coli 0.001 0.001 0.000 0.002 0.000 0.000 0.000 0.000 0.000 0.174 0.267 0.000 0.005
Prov 0.976 0.643 0.342 0.640 0.061 0.900 0.092 0.705 0.000 0.001 0.000 0.929 0.000
Kleb 0.023 0.028 0.003 0.044 0.001 0.001 0.000 0.002 0.174 0.001 0.111 0.009 0.018
Ser 0.001 0.001 0.000 0.001 0.000 0.000 0.000 0.000 0.267 0.000 0.111 0.001 0.006
Morg 0.979 0.591 0.400 0.508 0.213 0.995 0.195 0.857 0.000 0.929 0.009 0.001 0.000
Ps 0.023 0.002 0.000 0.004 0.000 0.000 0.000 0.000 0.005 0.000 0.018 0.006 0.000
Table 8: The P-values from statistical analysis individually comparing each strain tested with 100 pg/ml triclosan in the tests examining the bactericidal effects
of triclosan after a 5 minute contact time. The table includes five Pr. mirabilis strains B2, NP37, NP55, NSM 6 and NSM 42. Three mutant strains of Pr. mirabilis
B2: M44, M48 and M55. The Ps. aeruginosa, E. coli, K. pneumoniae, M. morganii, Pv. stuartii and Ser. marcescens strains tested have also been included.
NP 55 NSM 6 B 2 NSM 42 NP 37 M 44 M 48 M 55 E. coli Prov Kleb Ser Morg Ps
NP 55 0.018 0.389 0.057 0.007 0.011 0.427 0.007 0.000 0.001 0.000 0.000 0.078 0.000
NSM 6 0.018 0.025 0.057 0.809 0.807 0.018 0.797 0.001 0.513 0.002 0.009 0.058 0.000
B 2 0.389 0.025 0.101 0.010 0.012 0.829 0.007 0.000 0.001 0.000 0.000 0.156 0.000
NSM 42 0.057 0.057 0.101 0.008 0.022 0.033 0.011 0.000 0.001 0.000 0.000 0.815 0.000
NP 37 0.007 0.809 0.010 0.008 0.975 0.003 0.483 0.001 0.147 0.001 0.000 0.011 0.000
M 44 0.011 0.807 0.012 0.022 0.975 0.007 0.521 0.000 0.513 0.000 0.001 0.027 0.000
M 48 0.427 0.018 0.829 0.033 0.003 0.007 0.004 0.000 0.000 0.000 0.000 0.074 0.000
M 55 0.007 0.797 0.007 0.011 0.483 0.521 0.004 0.001 0.043 0.001 0.003 0.014 0.000
E. coli 0.000 0.001 0.000 0.000 0.001 0.000 0.000 0.001 0.000 0.089 0.037 0.000 0.001
Prov 0.001 0.513 0.001 0.001 0.147 0.513 0.000 0.043 0.000 0.000 0.000 0.005 0.000
Kleb 0.000 0.002 0.000 0.000 0.001 0.000 0.000 0.001 0.089 0.000 0.012 0.000 0.000
Ser 0.000 0.009 0.000 0.000 0.000 0.001 0.000 0.003 0.037 0.000 0.012 0.000 0.179
Morg 0.078 0.058 0.156 0.815 0.011 0.027 0.074 0.014 0.000 0.005 0.000 0.000 0.000
Ps 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.001 0.000 0.000 0.179 0.000
Table 9: The P-values from statistical analysis individually comparing each strain tested with 100 pg/ml triclosan in the tests examining the bactericidal effects
of triclosan after a 30 minute contact time. The table includes five Pr. mirabilis strains B2, NP37, NP55, NSM 6 and NSM 42. Three mutant strains of Pr. mirabilis
B2: M44, M48 and M55. The Ps. aeruginosa, E. coli, K. pneumoniae, M. morganii, Pv. stuartii and Ser. marcescens strains tested have also been included.
NP 55 NSM 6 B 2 NSM42 NP 37 M 44 M 48 M 55 E. coli Prov Kleb Ser Morg Ps
NP 55 0.032 0.330 0.008 0.001 0.018 0.143 0.000 0.000 0.000 0.000 0.000 0.052 0.000
NSM 6 0.032 0.053 0.034 0.911 0.854 0.068 0.658 0.008 0.513 0.020 0.003 0.092 0.004
B 2 0.330 0.053 0.164 0.003 0.033 0.600 0.001 0.000 0.002 0.000 0.000 0.273 0.000
NSM 42 0.008 0.034 0.164 0.002 0.032 0.402 0.000 0.000 0.000 0.000 0.000 1.000 0.000
NP 37 0.001 0.911 0.003 0.002 0.672 0.003 0.823 0.002 0.132 0.002 0.001 0.005 0.000
M 44 0.018 0.854 0.033 0.032 0.672 0.045 0.821 0.018 0.513 0.003 0.001 0.064 0.001
M 48 0.143 0.068 0.600 0.402 0.003 0.045 0.001 0.000 0.003 0.000 0.000 0.526 0.000
M 55 0.000 0.658 0.001 0.000 0.823 0.821 0.001 0.000 0.014 0.000 0.000 0.002 0.000
E. coli 0.000 0.008 0.000 0.000 0.002 0.018 0.000 0.000 0.000 0.299 0.023 0.000 0.005
Prov 0.000 0.513 0.002 0.000 0.132 0.513 0.003 0.014 0.000 0.000 0.000 0.004 0.000
Kleb 0.000 0.020 0.000 0.000 0.002 0.003 0.000 0.000 0.229 0.000 0.002 0.000 0.001
Ser 0.000 0.003 0.000 0.000 0.001 0.001 0.000 0.000 0.023 0.000 0.002 0.000 0.032
Morg 0.052 0.092 0.273 1.000 0.005 0.064 0.526 0.002 0.000 0.004 0.000 0.000 0.000
Ps 0.000 0.004 0.000 0.000 0.000 0.001 0.000 0.000 0.005 0.000 0.001 0.032 0.000
Table 10: The P-values from statistical analysis individually comparing each strain tested with 100 pg/ml triclosan in the tests examining the bactericidal
effects of triclosan after a 60 minute contact time. The table includes five Pr. mirabilis strains B2, NP37, NP55, NSM 6 and NSM 42. Three mutant strains o f Pr.
mirabilis B2: M44, M48 and M55. The Ps. aeruginosa, E. coli, K. pneumoniae, M. morganii, Pv. stuartii and Ser. marcescens strains tested have also been included.
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Figure 59: The pH values of artificial urine cultures containing different triclosan concentrations and inoculated with Pr. mirabilis mutant strains.
Artificial urine culture series’ were set up containing different concentrations o f triclosan, and inoculated with the mutant strains. These results show the pH 
values o f the cultures after the 6 h incubation period. The results are a mean o f three experiments. The black arrow indicates the mean pH of the uninoculated 
artificial urine controls after incubation
on the catheters when they blocked or after 48 h. The experiment was replicated three 
times.
The times to blockage for each control and triclosan treated replicate inoculated with 
the three mutants and Pr. mirabilis B2 are shown in Table 11. Models inoculated with 
M48 produced results similar to those using the wild-type strain (B2). All the controls 
blocked whilst the triclosan models drained freely for 48 h. The control and test 
models inoculated with M55 all blocked within 48 h. In models inoculated with M44 
two replicates blocked whilst the other did not for both the control and test models.
The pH and viable cell count results from the residual urine of models when they 
blocked or at the end of the experiment are presented in Figures 60a+b. The pH and 
viable cell count from the residual urine of the B2 and M48 triclosan test models were 
significantly lower (P < 0.05) than all the other test and control models. The pH and 
viable cell counts of the triclosan models inoculated with M44 and M55 were not 
significantly different (P > 0.05) from the controls. The amount of calcium and 
magnesium on the catheters at blockage or at the end of the experiment are shown in 
Figure 60c. Triclosan significantly reduced (P < 0.05) the amount of calcium and 
magnesium on catheters inoculated with Pr.mirabilis B2 and M48, but there was no 
significant difference (P > 0.05) between control and triclosan models inoculated with 
M44 and M55. There was no significant difference (P > 0.05) between the total 
encrustation, pH or viable cell count in the residual urine of the control Pr. mirabilis 
B2 inoculated models and the control models inoculated with the three mutant strains. 
The pH, viable cell count and total encrustation was however significantly higher (P < 
0.05) in the triclosan models inoculated with mutants M44 and M55 than in triclosan
Replicate no. Strain Control / tes t  m odel Time to b lockage (h)
Replicate 1 B2 control 25.5
Replicate 2 B2 control 35
Replicate 3 B2 control 35
Replicate 1 B2 10mg/ml triclosan in 5% PEG Did not block in 48 h
Replicate 2 B2 10mg/ml triclosan in 5% PEG Did not block in 48 h
Replicate 3 B2 10mg/ml triclosan in 5% PEG Did not block in 48 h
Replicate 1 M44 control Did not block in 48 h
Replicate 2 M44 control 29
Replicate 3 M44 control 30
R eplicate 1 M44 10mg/ml triclosan in 5% PEG 40
Replicate 2 M44 10mg/ml triclosan in 5% PEG 33
Replicate 3 M44 10mg/ml triclosan in 5% PEG Did not block in 48 h
Replicate  1 M48 control 38
Replicate  2 M48 control 34
Replicate  3 M48 control 28
Replicate 1 M48 10mg/ml triclosan in 5% PEG Did not block in 48 h
Replicate 2 M48 10mg/ml triclosan in 5% PEG Did not block in 48 h
Replicate  3 M48 10mg/ml triclosan in 5% PEG Did not block in 48 h
Replicate  1 M55 control 31
Replicate  2 M55 control 42
Replicate  3 M55 control 36
Replicate  1 M55 10mg/ml triclosan in 5% PEG 46
Replicate  2 M55 10mg/ml triclosan in 5% PEG 41
Replicate  3 M55 10mg/ml triclosan in 5% PEG 44
Table 11: Time to catheter blockage data from the control and triclosan test bladder 
models inoculated with mutants M44, M48 and M55 and their wild-type strain Pr.
mirabilis B2. The catheters o f test models were inflated with 10 mg/ml triclosan in 5% 
PEG, and those o f  the control models with water. The models were run for a maximum o f  
48 h and the experiment was performed in triplicate.
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Figure 60a: The mean pH of the residual urine.
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Figure 60b: Mean log10 (cfu/ml + 1) bacteria in the residual urine.
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Figure 60c: Mean amount o f calcium and magnesium (pg per catheter).
Figure 60: pH, viable cell count and calcium and magnesium results from models 
inoculated with Pr. mirabilis B2 and three of its mutant strains. The balloons o f control 
catheters were inflated with water, the balloons o f the test catheters were inflated with 10 
mg/ml triclosan in 5% PEG. The models were run for a maximum of 48 h. The results are a 
mean from three replicate experiments.
models inoculated with the wild-type strain. The encrustation rate of the control and 
test catheters inoculated with the wild-type and mutant strains were also calculated 
(Figure 61). There was no significant difference (P < 0.05) between the rate of 
encrustation of the control wild-type strain and the control models inoculated with the 
mutants. As opposed to the results comparing the total encrustation, statistical analysis 
of the rate of encrustation data revealed no significant difference (P >0.05) between 
the triclosan test models inoculated with Pr. mirabilis B2 and those inoculated with 
mutants M44 and M48. The rate o f encrustation for the triclosan models inoculated 
with M55 was however significantly (P < 0.05) higher than for the test model 
inoculated with the wild-type strain.
3.6.4. Have the triclosan resistant mutants also gained cross-resistance to antibiotics?
The antibiotic sensitivities of the 14 mutants whose stability had been verified, and 
their 5 wild-type strains were tested using antibiotic E-test strips. The E-tests produce 
elliptical zones of inhibition on inoculated agar plates (Figure 62). The results are 
presented in Table 12. The 8 boxes highlighted in yellow on the antibiotic sensitivity 
table show the mutant MICs that were higher than those of their wild-type strain, 
however these increases are only marginal.
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Figure 61: The rate of catheter encrustation (pg calcium and magnesium per catheter per hour) in control and test models 
inoculated with three mutant strains and the wild type strain Pr. mirabilis B2. Control models had catheter balloons inflated with 
water, test models had catheters inflated with 10 mg/ml triclosan in 5% PEG. The results are a mean from three replicate experiments.
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Figure 62: A picture illustrating the ty pical elliptical zone of inhibition created by the 
E-test strips. The MIC value was determined by observing where the edge o f the 
inhibition ellipse intersected the E-test strip.
ANTIBIOTICS
T est strain trim ethoprim ampicillin ciprofloxacin nitrofurantoin norfloxacin cefalexin nalidixic acid gentam icin
E.coli 10418 0.032 - 0.047 0 .5 -0 .7 5 0.003 - 0.004 2 - 3 0.023 2 - 3 0 .3 8 -0 .5 8 0.094
Pr. m irabilis B2 R R 0.023 - 0.032 6 4 - 9 6 0.047 6 2 - 3 0.38
M44 R R 0.032 3 2 - 4 8 0.047 4 - 6 1 . 5 - 2 0.38
M48 R R 0.01 6 -0 .0 2 3 2 4 - 4 8 0.047 3 - 4 1 . 5 - 2 0.25 - 0.38
M55 R R 0.023 - 0.032 48 0.047 4 1.5 0 . 3 8 - 0 . 5
Pr. m irabilis  NP14 R 16 0.064 3 2 - 4 8 0.25 3 3 0 .1 2 5 -0 .2 5
IN/119 R 1 2 - 1 6 0.047 - 0.064 3 2 - 4 8 0 .1 9 - 0 .2 5 4 2 - 3 0 .1 2 5 -0 .1 9
M21 R 16 0.047 - 0.064 48 0 .1 9 - 0 .2 5 3 - 4 3 0 .1 2 5 -0 .1 9
M23 R 1 2 - 1 6 0.047 - 0.064 3 2 - 6 4 0 .1 9 - 0 .2 5 3 2 - 4 0.094 - 0.125
Pr. m irabilis  NP37 R R 0.016 - 0.023 24 0.047 - 0.064 4 - 2 4 4 - 1 2 0 . 3 8 - 4
M26 R R 0.012 2 4 - 3 2 0.032 3 1 . 5 - 2 0 .1 2 5 -0 .1 9
M29 R R 0 .0 08-0 .0 12 1 6 - 2 4 0.032 - 0.047 2 - 4 2 - 3 0 .1 9 - 1
M31 R R 0 .0 08-0 .0 12 24 0.023 - 0.032 3 - 1 2 1 . 5 - 2 0 .1 2 5 -0 .2 5
Pr. m irabilis  NP43 0.38 0 . 3 8 - 0 . 5 0.012 48 0.047 4 2 0 .0 94 -0 . 125
M12 0 .1 9 - 0 .2 5 0 .1 2 5 -0 .1 9 0.006 - 0.008 1 2 - 3 2 0.023 1 . 5 - 2 1 . 5 - 2 0.064 - 0.094
M17 0.25 - 0.38 0 .1 9 - 0 .2 5 0 .0 06-0 .0 12 1 2 - 3 2 0.023 1 - 2 2 0.064 - 0.094
Pr. m irabilis NP55 R R 0.016 6 4 - 9 6 0.047 - 0.064 4 - 6 3 0 .1 2 5 -0 .2 5
M35 R R 0.0 16 -0 . 023 3 2 - 9 6 0.032 - 0.047 3 2 - 3 0.25
M40 R R 0 .0 12-0 .0 23 64 0.032 - 0.047 3 - 6 1 . 5 - 2 0 .1 2 5 -0 .1 9
M42 R R 0.016 4 8 - 6 4 0.032 4 2 - 3 0.25
Table 12: The MIC of eight antibiotics against Pr. mirabilis wild-type and mutant strains. The results highlighted in blue are those of the wild-type 
strains. The results highlighted in yellow are the mutant MICs that were above those of the wild-type strains. All results were determined using antibiotic E- 
test strips, and experiments were performed in triplicate. All MIC measurements are in pg/ml. R indicates that the bacterial isolates were resistant to the test 
antibiotics.
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4. Discussion
Indwelling bladder catheters are the most commonly deployed prosthetic medical 
devices (Darouiche, 2001). The incidence of infection, morbidity and mortality 
associated with their use is unacceptable (Kunin, 1988). Complications resulting from 
CA-UTI are not only distressing to the patients but are also a considerable drain on 
health service resources. Shih et al. (2003) carried out a prospective study examining 
the costs of labour, supplies and services involved in caring for long-term care 
residents with and without urinary incontinence. The cost of caring for patients with 
urinary incontinence was shown to be an additional $4,957 per patient per annum. 
Tambyah et al. (2002) investigated the additional direct costs of hospitalisation due to 
CA-UTIs in 1,497 newly catheterised patients. They reported that the extra cost of 
hospitalisation incurred in the management o f CA-UTI in 123 infected patients was 
$20,662 in extra diagnostic tests and $35,872 in extra medication costs. The mean cost 
for dealing with each CA-UTI was computed to be $589.
Results from a pilot study investigating the costs associated with long-term 
catheterisation in community based patients demonstrated a wide variation in direct 
costs associated with different patients over a three month period (Evans et al., 2000). 
In the seven patients studied, the costs varied from between £118.80 to £2588.26, the 
most significant part of this being staffing costs. The cost burden associated with 
dealing with these problems is likely to increase in future years with demographic 
changes to the human population. Whereas people over the age of 60 currently 
constitute a fifth of the British population, by 2030 this will rise to a third (Greengross
et al., 1997). A novel strategy for controlling the complications of CA-UTI would thus 
be beneficial to patients and the health service.
4.1. Novel methods for controlling biofilm formation on urinary catheters
Conceptually, the simplest approach to prevent biofilm formation would be to 
impregnate medical devices with a broad-spectrum antimicrobial agent that eluted into 
the surrounding environment. In this way planktonic bacteria in the vicinity of the 
device could be attacked before they colonize surfaces and adopt the antibacterial 
resistant biofilm phenotype (Danese, 2002). Although a simple idea, there are a 
number of technical obstacles that have limited the effectiveness of antimicrobial 
impregnated or coated IUCs. Firstly, impregnating or coating a catheter should not 
alter the physical properties of the device or change its compatibility with the host 
tissue. Secondly, the catheters must contain sufficient amounts of the chosen 
antimicrobial to allow sustained release of active concentrations of the agent for the 
lifetime of the device (Danese, 2002). Difficulties in delivering bacteriostatic or 
bactericidal concentrations of antimicrobial agents from catheters for long periods of 
time have limited the usefulness of antimicrobial catheters in patients undergoing 
long-term bladder management.
Cho et al. (2001) and Cho et al. (2003) developed catheters that were coated with the 
antibiotic gentamicin sulphate. The catheters were each loaded with 1.0 mg of the 
antibiotic. In vitro tests showed that on day one 200 jig of the antibiotic was released 
from the catheter and that by day seven the amount being eluted had reduced to 50 
pg/day. Further in vivo studies with catheterised rabbits established that the 
gentamicin catheters inhibited CA-UTI for at least five days, suggesting they may be
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useful in controlling infection in patients undergoing short-term catheterisation, but 
giving no indication regarding their usefulness for patients undergoing long-term 
catheterisation. Similarly although there is some evidence that silver-coated catheters 
are effective in preventing UTIs in short term catheterised patients, there is no 
evidence suggesting their usefulness for patients undergoing long-term bladder 
management (Saint et al., 1998).
Darouiche et al. (1997) examined the antimicrobial durability of IUCs impregnated 
with rifampin and minocycline by testing the antimicrobial activity of catheters that 
had been inserted into spinal injured patients. At different time intervals the catheters 
were removed and sections of the catheters were placed onto bacterial lawns of 
different urinary tract pathogens. The catheters produced detectable zones of 
inhibition against 10 uropathogens for up to 14 days, however after 21 days insertion, 
their activity was negligible. Johnson et al. (1999) used an in vitro agar diffusion 
assay to determine the durability of the activity of nitrofurazone and silver-coated 
urinary catheters. The activity was assessed by daily transference of catheter sections 
onto fresh agar plates. The nitrofurazone catheters were active against the test species 
(E. coli, K. pneumoniae. Citrobacter. freundii, S. aureus, Ent. faecium and coagulase- 
negative staphylococci) for a maximum of just five days. The silver catheters showed 
no activity after day one.
Richards et al. (2003) showed that it was possible to incorporate chlorhexidine 
digluconate (CHG) into a silicone elastomer. This material was then compression 
moulded to form a urinary catheter. In vitro tests with these catheters revealed that the 
concentration of CHG released on day one was equivalent to 2670 jig/cm2, but by day
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three this had dropped to less than 20 pg/cm2/day. From day 12 CHG was not 
detectable in the buffer used to suspend the catheter material. Schierholz et al. (1997) 
incorporated antistaphylococcal agents (flucloxacillin, ciprofloxacin, gentamicin and 
fosfomycin) into polyurethanes and monitored the drug release rates. In all polymers 
tested, more than half the total antibiotic concentrations were released after five days.
DiTizio et al. (1998) used liposomal technology to  try and control the rate of release 
of antibacterial agents from catheters. They developed a liposomal hydrogel system 
that consisted of a poly (ethylene glycol)-gelatin hydrogel in which liposomes 
containing ciprofloxacin were sequestered. This was cross-linked to the surface of 
silicone catheters and in vitro assays were performed to monitor the release of 
ciprofloxacin. Whereas catheters coated in a simple hydrogel containing ciprofloxacin 
lost all their antibiotics within 4 h, the drug was released steadily from the liposomal 
coating for up to seven days. The longevity o f the protective effect was severely 
limited however, by the amount of ciprofloxacin that could be loaded into the coating. 
It was only possible to incorporate 185 pg/cm o f ciprofloxacin into the catheter 
coating and achieve a release rate of 1.9 pg/cm/hr.
Another novel approach for controlling the rate o f  release of active concentrations of 
antibacterial agents is to sandwich a layer of an active antimicrobial agent within a 
material that controls its rate of diffusion into surrounding fluids. The aim of the 
research by Tcholakian and Raad (2001) was to develop a central venous catheter that 
could resist infection for longer time periods. They tested catheters that had a layer of 
minocycline and rifampin sandwiched within a silicone sheath which formed the 
external and luminal catheter surfaces. These catheters demonstrated significant
- i l l  -
I } | s \ j i i s s i o n
antimicrobial activity after more than 325 days incubation in human serum. As a 
control for the above experiment, polyurethane catheters coated with chlorhexidine 
were tested. Maki et al. (1997) had reported that these coated polyurethane catheters 
could reduce infection rates by at least fourfold compared to uncoated catheters. 
However, as opposed to the catheters with a sandwiched antimicrobial layer, these 
catheters lost all their antimicrobial activity within 14 days.
In view of the problems of exploiting conventional antibacterial agents in the 
protection of long-term prosthetic devices, some workers have turned to interesting 
alternative approaches. Singh et al. (2002) for example showed that lactoferrin blocks 
Ps. aeruginosa biofilm development They discovered that lactoferrin which is an iron 
chelator, stimulated bacterial twitching motility and that this prevented bacteria from 
attaching to and colonizing surfaces. The incorporation of iron chelators into 
biomaterials could therefore inhibit bacterial attachment and subsequent biofilm 
formation.
Several studies have suggested that using benign bacteria to prevent symptomatic 
infections by interfering with the growth of pathogenic bacteria may reduce CA-UTI. 
Darouiche et al. (2001) used the non-pathogenic E. coli 83972 strain to test the safety 
and efficacy of bacterial interference in preventing symptomatic CA-UTI in spinal 
injured patients. This non-pathogenic strain was isolated from a young girl who had 
asymptomatic bacteriuria for three years without altering renal function (Andersson et 
al., 1991). The E. coli suspensions were instilled into patients’ bladders, and the rate 
of symptomatic UTI in successfully colonized patients was compared to their rates of 
symptomatic infection prior to colonization, and to the rate of symptomatic infection
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in patients that were unsuccessfully colonized by the non-pathogenic E. coli strain. 
The results revealed that the rate of symptomatic UTI was 3 3-fold lower in patients 
that were colonized by the non-pathogenic strain versus those that were not 
successfully colonized. This suggested that bacterial interference could be a safe and 
effective way of controlling CA-UTI. The same non-pathogenic E. coli strain was also 
tested in vitro. These studies revealed that a coating of this strain of E. coli on IUCs 
significantly impeded bacterial colonization by Ent. faecal is, Pv. stuartii, 
uropathogenic E. coli and Candida albicans (Trautner et al., 2002; Trautner et al., 
2003). It was a pity that the ability o f the non-pathogenic E. coli to inhibit catheter 
colonization by Pr. mirabilis was not investigated. Trautner and Darouiche (2004) 
commented that since it has become apparent that bacteria can eventually overcome 
most methods that we come up with for treating them, it may be time for us to stop 
trying to outsmart them, and to try and get them to outsmart each other.
Davies et al. (1998) demonstrated that a mutation blocking the generation of quorum 
sensing signalling molecules in Ps. aeruginosa prevented the formation of a normally 
differentiated biofilm, resulting in the production of thin biofilms with densely packed 
bacterial cells. More recently furanones have been shown to control E. coli biofilm 
formation by inhibiting quorum sensing (Ren et al., 2001). McLean (2004) described 
a simple screening method that could be used to search for potential quorum sensing 
inhibitory activity by plants and bacteria. The samples were covered with a soft agar 
overlay containing indicator bacteria. These bacteria regulate pigment production by 
N-hexanoyl-HSL quorum sensor and are inhibited by AHL inhibitors, therefore a lack 
of pigment production by the indicator culture indicates quorum-sensing inhibition.
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Stewart (2003) suggested that an alternative approach of controlling biofilm formation 
would be to unglue the whole biofilm structure, either by dissolving the matrix 
polymer or by blocking its synthesis. Previously, Yasuda et al. (1993) had reported 
that treatment of Ps. aeruginosa biofilms with clarithromycin, a macrolide antibiotic 
with no antibacterial activity against Ps. aeruginosa, resulted in eradication of the 
membranous structures that covered the colonies in the biofilm. Using an in vivo rat 
infection model they showed that the therapeutic effect of ofloxacin against biofilms 
of Ps. aeruginosa was enhanced with oral co-administration of clarithromycin. They 
suggested that the clarithromycin induced loss of the glycocalyx was responsible for 
the increased therapeutic efficacies o f the ofloxacin against biofilms of Ps. 
aeruginosa. Yasuda et al. (1994) showed that low concentrations of clarithromycin 
also eradicated the glycocalyx matrix of S. epidermidis biofilms and resulted in the 
increased penetration of antibiotics through biofilms. Goto et al. (1999) investigated 
the activity of several classes of antibiotics alone or combined with a macrolide 
antibiotic on Ps. aeruginosa biofilm development in artificial urine on Teflon 
catheters. In vitro studies revealed that macrolide antibiotics only potentiated some 
classes of antibiotics. A clinical trial revealed that patients with IUCs treated with oral 
ciprofloxacin combined with clarithromycin achieved a higher clinical efficacy than 
ciprofloxacin alone, although the complete bacterial elimination rate did not differ 
between the two groups (Tsukamoto et al., 1999). The authors noted that whilst this 
trial suggested that clarithromycin may increase the anti-biofilm efficacy of 
ciprofloxacin in the clinical setting, further work should be carried out investigating 
the optimal duration and dosage of clarithromycin that should be used.
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There is certainly a need to develop novel strategies for inhibiting biofilm formation 
and to test them against crystalline Pr. mirabilis biofilms on catheters. It is important 
to bear in mind however that long-term devices, such as Foley catheters, need 
protection against encrustation for weeks and months rather than just for days. To date 
it has not been possible to load the devices with sufficient active agents or to control 
the release of the agent so that effective concentrations are sustained in the 
surrounding body fluids for the lifetime of the device. Exploitation of the catheter 
balloon as the reservoir for an active agent could solve both these problems. The 
balloon can be inflated with 10 ml of solutions containing high concentrations of an 
agent. The wall of the balloon provides a diffusion barrier which could control the 
release of active agents into the bladder urine. It was decided to investigate this 
approach using the agent triclosan that had been previously reported to be very active 
on Pr. mirabilis strains isolated from animal sources (Firehammer, 1987).
4.2. The sensitivity of Pr. mirabilis to triclosan
The results presented in Table 2 confirmed that strains of Pr. mirabilis isolated from 
CA-UTI are extremely sensitive to triclosan. Swarming was inhibited by 0.1 - 0.2 
pg/ml triclosan and the MICs ranged from 0.1 -  0.3 pg/ml. These results correlate 
well with those reported by Firehammer (1987), Bhargava and Leonard (1996) and 
Stickler (2002). MICs are typically used as a measurement of antibiotic sensitivity. It 
is important to bear in mind that biocides are usually used in concentrations well in 
excess of their MIC. Therefore, while MIC values provide useful starting points in 
studies on biocides, it is also necessary to examine their bactericidal effects (Russell, 
2003).
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There is ample evidence that the problem of catheter encrustation is brought about 
when urease activity of Pr. mirabilis raises the pH of the patients urine above the pH 
at which calcium and magnesium normally remain in solution (Kunin, 1989; Hedelin 
et al., 1991; Choong et al. 2001). Strategies to control catheter encrustation must be 
able to control the rise in urinary pH in the catheterised urinary tract infected with Pr. 
mirabilis. The MICs in artificial urine were carried out to establish whether triclosan 
would be as effective at inhibiting Pr. mirabilis growth in artificial urine, and to 
determine if this in turn would prevent an increase in the pH of the cultures. For six 
strains of Pr. mirabilis, the MICs of triclosan in artificial urine were similar to the 
concentrations inhibiting their growth in agar. It was also clear that at 0.2 pg/ml, 
triclosan was able to maintain the pH of the Pr. mirabilis urine cultures below 7.0 
(Figure 10). These experiments were performed in glass vessels and it is interesting to 
note that when they were performed in plastic universal containers the resulting MICs 
in artificial urine were 5 - 1 0  pg/ml.
Several studies have established that triclosan is bacteristatic at low concentrations, 
but that higher concentrations are required for a bactericidal effect against S. aureus 
and E. coli (McMurry et al., 1998a; Suller and Russell, 1999; Suller and Russell, 
2000). The ‘suspension tests’ monitoring the lethal effects of triclosan against Pr. 
mirabilis reported in Figure 15 were all carried out exposing 1 x 108cfu/ml bacterial 
cells to 100 pg/ml triclosan. No published data could be found regarding the lethal 
effects of triclosan against Pr. mirabilis. None of the five strains tested gave a 5-logio 
(cfu/ml) reduction with 100 pg/ml triclosan in 5 min, therefore, contact times of 30- 
and 60 min were also included. These results demonstrate that although concentrations 
of 0.2 pg/ml inhibit the growth of Pr. mirabilis, concentrations around 100 pg/ml are
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required to produce bactericidal effects, and that the lethal activity of triclosan against 
Pr. mirabilis is relatively slow acting. Suller and Russell (2000) for example 
demonstrated that 10 pg/ml triclosan produced a 6-logio reduction in viability of a 
standard strain of S. aureus after just a one-minute contact time.
In the experiments to establish what effect triclosan had on the growth of Pr. mirabilis 
cultures in pooled human urine, adding very low concentrations of triclosan (0.1 
pg/ml) at stationary phase inhibited log phase growth for 2 h (Figure 11). Adding 1.0 
pg/ml triclosan kept the cultures in stationary phase, but as expected from the 
bactericidal tests, higher triclosan concentration (10 or 100 pg/ml) were required to 
produce a lethal effect. Within 1 h of adding 100 pg/ml triclosan to the urine cultures, 
viable Pr. mirabilis cells could not be recovered. The higher temperatures used in 
these experiments (37°C) may explain the enhanced lethal effects in the urine cultures 
compared to the bactericidal tests. The results presented in Figure 12 show that the 
higher triclosan concentrations (1, 10 and 100 jig/ml) kept the pH values of the 
cultures significantly (P < 0.05) lower than the control culture.
Adding 100 pg/ml triclosan to mid-log phase growing Pr. mirabilis urine cultures 
resulted in a rapid 4-log reduction in the viable cell count (Figure 13). By t = 3 h, no 
viable cells could be detected in the culture. The results with the other triclosan 
concentrations were similar to those adding triclosan at stationary phase. The 
stationary and log phase cultures appear to be equally susceptible to triclosan. Suller 
and Russell (2000) also observed that strains of S. aureus in stationary and 
exponential growth phase were equally susceptible to triclosan. Similarly Gomez-
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Escalada et al. (2002) showed that triclosan had a rapid lethal effect against E. coli in 
all stages of growth.
Adding triclosan at mid-log phase had no effect on the terminal pH of the urine 
cultures (Figure 14). The pH curves for the test and control cultures were identical. 
These data suggest that in the experiment where triclosan was added at stationary 
phase, it prevented a rise in pH by preventing bacterial growth and the production of 
the urease enzyme. The bacterial cultures growing at log phase would have already 
produced a large amount o f urease by the time the triclosan was added. The results 
show that even after adding 100 pg/ml triclosan there was enough urease in the culture 
to keep the pH rising at the same rate as the control. Microbial urease enzymes appear 
to be cytoplasmic proteins (Mobley et al., 1995). The increase in culture pH following 
bacterial death is likely to be due to the liberation of urease enzymes from lysed 
bacterial cells.
All samples taken from the control and test human urine cultures were neutralised 
prior to commencing the viable cell counts, as were the suspensions in the 
experiments determining the lethal effects of triclosan. Neutralisation is often 
overlooked when testing the activity of antimicrobial agents. The neutralisation of an 
antimicrobial agent is essential to stop its activity at a given exposure time, its 
continued activity due to no or incomplete neutralisation leads to misleading results 
(McDonnell et al., 1998). The neutraliser used in this study effectively quenched the 
bactericidal activity of triclosan at concentrations up to 100 pg/ml (Table 3). No 
viable cells were detectable in the suspensions where Pr. mirabilis B2 was added to 
triclosan and water (final concentration 100 pg/ml), and there was no significant
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difference (P = 0.919) between the number of viable cells in the control suspension 
and in the mixture containing 100 pg/ml triclosan in the neutraliser. The non-toxicity 
o f the neutraliser (and the 1% DMSO used in the suspension tests) was confirmed for 
every strain that was tested (Table 4).
4.3. The feasibility of using the catheter retention balloon as a novel wav of 
introducing triclosan into the catheterised urinary tract
Having confirmed the sensitivity of Pr. mirabilis catheter isolates to triclosan and 
shown that concentrations as low as 0.2 pg/ml could maintain urine cultures below pH 
7, the next phase of the research involved investigating the feasibility of delivering 
triclosan to the infected bladder through the catheter balloon. If triclosan was to be 
used in this way, it had to be able to diffuse through the catheter balloon without 
having any detrimental effect on the balloon’s function. Triclosan is only sparingly 
soluble in water, and DMSO is too harmful to be used in the catheter balloon, 
therefore, preliminary experiments were carried out using 10 mg/ml triclosan in 5% 
PEG. PEG was chosen as it is known to be a good solvent for triclosan and has also 
been shown to modify the diffusion characteristics of silicone (Ciba-Geigy 
corporation, 1988; Kim et al., 2000). The triclosan in PEG had to be heated and stirred 
to produce a white colloidal suspension, and needed to be continually stirred to keep it 
in suspension.
In the experiments to determine the concentration of triclosan passing through the 
catheter balloon of all-silicone catheters, the concentration of triclosan in each sample 
was determined by HPLC. Figure 16 shows that low concentrations of triclosan (0.02 
- 0.16 pg/ml) were detected in each of the artificial urine samples taken over the 48 h
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period. The low concentration of triclosan in the first sample taken from both 
replicates suggests that the triclosan may take a couple of hours to diffuse through the 
catheter balloon. The difference between the amount of triclosan released by the two 
different replicates may be attributed to differences in balloon thickness. None of the 
control urine samples produced a peak at the retention time close to the triclosan peak. 
This experiment established the effectiveness of this method for extracting and 
quantifying the concentration of triclosan in artificial urine samples, and confirmed 
that triclosan could diffuse from the retention balloon of all-silicone catheters. The 
maximum concentration of triclosan being delivered through the balloon over the 48 h 
test period was 0.16 pg/ml, with an average daily flow rate of 0.5 ml per minute, 115 
pg triclosan is released from the catheter daily. Given that the balloon is inflated with 
10 ml of a 10 mg/ml triclosan solution, if  the same release rate was maintained, it 
would take over 850 days for all the triclosan to be released from the catheter balloon.
The extraction of triclosan from the artificial urine was time consuming, therefore, 
only two replicates were performed. Further replicates may have indicated a more 
definite trend in the way triclosan was released from catheter balloons. Other 
experiments based on this method that would provide useful information would be 
those investigating the concentration of triclosan that can pass through the balloons of 
latex-based catheters. Although setting up models for longer periods o f time may 
provide useful information, running the bladder models for extended periods of time 
can be difficult due to contamination problems. Future experiments could determine 
whether using triclosan in different solvents or formulations would increase the 
concentration of triclosan passing through the balloon into the urine. For example it 
may be possible to use different pore-formers to increase the concentration of triclosan
- 120-
1 discussion
being released from the balloon. Kim et al. (2000) tested the feasibility of controlling 
the release of antibiotics from polymers using pore-formers. These are compounds 
that facilitate the release of drugs by forming channels in the polymer matrix. Using 
these agents can help release active agents out of polymers regardless of their 
solubility. Kim et al. (2000) showed that it was possible to control the release of 
antibiotics from a polymer matrix by changing the particle size and loading dose of 
the pore former.
Preliminary experiments to determine the MIC of triclosan against Pr. mirabilis in 
artificial urine revealed that triclosan could bind to the plastic universal containers. 
Experiments were therefore carried out to determine if inflating the catheter balloon 
with a triclosan solution would result in triclosan becoming impregnated in the 
catheter material. The balloons o f the catheters that were impregnated in the models 
were thoroughly rinsed out 10 times with sterile water. This was to ensure that any 
zone of inhibition created by the catheter sections resulted from the triclosan being 
impregnated in the catheter sections and not from any triclosan residues left in the 
inflation line. Only the top section from directly beneath the catheter balloons 
produced a zone of inhibition with the hydrogel-coated latex catheters, whilst none of 
the silicone elastomer-coated latex catheter sections produced a zone of inhibition 
(Figure 17). With the all-silicone catheters, one of the 0.5 cm sections was cut in half 
lengthways, so that one half included the catheter inflation line, whilst the other did 
not. All these catheter sections produced zones of inhibition, indicating that triclosan 
completely impregnated the full length of the all-silicone catheters.
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If a new solution is to be used instead of water it must not compromise the function of 
the retention balloon. It is also important that the catheter balloon can still be deflated 
after 8 - 1 2  weeks. In the experiment to determine how triclosan and 5% PEG might 
affect the catheter balloons, no change was observed in the balloon morphology of the 
three catheter types inflated with the three solutions (10 mg/ml triclosan in 5% PEG, 
5% PEG and deionized water). All the catheter balloons could still be deflated after 
the eight-week period. The physical properties o f the catheter balloons inflated with 
the different solutions were tested using the LRK10 Lloyds testing instrument. This 
allowed a comparison of the load (N) that each section could take, its tear strength 
(N/mm) and its percentage elongation. Because of the strength of even small samples 
of balloon material, a standard incision was placed half way down the sample to 
facilitate tearing. It was impossible to tear the catheter balloons of the latex-based 
catheters, therefore only results on the effect o f triclosan and 5% PEG on the physical 
properties of all-silicone catheter balloons were obtained. As well as testing the all­
silicone catheters that had been inflated with the different solutions for eight weeks, a 
catheter balloon section taken straight from its packaging was also tested. There was 
no significant difference (P > 0.05) between the tear strength (N/mm), load (N) or 
percentage extension between the four groups (Figure 18). These results indicated that 
triclosan and 5% PEG do not have a detrimental effect on the physical properties of 
the all-silicone catheter balloons.
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4.4. The effect of introducing triclosan into the catheterised urinary tract on the 
development of crystalline bacterial biofilm formation bv Pr. mirabilis in in-vitro 
models of the catheterised bladder
Experiments were performed to determine how inflating catheter balloons with 
triclosan in 5% PEG would affect crystalline biofilm formation by Pr. mirabilis B2 on 
all-silicone catheters (Figure 19). The control catheters inflated with water blocked 
with crystalline biofilm after a mean time of 26 h. At blockage the pH of the residual 
urine in the models had increased from 6.1 to a mean of 8.63, and the mean viable cell
*T
count was 7.80 x 10 cfu/ml. The all-silicone catheters inflated with even the lowest 
test concentration of triclosan (10 pg/ml) took a significantly longer (P < 0.05) time to 
block compared to the control models. Catheter balloons inflated with triclosan 
concentrations of 500 pg/ml or higher in 5% PEG enabled the catheters to drain freely 
for the duration of the experiment. When catheters were inflated with 1 and 10 mg/ml 
triclosan in 5% PEG the mean pH value of the residual urine stayed acidic for seven 
days, and the residual urine in the models remained clear throughout the experiment 
(Figure 22). The mean number of viable cells in the urine of these models was reduced 
to around 104 cfu/ml at seven days.
LV-SEM revealed significant crystalline biofilm formation on the control catheters at 
blockage (Figure 23), whilst Figure 26 reveals little evidence of biofilm colonization 
or encrustation on all-silicone catheters inflated with 10 mg/ml triclosan in 5% PEG 
after seven days. Electron micrographs of the critically point dried control catheter 
sections fixed with and without the RHT revealed a crystalline bacterial biofilm where 
Pr. mirabilis bacilli were associated with crystalline material (Figures 35 and 38). 
Large blocky crystals as seen in Figure 35b were clearly recognisable as struvite
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crystals, whilst crystallites powdery in appearance, typical o f hydroxyapatite can be 
seen in Figure 35e. Large crystals of struvite could often be seen embedded in the 
hydroxyapatite (Figure 35b). These observations are similar to those made by Cox et 
al. (1989a) and Stickler et al. (1993). Although it is reasonable to assume that these 
are crystals of calcium and magnesium phosphates, x-ray microanalysis of the catheter 
sections, similar to that performed by Winters et al. (1995) could have confirmed their 
identities.
Cox (1990) investigated the surface morphologies of different types of Foley catheters 
by SEM. Their study revealed the rough irregular nature of catheter surfaces. From 
their observations on images of used and unused catheter surfaces, Axelsson et al. 
(1977) had previously concluded that the ideal catheter surface should be free from 
surface irregularities, and noted that if this were the case, it would lower the incidence 
of complications associated with the long-term use of catheters. The manufacturing 
process for catheters commonly involves mechanically punching out the catheter eye­
holes. Electron micrographs of unused catheters have revealed that this results in 
catheters with narrow eye-holes that have rough irregular surfaces (Stickler et al., 
2003). Electron micrographs from the study by Stickler et al. (2003) also illustrated 
how Pr. mirabilis biofilm formation begins from microcolonies formed within the 
depressions of the irregular surface before spreading across the eye-hole rims. The 
electron micrographs in this study have also shown that the catheter eye-hole can be 
rough and irregular (Figure 36a), and that bacteria can become trapped within these 
surface imperfections (Figure 35d). Observations on electron micrographs in Figure 
41 also shows that the biofilm appears to spread down the catheter. Stickler et al. 
(2003) concluded that developing catheters with larger internal lumens and smoother
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surfaces would substantially reduce the problems associated with these devices. 
Developing manufacturing techniques capable of achieving these goals should be 
possible, if only the medical device industry was prepared to take up the challenge.
Stickler et al. (2003) used RHT to stabilise polyanionic components of the bacterial 
polysaccharide matrix prior to fixation in osmium. To determine if there was any 
benefit to using RHT, two critically point dried control catheters were observed by 
SEM in this study, fixed either with or without RHT. Although Figure 35c shows a 
web-type matrix covering the Pr. mirabilis bacilli fixed without RHT, it was not 
possible to get a detailed view of the cells appearance at higher magnifications. In 
contrast, much more detail could be seen on the Pr. mirabilis cells on the catheter 
sections fixed with RHT. The images show that Pr. mirabilis has elaborate surface 
structures, with hair like extensions coming off the cell wall (Figure 38b,c). Figure 
38e shows an extensive polysaccharide matrix, which appeared to be attached to 
hydroxyapatite crystals and Pr. mirabilis cells. From these images it was concluded 
that fixation with RHT produces better and more detailed images, and should be 
included in the fixation of all catheters prepared for critical point drying in future 
experiments.
The images shown in Figure 36 and 37 are of catheters that had drained freely in the 
bladder models for seven days. The catheter in Figure 36 had its balloon inflated with 
10 mg/ml triclosan in 5% PEG throughout the seven day test period. The images 
shown in Figure 37 are of the catheter that was impregnated with triclosan in the 
bladder models for 24 h, and then the triclosan was replaced with water and the model 
was inoculated with Pr. mirabilis B2. Both catheters were fixed without RHT. In
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contrast to the control catheters, very little crystalline material was visible on the 
catheter sections. Large clusters of cells could be seen on the control catheter sections, 
whilst cells on the triclosan treated catheters were attached as individuals or in small 
groups. The morphology of the bacilli also differed on the triclosan treated catheters 
compared to the control catheters, many o f the images (Figures 36e, f, 37b, d, f) show 
structures which appear to be clusters o f cells fused together. Figure 36e, shows what 
appear to be normal looking bacilli next to very small looking cells. The images of 
catheter sections taken from the impregnated catheter and the catheter that had its 
balloon inflated with lOmg/ml triclosan are very similar. This suggests that over the 
24 h period sufficient triclosan must have been absorbed by the silicone of the 
impregnated catheter to protect it from bacterial colonization and encrustation.
The lowest concentration of triclosan in the catheter balloon which inhibited the 
blockage of all-silicone catheters was 500 pg/ml in 5% PEG. The images presented in 
Figure 39 show electron-micrographs of a catheter which drained freely for seven 
days that had its balloon inflated with 500 pg/ml triclosan and that was fixed with 
RHT. These images also show disfigured and very small bacterial cells (Figure 39b, c, 
d, e) Unlike the control RHT treated catheter sections, no hair-like structures could be 
seen on the Pr. mirabilis cells colonizing the triclosan treated catheter. Triclosan thus 
appears to have an effect on the structure of the Pr. mirabilis bacilli. It would be 
interesting to compare the development of Pr. mirabilis biofilms in control catheters 
inflated with water and in test catheters inflated with triclosan solutions. Studies 
taking the control and test catheters inflated with the maximum concentrations of 
triclosan out o f the bladder models at regular intervals after inoculation would give 
more information about how triclosan affects the process of biofilm formation. We
know that initially only a low concentration of triclosan passes through the catheter 
balloon. Therefore, it would be interesting to investigate the early stages of 
colonization. This would determine if the initial concentration of triclosan passing 
through the catheter is high enough to prevent cells from attaching to the surface, or 
whether cells attach but fail to develop a biofilm because triclosan is released. The use 
o f transmission electron microscopy (TEM) would also give more details on the effect 
triclosan has on the morphology of Pr. mirabilis cells.
The bladder model experiments are designed to simulate placing a new catheter into a 
patient already with significant Pr. mirabilis bacteriuria and a high urinary pH. To 
allow a comparison between different experiments, chemically defined artificial urine 
was used in most bladder model experiments, a standard inoculum was added and all 
experiments were run under standard conditions. Catheter blockage is easily detected 
in the bladder models because the urine level of the reservoir rises above the eyehole. 
It is difficult to correlate the times of catheter blockage in the models to the time it 
will take the catheters to block in patients. However, comparing the times to blockage 
o f test models to a control model gives an indication whether a new catheter care 
regime is likely to prevent or delay catheter blockage. All-silicone catheter balloons 
inflated with the higher concentrations of triclosan prevented catheter blockage for the 
duration of the seven day experiment even after what was considered to be a severe 
challenge with a dense population (108 cfu/ml) o f Pr. mirabilis. The results presented 
in Figure 19 thus suggest that this approach could have practical applications in 
controlling catheter encrustation.
Experiments using the two ready-made formulations obtained from CIBA containing 
1% (w/v) triclosan to inflate the catheter balloons of all-silicone catheters gave similar 
results to those using the highest concentrations of triclosan in 5% PEG (Figure 19). 
Placebo formulations not containing triclosan were not available to test, therefore the 
inhibitory effect o f inflating the balloons with these formulations cannot conclusively 
be attributed to the effects of triclosan alone. In all other bladder model experiments, 
the activity o f the triclosan solvent was tested in the balloon to determine if they had 
any inhibitory effects. Catheters inflated with 5% PEG did not perform significantly 
differently (P > 0.05) from those inflated with water.
Having established that all-silicone catheters inflated with triclosan could control 
catheter encrustation, further experiments were performed using hydrogel- and 
silicone-coated latex catheters (Figures 20 and 21). The mean time to blockage for 
control models of both types of latex catheters was under 24 h. Concentrations of 1 
mg/ml triclosan were required in the latex catheter balloons to prevent blockage for 
the full seven days. This may be attributed to the fact that unlike the all-silicone 
catheters, the latex-based catheters do not become impregnated with the antibacterial 
agent (Figure 17). The electron micrographs presented in Figures 24, 25, 27 and 28 
illustrate the encrustation occurring on the latex-based catheters, confirming the lack 
of colonization of the eye-holes and luminal surfaces when triclosan was used to 
inflate the balloons.
The mean pH value from the residual urine o f the control models for both types of 
latex catheters was above pH 8.5 at blockage (Figures 20b and 21b), and their viable 
cell counts were around 1 x 108 cfu/ml (Figures 20c and 21c). The higher triclosan test
concentrations (1 and 10 mg/ml triclosan in 5% PEG) significantly reduced (P < 0.05) 
the pH and viable cell count in the residual urine at the end of the experiment 
compared to the control models at blockage. The number of viable cells in the residual 
urine of the triclosan models varied from one run to the other. This could be because 
of differences in the thickness o f the catheter balloons from one catheter to another, 
resulting in different concentrations o f triclosan being delivered from the balloon to 
the urine.
It was considered important to investigate what effect using triclosan in the catheter 
balloon would have on the development of crystalline biofilms by other strains of Pr. 
mirabilis. The test models fitted with all-silicone catheters inflated with 10 mg/ml 
triclosan in 5% PEG and inoculated with each of the four different Pr. mirabilis 
strains drained freely for the duration of the seven day experiment. The control models 
all blocked in a mean of 22 -  46 h (Figure 29a). The pH and viable cell count in the 
residual urine of the test models at seven days was also significantly lower (P < 0.05) 
than in the control models at blockage (Figures 29b and 29c).
The time to blockage of the control models from the experiment with different 
triclosan concentrations in the balloon were 18.75 h ± 1.85 h for the silicone-coated 
latex catheters, 22.86 h ± 2.60 h for the hydrogel-coated latex catheters and 26.32 h ± 
2 47 h for the all-silicone catheters. Statistical analysis of these data however revealed 
that there was no significant difference (P = 0.082) between the times to blockage of 
the control models fitted with the three different catheter types. An earlier study with 
Pr. mirabilis infected bladder models by Morris et al. (1997) reported that while latex 
catheters blocked at mean times of around 20 -  30 h, the Bard size 14 ch all-silicone
catheter took 50 h to block. These findings were consistent with the clinical 
experience reported by Kunin et al. (1987 b) that encrustation and blockage was a 
greater problem with latex than silicone catheters. A possible explanation for the 
poorer performances o f the recent all-silicone catheters in the bladder models could be 
due to changes in the manufacturing process for these catheters.
There are constituents present in human urine which are not present in artificial urine. 
Therefore, it was important to test this novel strategy in models supplied with human 
urine. Because of the difficulties of collecting and sterilizing the large volumes of 
urine required to run the bladder models for seven days, in these experiments the 
effect o f triclosan was assessed by examining the amounts of calcium and magnesium 
forming on test and control catheters over a 48 h period. None of the control or test 
models supplied with human urine blocked within the 48 h experimental time period. 
However, as with the artificial urine experiments, the control models were very cloudy 
at the end of the experiment, whilst the test models remained clear (Figure 22). The 
test models fitted with catheter balloons inflated with 10 mg/ml triclosan in 5% PEG 
also significantly reduced (P < 0.05) the pH and viable cell count in the residual urine 
compared to the control models (Figure 30a and 30b). Calcium and magnesium 
analysis o f the catheters established that there was significantly less (P = 0.000) 
encrustation on the test catheters compared to the controls (Figure 30c), these 
observations were confirmed by LV-SEM images (Figure 31) showing little 
encrustation on the test catheter and heavy encrustation on the control. This 
established that although models supplied with pooled human urine take longer to 
block than those supplied with artificial urine, there was significant encrustation on
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the control catheters, which was inhibited by the use of triclosan in the catheter 
balloon.
In the experiments reported in Figure 32, the catheters used were inflated with 
triclosan for various time periods, the balloons were emptied, washed and re-inflated 
with water. The idea was to test whether simply impregnating the silicone of the 
catheter in this way could inhibit encrustation. Test catheters impregnated with 
triclosan in the models for 24 h drained freely for the duration of the seven day 
experiment, and the residual urine in the models remained acidic (Figure 32a and 
32b). No viable cells were cultured from the residual urine at the end of the 
experiment (Figure 32c). The viable cell counts were lower after seven days than with 
catheters inflated with 10 mg/ml triclosan in 5% PEG. This can be explained by the 
experiments monitoring the concentration of triclosan that passed through the catheter 
balloon, which showed that there was an initial delay in the release of triclosan. 
Triclosan is absorbed throughout the length of the catheter impregnated in the model 
at the time of inoculation, which might reduce the initial delay in the release of 
triclosan from the catheter material. The sections o f the triclosan-impregnated catheter 
were placed onto Pr. mirabilis B2 bacterial lawns at the end of the seven day 
experiment. Large zones of inhibition were observed around all the sections (Figure 
34), indicating that triclosan remained in the catheter material after seven days in situ 
in the model. Electron micrographs of the triclosan impregnated catheter (Figure 33) 
at the end of the experiment revealed no sign of encrustation.
The results with catheters that had been impregnated in their packaging for different 
time periods were more variable than those with the catheters impregnated in the
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models. One or two replicates for each time period blocked whilst the others drained 
freeh for seven days (Figure 32a). The enhanced performance of the catheters 
impregnated in the models for 24 h compared to the same time period impregnated in 
the packaging could be attributed to the triclosan in the artificial urine which had been 
flowing though the catheter adsorbing to the drainage lumen. Another possibility is 
that a concentration gradient between the triclosan solution in the balloon and the 
residual urine in the model may have led to higher concentrations of triclosan 
impregnating these catheters. The results also show that to protect catheters from 
encrustation by pre-loading them with triclosan prior to their placement in the bladder, 
it would be necessary to retain the triclosan solution in the balloon for about an hour. 
This might well restrict the practicality o f using this particular strategy on patients.
Experiments using the bladder models thus far focused on preventing the development 
of crystalline bacterial biofilms by Pr. mirabilis. Since these results were so 
successful, the possibility of using triclosan to remove established biofilms or to 
inhibit their further development was considered. The effect of adding triclosan into 
the balloons of catheters on which crystalline Pr. mirabilis biofilm had formed for 18 
h was investigated. Replacing water in the balloons of encrusted catheters with 10 
mgml triclosan in 5% PEG after the 18 h pre-incubation period failed to have a 
significant effect (P > 0.05) on the total time to blockage or pH and viable cell count 
in the residual urine (Figure 40). From the time the triclosan was added to the test 
model at t = 18 h to the time it took for the catheters to block, there was no significant 
dtference (P = 0.103) between the test and control catheters. These results indicate 
tins novel strategy would be less successful at preventing catheter blockage once 
encrustation had begun. The results indicate that if the strategy is to be used in patients
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it will be necessary to replace the encrusted catheter and inflate the new catheter with 
the triclosan solution.
It is now accepted that if the objective of an antimicrobial agent is to treat biofilms, 
then the agent must be tested against bacteria growing as communities on surfaces 
(Donlan and Costerton, 2002). It is therefore important that more realistic in vitro tests 
be devised to study the ability of antimicrobial agents to treat infections involving 
medical devices (Anwar et al., 1990). The aim of the experiments reported in Figures 
42 -  47 was to determine the concentration of triclosan required in the artificial urine 
supplying the bladder models to eradicate or prevent further development of an 
established biofilm. Preliminary experiments revealed that with size 16 Ch catheters 
there was an even crystalline biofilm along the length of the catheter 16 h after 
inoculation (Figure 41), therefore the urine supply was changed to contain triclosan at 
this time. The control and DMSO control models blocked within the duration of the 
experiment, whilst 10 and 100 pg/ml triclosan in the urine prevented catheter blockage 
for the 66 h experimental period. For the models supplied with 0.1 pg/ml triclosan, 
two of the three test models blocked and one of the models supplied with 1 pg/ml 
triclosan blocked. By running a second control model, and taking it down at the time 
the urine supplies were changed to contain triclosan, it was possible to compare the 
amount of encrustation that had developed on the catheters from that time. Die 
amounts of calcium and magnesium on the control, DMSO control, 0.1 pg/ml and 1 
pg/ml triclosan catheters was significantly higher (P < 0.05) than on the catheters 
taken out at 16 h (Figure 46). There was no significant difference (P > 0.05) between 
the amounts of calcium and magnesium on the catheters taken down at 16 h compared 
to those treated with 10 and 100 pg/ml triclosan. It therefore appears that 10 pg/ml is
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the minimum triclosan concentration required in the urine to inhibit and prevent 
further development of Pr. mirabilis crystalline biofilms. In this experiment some 
catheters drained for the full 66 h whilst others blocked at different times, in view of 
this the rates of catheter encrustation for the test and control models were also 
determined (Figure 47). The rate of encrustation was significantly lower (P < 0.05) 
than the controls in only those models supplied with 100 pg/m 1 triclosan. 
Concentrations of 10 and 100 pg/ml triclosan in the artificial urine also significantly 
reduced (P < 0.05) the viable cell count and pH of the urine compared to the controls.
As well as determining the biofilm inhibitory concentration of triclosan against Pr. 
mirabilis, these experiments also showed that the in vitro models could easily be 
adapted to determine the concentration of antimicrobial agents required in the urine of 
patients to inhibit further biofilm development. This method could easily be modified 
to determine the concentration of antimicrobials required in urine to prevent 
crystalline bacterial biofilm formation or it could also be used to determine the 
concentration of antimicrobial agents required for treating CA-UTI.
4.5. Formulation of triclosan
If using triclosan formulations to inflate catheter balloons is to form a new strategy for 
controlling catheter encrustation, the solution must be as easy to use in the retention 
balloon as water. For this reason the triclosan solution should fit the following criteria: 
it should need no preparation prior to use, it should be sterile, be stable in solution, 
and should easily inflate the catheter balloon. Unfortunately the formulation of 
triclosan used in this work (10 mg/ml in 5% aqueous PEG) does not meet all these 
criteria. The triclosan needs to be stirred and heated (60°C) to get it to dissolve and
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even then it only forms an emulsion that settles out on standing, rather than form a 
solution. Because of the possibility of degradation at high temperatures, sterilization 
by heating was not an option. Membrane filtration led to separation of the phases, the 
resulting filtrate was found to be an aqueous solution containing very little triclosan. 
Since the intended use for this solution is in busy hospitals and by nurses looking after 
community based patients, the use of this formulation was not feasible. Alternative 
solutions for dissolving triclosan which could be used instead of 5% PEG were 
investigated.
Whilst searching for new solvents, only those that would be safe to use in the bladder 
were considered. The search for a new solvent involved several stages. Firstly, 
determining the ability of different solvents to dissolve triclosan. Secondly, catheters 
were inflated with the new solutions to make sure they could inflate the balloon, and 
the catheters were soaked in water for eight weeks to establish what effect the solvent 
had on the catheter balloons. Finally any solution that passed the first stage were 
tested to determine if they would be as effective at preventing catheter blockage as the 
triclosan suspension in 5% PEG.
The first solution tested in this experiment was triclosan in 70% ethanol. Although 
triclosan dissolved quickly, the alcohol leaked out of the catheter balloons within 1 
week. The use of castor oil or olive oil to dissolve triclosan was an attractive prospect 
because of their non-toxicity. Both these oils were capable of dissolving triclosan 
without heating, but their viscosity made it hard or impossible to inflate the catheter 
balloon with them, therefore their use was ruled out. Although propylene glycol could 
easily dissolve triclosan, and could be used to inflate the catheter balloon, after a
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couple of days soaking the catheters in water, the catheter balloons became swollen. 
0.1 M sodium carbonate could dissolve 3 mg/ml triclosan with stirring but no heat in 
under 1 h. T he resulting clear solution could inflate the all-silicone catheters and both 
types of latex-based catheters. There were no visible changes to the balloons of all­
silicone or latex-based catheters inflated with 0.1 M sodium carbonate with and 
without triclosan after being soaked in water for eight weeks. All the catheters could 
be deflated a t  the end of the eight-week period and the use of the sodium carbonate 
with and without triclosan resulted in significantly more (P < 0.05) fluid being 
retained in th e  all-silicone catheters than in those inflated with water (Figure 48). The 
loss of water from silicone catheter balloons can be a problem; therefore this 
secondary consequence of using sodium carbonate would be an added beneficial 
effect.
After identifying triclosan in sodium carbonate as a possible formulation that could be 
used to inflate the catheter balloons, its ability to inhibit crystalline biofilm formation 
was tested in  the bladder models. The limit of solubility of triclosan in 0.1 M sodium 
carbonate w as found to be 3 mg/ml. The range of concentrations tested in the bladder 
models was therefore from 10 pg/ml to 3 mg/ml. The data from these experiments 
(Figure 49) revealed no significant difference (P > 0.05) between the sodium 
carbonate controls and the models that had water in the balloon in terms of time to 
blockage and viable cell count and pH in the residual urine at blockage. The use of 1 
and 3 mg/ml triclosan in 0.1 M sodium carbonate successfully prevented catheter 
blockage for the duration of the seven-day experiment. The pH and viable cell count 
from the residual urine in these models after seven days were significantly lower (P < 
0.05) than those from the control models at blockage. One replicate that had its
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balloon inflated with 500 pg/ml triclosan in 0.1 M sodium carbonate blocked and the 
others drained freely for the duration of the experiment, whilst none of the all silicone 
catheters inflated with 500 pg/ml triclosan in 5% PEG blocked. However, there was 
no significant difference (P > 0.05) between the time to blockage, pH or viable cell 
count at blockage using the 100 pg/ml triclosan in 5% PEG or in 0.1 M sodium 
carbonate. Statistical analysis of the results from the experiments with catheter 
balloons inflated with 10 mg/ml triclosan in 5% PEG and 3 mg/ml triclosan in 0.1 M 
sodium carbonate revealed there was no significant difference (P > 0.05) between the 
pH and viable cell count after seven days. This set of experiments confirmed that 
triclosan in both solvents was effective in controlling urinary pH, Pr. mirabilis growth 
and catheter blockage. Figure 50 shows little encrustation on the all-silicone catheter 
that had its balloon inflated with 3 mg/ml triclosan in 0.1M sodium carbonate after 
seven days in the bladder model.
To determine if the type of solvent used affected the ability of triclosan to prevent 
catheter blockage, bladder model experiments were carried out with all-silicone, 
silicone-coated latex and hydrogel-coated latex catheters having their balloons inflated 
with simple suspensions of triclosan in water. The results of the time to blockage, pH 
and viable cell count in the residual urine (Figures 51) of all-silicone catheters using 
100 pg/ml triclosan in aqueous suspension were not significant different (P > 0.05) 
from the same concentration in 5% PEG or 0.1 M sodium carbonate. Test models 
were also set up with all-silicone catheter balloons inflated with 10 mg/ml triclosan in 
aqueous suspension and these drained freely for the duration of the seven day 
experiment. There was no significant difference (P > 0.05) between the pH and 
numbers of viable cells cultured from the residual urine of these models (data not
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shown) compared to those inflated with 10 mg/ml triclosan in 5% PEG in previous 
experiments. There was no significant (P > 0.05) difference in the results obtained 
using hydrogel-coated latex catheters that had their balloons inflated with 100 pg/ml 
triclosan in 5% PEG or in aqueous suspension, however, the use of 5% PEG improved 
the ability of triclosan to prevent catheter blockage with silicone-coated latex 
catheters. The time to blockage increased significantly (P < 0.05) using 100 pg/ml 
triclosan in 5% PEG compared to the same concentration in aqueous suspension, and 
the pH and viable cell count in the residual urine were also significantly (P < 0.05) 
lower using triclosan in 5% PEG.
Triclosan is only poorly soluble in water and at 10 mg/ml it forms a particulate 
suspension. In experiments with this suspension, it was observed that leakage 
occurred from some catheters at the inflation port. This was probably due to the un­
dissolved triclosan particles preventing the valves at the inflation port sealing 
properly. For this reason it is unlikely that simple aqueous suspensions of triclosan 
could be used to inflate patients’ catheters.
4.6. The sensitivity of other urinary tract pathogens to triclosan
The aim of this part of the study was to determine the sensitivity to triclosan of other 
urinary tract pathogens that commonly infect catheterised patients. The ability of these 
organisms to form biofilms on urinary catheters was examined and the effect of 
triclosan on the development of these biofilms tested. The MIC of triclosan against the 
eight different uropathogenic species tested is shown in Table 5. E. coli, Pv. stuartii, 
K. pneumoniae and S. aureus were all very sensitive to triclosan. The MIC of triclosan 
for S. aureus was between 0.1 - 0.6 pg/ml. Bhargava and Leonard (1996) reported that
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the MIC of triclosan against culture collection strains of S. aureus was 0.01 - 0.1 
pg/ml, Suller and Russell (2000) however reported that the MIC of triclosan for 
clinical isolates of S. aureus was between 0.025 and 1 pg/ml. The MIC of triclosan for 
E. coli was 0.2 - 0.3 pg/ml which correlates well with those values reported by 
Bhargava and Leonard (1996) of 0.1 - 0.3 pg/ml. Bhargava and Leonard (1996) 
reported MICs of triclosan against K. pneumoniae of 0.3 pg/ml, however higher 
concentrations were required to inhibit the growth of catheter isolates of K. 
pneumoniae (0.3 - 0.8 pg/ml). All strains of Ent. faecalis tested had MICs of 7 pg/ml, 
this value is slightly lower than the MIC of 10 pg/ml triclosan against Ent. faecalis 
reported by Heath and Rock (2000). The MIC of triclosan against Ser. marcescens, M  
morganii and Ps. aeruginosa was over 100 pg/ml. These findings correlate well with 
the values reported by Bhargava and Leonard (1996), they noted that the MIC for Ps. 
aeruginosa was over 1000 pg/ml, and over 100 pg/ml for Ser. marcescens.
The bactericidal effect of triclosan against one strain of each species was also tested 
(Figure 52). As expected Ps. aeruginosa was the most resistant to the lethal effects of 
triclosan. Statistical analysis of the data (Table 10) showed that the mean logio 
(cfu/ml) reduction with Ps. aeruginosa was significantly lower than all the other 
strains tested after 60 min contact time. For Ser. marcescens the mean logio (cfu/ml) 
reduction given by 100 pg/ml triclosan was less than one for each contact time tested. 
Although the MIC for M  morganii was over 100 pg/ml, the strain tested in the 
suspension test gave a logio (cfu/ml) reduction of over five after a 60 min contact time 
with 100 pg/ml triclosan. On the other hand, although the MICs for E. coli and K. 
pneumoniae were very low, the mean logio (cfu/ml) reduction for each contact time 
with 100 pg/ml triclosan was less than one. Although the Ent. faecalis was moderately
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susceptible to the inhibitory effects o f triclosan, it was very susceptible to it lethal 
effects, 20 pg/ml gave a logio (cfu/ml) reduction of over five after 5 min contact time. 
Since only one strain of each species was tested however, the results may not be 
representational of the entire species, therefore future studies may consider 
performing suspension tests with more strains of each species to conclude whether 
there are any trends between inhibitory and lethal effects. Messager et al. (2001) 
tested the bactericidal activity of triclosan against several micro-organisms. Although 
it is not possible to compare data from this study directly with their data since 
different triclosan concentrations and different contact times were tested, similar 
trends were observed. After a one minute contact time with 500 pg/ml triclosan, the S. 
aureus and Ent. faecalis were very sensitive to the lethal effects of triclosan resulting 
in a logio reduction in viable bacteria (cfu/ml) of between 1 and 2. The E. coli and Ps. 
aeruginosa however appeared more resistant to the lethal effects, the logio (cfu/ml) 
reduction in viable bacterial cells was less than one.
In the experiments with these species in the bladder models, it was clear that none of 
them were capable of producing alkaline conditions in urine. The pH of the 
inoculating culture and the pH of the residual urine from the control and test bladder 
models inoculated with each organism after 24 and 48 h are shown in Figure 53. As in 
previous experiments, the pH of the residual urine in the control models infected with 
Pr. mirabilis increased to over 8 within 24 h and the catheters blocked with crystalline 
biofilm within 48 h (data not shown). All the triclosan test models inoculated with Pr. 
mirabilis drained freely for 48 h, as did the control and triclosan models inoculated 
with the other eight bacterial species. The residual urine in the Pr. mirabilis test model
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and the test and control models infected with the eight different uropathogens 
remained acidic throughout the experiment.
Figures 56 and 57 show electron micrographs of test and control catheters taken out of 
E. coli and Ps. aeruginosa inoculated bladder models after 48 h. The images were 
taken at four different positions down the length of the catheters. Images of control 
and test catheters inoculated with the six other bacterial species are shown in 
Appendix 2. A biofilm can be seen on the eye-hole of the control E. coli catheter, but 
there is no sign of biofilm formation on the triclosan test catheter. A substantial 
biofilm can be seen on the eye-hole of the control and test Ps. aeruginosa catheters, 
and a thin biofilm can be seen along the length of the catheters. In contrast to the Pr. 
mirabilis infected models, none of the other bacterial species tested produced a 
crystalline biofilm. Therefore, despite being capable of producing urease, Ser. 
marcescens, S. aureus, K. pneumoniae, Ps. aeruginosa and M. morganii failed to 
produce a crystalline bacterial biofilm or turn the residual urine alkaline. It would 
have been interesting to fix, critically point dry and gold-coat the control and triclosan 
catheters inoculated with the different organisms to observe the sections under HV- 
SEM. This may have revealed biofilms that were not visible by LV-SEM. It would 
also be interesting to observe any differences in the morphology of the bacteria on the 
triclosan treated compared to the control catheters.
The finding that Pr. mirabilis rapidly elevates the urinary pH forming crystalline 
biofilms, while other urease producers fail to do so correlates well with clinical 
observations. For example Mobley and Warren (1987) found a significant association 
between catheter obstruction and the presence of Pr. mirabilis in urine, but not
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between any other urease-positive species. Whilst bacteriological analysis of catheters 
removed from patients undergoing long-term bladder management revealed that 
catheters colonized with Pr. mirabilis formed crystalline biofilms, significant 
crystalline material was absent in non -Proteus biofilms (Stickler et al., 1993). The 
results of these experiments also confirms and extends those reported by Stickler et al. 
(1998b) showing that Pr. mirabilis produced more encrustation on catheters in the 
bladder model than other urease positive organisms.
Inflating the catheter balloons with triclosan significantly (P < 0.05) reduced numbers 
of viable cells in the biofilm for all strains tested except Ps. aeruginosa (Figure 55). 
Although there were slightly fewer viable cells on triclosan treated Ps. aeruginosa 
catheters compared to the control catheters, the difference was not significant (P = 
0.063). Figure 54 shows the logio (cfu/ml + 1 ) data of the inoculating culture, and of 
the residual urine from the control and test bladder models from each organism at 24 
and 48 h. For the Pr. mirabilis, Pv. stuartii, E. coli, S. aureus, Ent. faecalis and K. 
pneumoniae there were significantly lower numbers (P < 0.05) of viable cells in the 
residual urine of the triclosan treated models compared to the controls at 24 and 48 h. 
This suggests that this novel approach of controlling catheter encrustation could also 
help control a range of other urinary tract pathogens.
Most of the information regarding the use of triclosan to control biofilms has centred 
on its ability to control dental plaque. For example, investigating the effect of triclosan 
on the microbial composition o f dental plaque, Walker et al. (1994) reported that in 
subjects assigned to use a triclosan containing dentrifice, there was a more 
pronounced decrease in culturable flora after three and six months compared to the
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control subjects. The antibacterial activity of an amine fluoride, sodium fluoride and 
triclosan containing mouthwash was investigated by Arweiler et al. (2002). Compared 
to the control, the test mouthwash displayed significantly better antibacterial and anti­
plaque activity. Few studies have considered using triclosan to prevent or treat other 
forms of bacterial biofilms. Jones et al. (1994) showed that liposomes carrying 
triclosan could inhibit the growth of biofilms of S. epidermidis. It was reported that 
even after exposing the biofilms to the triclosan liposomes for short periods of time, 
triclosan concentrated preferentially in the biofilm rather than in the liposome lipid 
carriers. A study comparing the effects of incorporating triclosan into plastics (at the 
same concentrations it is used in many consumer plastic products) revealed no 
significant difference between attached bacterial population onto the triclosan 
incorporated plastics compared to control plastic sections (Junker and Hay, 2004). It 
was suggested that the ability of biofilms to form on these plastic surfaces was due to 
the limited desorption of triclosan from the material.
The results presented in Figures 52, 54 and 55 illustrate the intrinsic resistance of Ps. 
aeruginosa to triclosan. Chuanchuen et al. (2001) demonstrated that triclosan was the 
substrate for multiple Ps. aeruginosa efflux pumps, and showed that under laboratory 
conditions, Ps. aeruginosa exposure to triclosan could select for multi drug resistant 
mutants. As yet, however, there is no evidence to suggest that this has happened in a 
non-laboratory setting. Subsequent studies using defined mutant strains showed that 
the ability of Ps. aeruginosa to survive in concentrations of triclosan exceeding 1000 
pg/ml was attributed solely to the expression of efflux pumps (Chuanchen et al., 
2003). The authors comment that since triclosan is an excellent substrate for efflux 
pumps that a link between triclosan and antibiotics must exist, and note that at the
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very least, in triclosan treated environments, Ps aeruginosa “should be well equipped 
to tip the ecological balance in their favour”. Schweizer (2001) also comments that the 
widespread use of triclosan could lead to the selection of triclosan resistant bacteria 
such as Ps. aeruginosa. This should be an important consideration when thinking 
about introducing triclosan into any setting. Ps. aeruginosa is a clinically significant 
pathogen, and infections associated with this bacterium are often difficult to treat due 
to its many acquired and intrinsic antibiotic resistances. If clinical trials introducing 
triclosan into the catheter care regime go ahead, its effect on the microbial ecology of 
the urinary tract would have to be monitored closely for any untoward shifts in 
microbial flora. If the overgrowth of Ps. aeruginosa becomes a problem, formulating 
a solution combining triclosan with an anti-pseudomonal agent may become an 
option. It is, however, impossible to guess how introducing triclosan into catheter care 
will affect the microbial balance, the only way of finding out is to carry out closely 
monitored clinical trials.
Stickler et al. (1998b) showed that whilst urease positive M. morganii, K. pneumoniae 
and Ps. aeruginosa failed to raise the urinary pH and form crystalline biofilms, strains 
of Pr. mirabilis, Proteus vulgaris and Providencia rettgeri generated alkaline urine 
and crystalline biofilms. Pr. vulgaris and Pv. rettgeri are however, not frequently 
isolated from the catheterised urinary tract (Kunin, 1989), and a clinical study of long­
term catheterised patients revealed no trend between the presence of Pr. vulgaris and 
Pv. rettgeri in the catheterised urinary tract and catheter obstruction (Mobley and 
Warren, 1987). Experiments determining the sensitivity of both these species to 
triclosan should be carried out in future studies. The insensitivity of one of these 
bacterial species to triclosan could result in the overgrowth of bacteria capable of
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forming encrustation in the triclosan treated catheterised urinaiy tract. Bladder models 
should also be run inoculated with these organisms to determine how inflating the 
catheter balloon with a triclosan solution would affect biofilm development.
After the first couple of weeks of catheterisation, most patients become colonized with 
several different bacterial species. Warren et al. (1982) showed that in patients with 
chronic IUCs, bacteriuria was polymicrobial with up to five different bacterial species 
in 77% of all weekly urine specimens. Therefore, one of the most important 
experiments to carry out in future studies should involve monitoring the effect of 
triclosan on the development of catheter biofilms in bladder models infected with 
mixed bacterial communities. This may allow us to gain an insight into any untoward 
changes to look out for in clinical trials with the triclosan inflated catheters.
4.7. Triclosan mode of action and concerns about resistance
Bacteria employ three general classes of resistance mechanisms; target alteration, 
reduction in target access or inactivation of the inhibitor (Chapman, 1998). Bacterial 
resistance to biocides can either be intrinsic or acquired (Russell, 1995). Acquired 
resistance to antimicrobial agents results from either bacterial acquisition of plasmids 
or transposons, or can arise from a mutation within a bacterial population exposed to 
an antimicrobial agent (Russell, 1995). The use of biocides as disinfectants is an 
important part of our armoury in the fight against infectious diseases (Heinzel, 1998). 
There is an increasing concern that exposure of bacterial communities to sub-lethal 
concentrations of biocides could result in the development of strains that have 
decreased sensitivities to these agents. The importance of preserving the efficacy of 
biocides is heightened by the decreasing rate at which new disinfectants are being
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introduced (Chapman, 1998). Although a change in biocide sensitivity is unlikely to 
influence the lethal effects of biocides (due to the high concentrations of biocides 
usually in use), it could alter the susceptibility of bacterial communities to other 
antibacterial agents, particularly when the biocide and other antibacterial agents share 
the same target site or when induction of efflux pumps can confer resistance to several 
agents.
Some authors have raised concerns that the extensive use of triclosan will select for 
bacteria resistant to it and cross-resistant to other antibiotics or antimicrobial agents 
(Levy, 2001; White and McDermott, 2001). Similarly, research by other groups has 
led them to suggest that if stable low-level triclosan resistant mutants occur in the 
environment, they may encourage preferential survival of mutants resistant to other 
antimicrobial agents (Heath et al., 1998; McMurry et al., 1998a). Some authors have 
emphasised that like all antimicrobial agents, the use of triclosan should be limited to 
clinically useful situations but have cast doubts over the proposal that triclosan use 
will lead to antibiotic resistance (Gilbert and McBain, 2001; McBain et al., 2003; 
Russell, 2003).
Studies by Villalain et al. (2001) confirmed that the membrane destabilising effects of 
triclosan leads to leakage of cytoplasmic constituents. It has also been shown that 
triclosan has a specific bacterial target site. McMurry et al. (1998a) reported that at 
low concentrations, the inhibition of growth of E. coli by triclosan resulted from a 
block in lipid synthesis. The agent specifically inhibited the NADH-dependent enoyl- 
acyl carrier protein (ACP) reductase, Fabl. This enzyme plays a crucial role in 
completing rounds of fatty acid elongation (Heath and Rock, 1995). McMurry et al.
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(1998a) and Levy et al. (1999) showed that mutations in/or over-expression of the 
gene that encodes enoyl-ACP reductase, prevented the blockage of lipid synthesis by 
triclosan. Analysis o f the crystalline structure of wild-type and mutant E. coli FabI 
protein revealed that all mutations were at residues that lined the cleft of the enzyme 
to which the nicotinamide co-factor and substrate bind. This was the first evidence 
that triclosan was not a non-specific biocide, and that it acted upon a specific bacterial 
target.
Levy et al. (1999) and Roujeinikova et al. (1999a) carried out structural analysis and 
inhibition experiments on the enoyl-ACP reductase complex of E. coli with triclosan 
and NAD+. The electron density maps of the enoyl-ACP-reductase complexed with 
NAD+ and triclosan revealed that triclosan binds to the complex adjacent to the 
nicotinamide ring of the nucleotide cofactor in the enzyme’s active site, taking the 
place of where the substrate usually binds. The similarity between the structure of 
triclosan and the enzyme’s natural substrate showed that triclosan could bind tightly to 
this active site (Figure 63). This indicated that triclosan acted as a competitive 
inhibitor of the ACP-reductase, being able to form a stable complex with it and its co­
factor NAD+. Heath et al. (1998) also reported that enoyl-ACP-reductase is the 
primary site for triclosan action, and concluded that the effect triclosan has on the 
structure and function of membranes is a consequence of its specific inhibitory action 
against fatty acid biosynthesis.
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Figure 63: Chemical structure of triclosan and of the substrate for the enoyl-ACP reductase enzyme
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It was not clear however, whether this single enzyme was responsible for both the 
bacteriostatic effect exhibited by triclosan at low concentrations and its bactericidal 
effects at higher concentrations. Antibiotics generally only have a single mode of 
action and therefore a single cellular target. Mutations which lead to increased 
antibiotic MICs are usually an indication of therapeutic failure. In contrast with 
biocides, an increase in MIC is generally not correlated with a decrease in bactericidal 
activity since these antibacterial agents have multiple target sites (McDonnell and 
Pretzer, 1998). In any case, when used as disinfectants, biocides such as triclosan are 
used in concentrations far in excess o f the MIC. Suller and Russell (1999) investigated 
the susceptibilities of methicillin resistant S. aureus (MRSA) and methicillin sensitive 
S. aureus (MSSA) to different biocides including triclosan. They noted that although 
the triclosan MIC results for MRSA were higher than 1 pg/ml (compared with 0.025 
pg/ml for MSSA), the MRSA and MSSA remained equally susceptible to its killing 
effects at 2, 5 and 10 pg/ml. A survey of bacterial tolerance to biocides in industrial 
environments where the agents were being manufactured recovered just two isolates 
of Pv. stuartii and Acinetobacter johnsonii that exhibited increased tolerance in terms 
of MICs to triclosan. Neither strain was more difficult to kill by “in-use” 
concentrations of triclosan than corresponding culture collection strains of the same 
species (Lear et al., 2002). A strain of MRSA with an increased triclosan MIC was 
isolated from a hospital patient; however the rate of kill by triclosan for this isolate 
remained unchanged (Cookson et al., 1991).
Suller and Russell (2000) noted that if the sole target of triclosan was this enoyl- 
reductase enzyme involved in lipid synthesis, then organisms growing exponentially 
should be more susceptible. They found however that exponential and stationary
-148-
1 ) i s cuss i on
phase cells of S. aureus were equally sensitive to triclosan. Similarly, the results 
reported in Figures 11 and 13 showed that stationary and log phase cultures of Pr. 
mirabilis in human urine were equally sensitive to the lethal effects of triclosan. 
McDonnell and Pretzer (1998) proposed that triclosan, as other biocides has multiple 
cellular targets, primarily the cytoplasmic membrane but also intracellular targets such 
as the enoyl-ACP reductase.
McMurry (1998b) established that over-expression of the multi-drug efflux pump 
locus acrAB, or of mar A or soxS, both of which are positive regulators of acrAB could 
decrease triclosan susceptibility two fold. It must be noted that concentrations of 
triclosan used in clinical practice are much higher than the concentrations used in 
experiments by McMurry et al. (1998a) and McMurry et al. (1998b), although since 
triclosan persists in the environment, it is reasonable to assume that some areas will 
come into contact with lower triclosan concentration. Braoudaki and Hilton (2004) 
showed that exposure of E. coli 0157 to sub lethal triclosan concentrations under 
laboratory conditions resulted in the development of strains with increased triclosan 
resistance. These strains also demonstrated decreased susceptibilities to other 
antibiotics and biocides, prompting the authors to note that inappropriate use of 
triclosan could contribute to the problem of microbial resistance. The development of 
resistant bacteria in the laboratory is not conclusive evidence that resistant bacteria 
will develop in the clinical setting. In the ‘real world’, such mutants would also be 
faced with challenges not present in the laboratory setting including competition from 
other organisms as well as a host of environmental factors.
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The discovery of a specific target site for triclosan led to concerns about it sharing its 
target sites with other therapeutic agents. The target site for isoniazid, currently the 
most widely used anti-tuberculosis drug is the enoyl reductase (InhA) of 
Mycobacterium tuberculosis. McMurry et al. (1999) demonstrated that InhA (the 
mycobacterial analogue of the FabI protein) is a target for triclosan and isoniazid in 
M. smegmatis and concluded that the overuse of triclosan could select for isoniazid 
resistant mycobacteria. It must be noted, however, that M. tuberculosis is intrinsically 
resistant to triclosan (Fraise, 2002). Further experiments have revealed that the enoyl 
reductase of E. coli is also a target for hexachlorophene and the experimental 
diazaborine family o f antibacterial agents (Roujeinikova et al., 1999b; Heath et al., 
2000).
There is an increasing view that triclosan should be retained for important 
applications. The growing public interest in preventing the transmission of infectious 
diseases, together with clever marketing techniques has led to an increase in products 
that contain “antibacterial agents” to “kill germs”. Hundreds of products have flooded 
the market claiming to combat germs. These products range from toilet seats to toys. 
Studies investigating the antibacterial activity of such products generally fail to 
demonstrate their efficacy. For example, Braid and Wale (2002) investigated the 
antibacterial activity of triclosan impregnated food storage boxes against S. aureus, E. 
coli, Ps. aeruginosa, Bacillus cereus, and Shewanella putrefaciens in conditions 
simulating domestic use. At 4°C they found the boxes exhibited no antibacterial effect 
against these species. Triclosan incorporated plastics have been moulded into products 
such as sinks showers and spas. Junker and Hay (2004) simulated the conditions in 
which these plastics are used, and observed no significant difference between attached
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biofilm populations on triclosan-incorporated and control plastic sections after one to 
three weeks exposure to drinking water. It was also found that only trace amounts of 
triclosan desorped from the triclosan-incorporated plastics. The authors therefore 
questioned the long-term utility of triclosan-incorporated materials and suggest that 
the efficacy of such agents has yet to be proved.
Favero (2001) made the important point that incorporation of antimicrobial agents 
into plastics such as toys could not be expected to kill transient bacteria. Water must 
be present to transport the antibacterial agents across the bacterial cell wall. So these 
products have to be washed with soap and water to remove any microbial 
contamination. The inclusion of antimicrobial agents into products such as toys, 
telephones and mattresses offers no obvious public health benefit. Common sense 
approaches to hand washing and home hygiene usually provide a healthy environment 
in homes and other settings (Favero, 2001). There is now a general consensus that 
frivolous and unnecessary applications of triclosan should be eliminated. The aim for 
the future should therefore be to retain triclosan for important and valuable 
applications (Russell, 2004). These include dental hygiene products (Fine et al., 1998) 
and hand and body washes to control MRSA (Brady et al., 1990; Webster et al., 1994; 
Zafar et al., 1995; Irish et al., 1998).
Recent surveys on the use of triclosan and other biocides have failed to establish a 
relationship between their use and antibiotic or antibacterial resistance. In a 
randomised study, Cole et al. (2003) collected environmental and clinical samples 
from the homes o f antibacterial (triclosan and other biocides) product users and 
nonusers. They could find no relationship between the use of the antibacterial
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products and antibiotic resistance. A prevalence survey of households also revealed no 
significant difference in antibiotic resistance or the numbers and kinds of bacteria 
found in the homes where antimicrobial agents were or were not being used (Marshall, 
2003). A study of bacterial tolerance to biocides in industrial environments failed to 
demonstrate an association between the presence of residual biocides and the 
emergence of resistant bacteria (Lear et al., 2002). Research by McBain et al. (2003) 
examined the effect triclosan may have on domestic-drain biofilm microcosms. The 
results showed that low-level exposure of environmental biofilms to triclosan did not 
affect antimicrobial susceptibility and they concluded that the emergence of antibiotic 
resistance through triclosan use in the kitchen is highly improbable.
The incorporation of triclosan into oral products also raised concerns about its use 
resulting in the development of intrinsically triclosan-resistant communities or of 
mutants with reduced susceptibility to triclosan and other antibacterials. Studies over 
extended time periods (28 weeks) revealed that the use of dentifrice containing 0.3% 
triclosan did not result in untoward shifts in micro-flora of supragingival plaque 
towards pathogenic bacterial species (Zambon et al., 1990). Further studies confirmed 
these findings and demonstrated that the use of triclosan did not result in the 
emergence of resistant strains (Walker et al., 1994; Zambon et al., 1995; Fine et al., 
1998). The consensus view seems to be that there is no evidence that the use of 
triclosan in dental hygiene products results in the development of resistant, 
opportunistic or pathogenic microorganisms in the mouth (Expert Review Panel, 
2000). A review by Sreenivasan and Gaffar (2002) of microbiological results obtained 
from clinical studies also concluded that the use of oral care products containing 
antimicrobial agents resulted in no adverse alterations in the bacteria found in dental
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plaque, or in the emergence of resistant microflora. McBain et al. (2004) used the 
gradient plate technique to investigate the effect of triclosan exposure on the 
antimicrobial susceptibilities of important dental bacteria. Few major changes in 
triclosan susceptibility were observed, and triclosan exposure caused no significant 
decrease in the susceptibility of the bacteria towards chlorhexidine, metronidazole or 
tetracycline. The incorporation of triclosan into dental care products and its beneficial 
effects in reducing plaque is now considered as one of the justified uses of triclosan.
The work reported in section 3.6 of this thesis addressed the question of whether 
exposure of Pr. mirabilis to triclosan could result in the selection of resistant mutants, 
and whether any such mutants could gain cross-resistance to antibiotics. Two methods 
were used to select for mutants with decreased triclosan sensitivities, the ‘disk 
diffusion’ and the ‘heavy inoculum’ method. Interestingly Pr. mirabilis swarmed into 
the zones of inhibition created by the triclosan disks, ruling out the possibility of using 
this method to generate mutants. The heavy inoculum method was much more 
productive however and 55 mutants from five different strains of Pr. mirabilis were 
isolated. The MICs and MISCs of each of these mutants are given in Table 6. All 
mutants had elevated MICs compared to their corresponding wild-type strain. The 
MIC values ranged from twice to 200 times greater than their respective wild-type 
strain. A selection of 14 mutants isolated from each of the five wild-type strains with 
varying degrees of increased resistance to triclosan were chosen for further study. 
Some resistance phenotypes can be unstable and lost in the absence of a selective 
pressure (Chapman, 1998). The MIC of the 14 selected mutants was determined after 
1, 3, 7, 11 and 15 subcultures in the absence of triclosan. The results (Table 7) reveal 
that the MICs were generally very stable.
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Three of the mutants (M44, M48 and M55) derived from the wild-type strain Pr. 
mirabilis B2 were tested for their sensitivity to triclosan in bactericidal suspension 
tests. The mean logio (cfu/ml) reductions given by 100 pg/ml triclosan for these 
mutants and the wild-type strain Pr. mirabilis B2 over three different contact times are 
presented in Figure 58. Tables 8-10 show the P-values from statistical analysis 
individually comparing each strain tested in the suspension tests throughout this 
project at 5, 30 and 60 min. After 5 min contact time, there was no significant 
difference (P > 0.05) in the reduction of viability between the mutants and the wild- 
type. The logio (cfu/ml) reductions of M44 and M55 were significantly lower (P < 
0.05) than the wild-type strain after 30 and 60 min contact time. It must be noted 
however, that the bactericidal activity was not significantly different (P > 0.05) from 
other wild-type Pr. mirabilis strains (NSM 6 and NP 37) after these contact times.
The MICs of triclosan against the three selected Pr. mirabilis B2 mutants in artificial 
urine ( 3 - 8  pg/ml) were significantly higher (P < 0.05) than for the wild-type strain 
(0.2 pg/ml). In the case of the mutants, the concentration of triclosan required to keep 
the artificial urine acidic was 3 - 8  pg/ml (Figure 59). In contrast, only 0.2 pg/ml was 
required to prevent alkaline conditions developing by the wild-type Pr. mirabilis B2 
(Figure 10). The ability of these selected mutants to form biofilms and the effect of 
inflating the balloon with triclosan on their development was determined using the 
bladder models. Models inoculated with M48 produced results similar to those using 
the wild-type strain B2 (Table 11). All the controls blocked whilst the triclosan 
models drained freely for 48 h. All control and test models inoculated with M55 
blocked within the 48 h experimental time period. Two replicates blocked whilst the 
other did not for both the control and test models inoculated with M44. In models
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inoculated with M44 and M55, the pH and viable cell counts of the triclosan and 
control models were not significantly different (P > 0.05) at the end of the experiment 
(Figure 60). The results presented in Figures 60 and 61 also show that triclosan 
significantly reduced (P < 0.05) the calcium and magnesium deposited on catheters in 
models inoculated with Pr. mirabilis B2 and M48, but had no significant effect (P >
0.05) in models inoculated with M44 and M55. It is interesting that the MICs of 
triclosan for M44 and M55 were both 40 pg/ml, compared to 2 -  5 pg/ml for M48. It 
appears then that if the clinical use of triclosan generated mutants with MICs in the 
region of 40 pg/ml or above, the success of the triclosan strategy to control catheter 
encrustation could be undermined.
The relative sensitivities of the five wild-type strains and their 14 triclosan resistant 
mutants to eight antibiotics that are used to treat UTIs caused by Gram-negative 
bacilli were examined using E-test strips. The antibiotic E-test strips were introduced 
in the late 1980’s. They are plastic strips that release a continuous concentration 
gradient of a given antimicrobial agent when placed on an agar plate. Research 
comparing the discriminatory power of the E-tests with conventional susceptibility 
testing methods soon followed. Baquero et al. (1992) showed that the E-tests provided 
quantitative data similar to using the agar dilution method, and that they were far 
superior to the disk diffusion tests. A review of the numerous studies comparing the 
E-tests to other susceptibility testing methods concluded that the E-test compared 
favourably to other methods (Sanchez and Jones, 1992).
The antibiotic sensitivities of the mutants and the wild-type strains are shown in Table
12. There was some variation between the antibiotic sensitivities of the wild-type Pr.
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mirabilis strains. For example, Pr. mirabilis NP14 and NP43 were sensitive to 
ampicillin whilst the other three strains were resistant, and Pr. mirabilis NP43 was the 
only strain sensitive to trimethoprim. However, the strains were all equally sensitive to 
triclosan in terms of MICs (0.1 - 0.2 pg/ml). The eight boxes highlighted in yellow 
(Table 12) show the mutants with MICs against particular antibiotics higher than that 
of their corresponding wild-type strain. These increases are only slightly above those 
of the wild-type strains however, and these types of variations can be expected using 
the E-test strips with Proteus. This data therefore suggests that although these mutants 
have an increased tolerance to triclosan, there does not appear to be any cross­
resistance to the antibiotics tested. The E-test strips give detailed information about 
the MIC of different antibiotics to bacterial strains, and they are quick and simple to 
use. They are however expensive to use, therefore only 14 of the mutants were tested. 
If time and money had not been limited, the stability of all the mutants should have 
been verified and their antibiotic sensitivities determined.
Training experiments have been used to select for mutants of Acinetobacter johnsonii 
and Pseudomonas stutzeri with increased sensitivities to triclosan (Lear et al., 2002). 
This involves exposing bacterial strains repeatedly to increasing concentrations of 
antimicrobial agents and checking for any elevated tolerances. In future experiments it 
would be interesting to see if the training method could be applied to the bladder 
models. Bladder models with catheters inflated with triclosan could be set up and 
inoculated, after running the models for a given time, organisms isolated from the 
urine and any catheter biofilms at the end of the experiment could be used to re- 
inoculate a series of other bladder-models.
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The stability of the mutants’ MICs indicates that it would be possible for any mutants 
that were generated to spread in the absence of triclosan. The results also show that 
should Pr. mirabilis strains with increased triclosan resistance develop, they could 
interfere with the effectiveness of this novel way of controlling catheter encrustation. 
However, it must be considered that the generation of mutants in the ‘real world’ 
would be in conditions very different from the conditions used in the laboratory 
setting. It is important that this study has highlighted the potential for the development 
of Pr. mirabilis strains with decreased sensitivities to triclosan, however, the only way 
to determine if resistance will occur outside the laboratory is to run clinical trials and 
monitor performance in clinical practice. These studies must screen for any alterations 
in susceptibilities of organisms to triclosan before and after introducing the strategy 
into the catheter care regime. Although the data is limited in this present study, it does 
suggest that should Pr. mirabilis mutants arise, their antibiotic susceptibilities will 
remain unchanged. Future studies may consider testing the sensitivities of the mutants 
and wild-type strains to other biocides to determine if there is any cross-resistance. 
Although this study failed to establish a link between triclosan resistance and 
increased antibiotic tolerance in Pr. mirabilis, its effect on other organisms present in 
the catheterised urinary tract was not tested. Future studies should consider 
investigating if there is any link between triclosan use and possible increased 
antimicrobial tolerance to other agents with other bacterial species. Any clinical study 
should monitor the antimicrobial sensitivities of all the organisms isolated from the 
catheterised urinary tract.
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4.8. Concluding remarks and future work
From the results using the in-vitro bladder models inoculated with catheter isolates of 
Pr. mirabilis, the potential for using triclosan in the catheter balloon to prevent 
crystalline bacterial biofilms has been established. The catheters inflated with the 
higher concentrations of triclosan prevented catheter blockage for the duration of the 
seven days experiments. The ability of the catheters inflated with triclosan to resist 
encrustation by a severe challenge with a pure culture of Pr. mirabilis suggests that 
this approach could have practical applications in controlling catheter encrustation.
Unlike other ways of preventing biofilm formation on urinary catheters, this method 
provides a multi-pronged bacterial attack. Triclosan diffuses from the balloon and 
targets planktonic bacteria in the residual urine. In the case of all-silicone catheters, 
the cells in any biofilms attempting to form on the catheter will be attacked from 
above by triclosan in the urine and from below by triclosan diffusing from the 
silicone. Using the balloon also allows the catheter to be loaded with large amounts 
(up to 100 mgs) of the active agent. This is a much higher concentration than can be 
used to coat the surface of catheters. For example, Cho et al. (2001) were only able to 
load 1.05 mg gentamicin onto the surface of gentamicin-coated urethral catheters. 
Even with larger catheters, Darouiche et al. (1997) estimated that the total amounts of 
minocycline and rifampin bound to the length of a size 18 Ch silicone Foley catheter 
was only 22.3 and 16.4 mg respectively.
The failure of any method currently available to successfully control catheter 
encrustation fuels the need for the results of this study to be confirmed by a controlled 
clinical trial. The simplicity of this method that involves using catheters that are
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currently in use should facilitate its clinical development. It is important that clinically 
useful agents such as triclosan are not exploited indiscriminately, therefore the use of 
triclosan in the catheter balloon should be limited to those patients classified as 
“blockers”. Before inflating the patients’ catheter balloons with the triclosan solution, 
the clinical study should firstly monitor patients with their catheter balloon inflated 
with water. This would provide information about how long the catheters take to 
block, the urinary pH and the organisms that colonize the catheterised urinary tract 
before and after triclosan was used to inflate the catheter balloon. The numbers of 
bacteria colonizing the catheters should also be enumerated before and after 
introducing triclosan into the catheter care regime. The monitors of the clinical trial 
would have to make sure that there were no changes to the patients’ daily routine 
during the study that would affect the outcome of the trial, and any antibiotic use 
should be noted. A simple sensor that signalled the early stages of encrustation on 
catheters could give a useful early warning of impending blockage. Such a device 
would provide a “sensor/ modulator” strategy so that triclosan is exploited only in 
those situations where it is needed.
Sections of this study have highlighted areas that should be monitored carefully when 
a clinical trial is held. Any change in patients’ bacterial flora should be carefully 
observed to check that there is not an increase in bacterial strains resistant to triclosan. 
By determining the patients’ flora before inflating the balloon with triclosan, any 
untoward changes in the microbial flora can be monitored. The triclosan sensitivity of 
bacterial strains isolated prior to and during the study should be continually 
monitored. No cross-resistance to antibiotics was seen in mutants with higher 
tolerances to triclosan in this study, however any strains that appear to have increased
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triclosan sensitivities should be tested against other antimicrobials. Although it is 
possible to speculate about a shift in microbial flora, or the development of resistant 
mutants, the only way we will ever know if these problems are likely to occur are by 
setting up clinical trials and by monitoring any subsequent clinical practice. If the 
clinical trial successfully controls catheter encrustation, it would be interesting to 
determine what the cost savings would be to the health service by lowering the 
incidence of complications associated with these devices.
Laboratory investigations are needed to continue research in this area, in particular to 
investigate new agents that could be used in the catheter balloon with triclosan to 
increase its antimicrobial spectrum. The process of choosing antimicrobial agents to 
test would be much simpler if there was a rational way of selecting agents that could 
diffuse through the catheter balloon. Malcolm et al. (2003) assayed the release 
characteristics of eight low-molecular weight drugs from a silicone matrix-type 
intravaginal ring in-vitro. The major factors involved in influencing the permeation of 
the drugs through the silicone-elastomer were determined. An equation was produced 
that allowed the release rates of new substances from the silicone-elastomer to be 
predicted based on their molecular weights and melting points. It would be interesting 
to collaborate with polymer chemists and perform similar experiments assaying the 
ability of different antimicrobial agent to diffuse through the balloons of the all­
silicone and latex-based catheters. It may be possible to develop an equation which 
would allow us to predict which type of agents would diffuse best through the latex 
balloons.
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The use of agents other than antimicrobials in the catheter balloon should also be 
considered. For example, the toxicity of urease inhibitors has restricted their use 
(Williams et al. 1984), therefore this non-systemic way of introducing the agents into 
the catheterised urinary tract may prevent these side effects. If high enough 
concentrations of the urease inhibitors could be passed through the catheter balloon, it 
could be an effective way of controlling catheter encrustation. It may also be possible 
to use other agents that disrupt biofilm development such as quorum sensing 
inhibitors. Experiments should investigate the feasibility of delivering antibiotics to 
treat CA-UTI through the retention balloon. This would allow antibiotics to be 
delivered directly into the catheterised bladder without exposing the gut flora to their 
action. It might also be possible to exploit the catheter balloon to deliver 
pharmacologically active compounds into the bladder.
In future experiments the bladder models should be used to develop a training method 
that better simulates how resistance in biofilms could develop in the clinical setting. It 
would also be interesting to observe the control and test catheters inoculated with the 
different uropathogens using HV-SEM, and to observe in closer detail the effect 
triclosan has on biofilm formation by Pr. mirabilis. Apart from Pr. mirabilis, the other 
urease producing bacteria were only run in the bladder models for 48 h, future 
experiments could determine if they form crystalline biofilms on longer incubation in 
the bladder models. The bactericidal activity of triclosan was tested against one strain 
of each different uropathogenic species, to establish if there are any trends between 
the inhibitory and lethal effects, more strains of each species should be tested. The 
bladder model could also be used to determine the concentrations of other agents that 
are required in the urine to eradicate biofilms or inhibit their development.
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There are many other questions that remain to be investigated. For example, can 
chemical agents be added to the triclosan solution in sodium carbonate to potentiate its 
delivery into the bladder? Are Pv. stuartti and Pr. vulgaris sensitive to triclosan? Does 
triclosan prevent biofilm development by Pv. stuartti and Pr. vulgaris? What 
concentration of triclosan passes through the balloon of latex based catheters? What 
concentration of triclosan impregnates the all-silicone catheter? Is triclosan in sodium 
carbonate as effective at preventing crystalline biofilm formation in latex catheters as 
triclosan in 5% PEG?
It is important that the triclosan solution in sodium carbonate can be easily sterilized. 
Since we have established that triclosan binds to plastic and silicone, it will be 
necessary to check that the triclosan does not bind to the membrane of the filter. 
Simple experiments could be carried out to determine the concentration of triclosan in 
the sample before and after filtration.
Currently there are no effective methods for controlling the problem of catheter 
blockage by encrustation. If the triclosan strategy can be transferred successfully from 
the laboratory to the clinic, it could bring major improvements in the bladder 
management of many elderly and disabled patients. It is important to bear in mind that 
no particular strategy is likely to provide a “once and for all” final solution to the 
problem. History warns us that bacteria, with their immense facility for genetic 
variation, manage to overcome most of the approaches designed for their elimination. 
It is crucial therefore, that research in this field continues to develop further schemes
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to control a problem that profoundly affects the quality of life and well-being of so
many people.
4.9. General conclusions
1. Isolates of Pr. mirabilis from encrusted catheters were all extremely sensitive to 
triclosan. Concentrations of 0.1 -  0.2 pg/ml of the agent in agar inhibited 
swarming and 0.1 -  0.3 pg/ml inhibited growth.
2. The artificial urine MIC tests showed that concentrations of 0.2 fig/ml triclosan 
prevented the generation of alkaline conditions by Pr. mirabilis.
3. In batch cultures in human urine, 0 . 1 - 1  pg/ml of triclosan had inhibitory effects 
on the growth of Pr. mirabilis, but concentrations of 10 -  100 fig/ml were required 
to produce a bactericidal effect.
4. Suspension tests in aqueous solutions of triclosan showed that 100 pg/ml were 
required to produce a bactericidal effect.
5. Experiments in models of the catheterised bladder demonstrated that inflation of 
all-silicone catheter balloons with triclosan (10 mg/ml in 5% PEG) resulted in 
diffusion of the biocide through the balloon into the urine. Using the information 
gained from this experiment about the release rates of triclosan form all-silicone 
catheters, it was calculated that if the same release rate was maintained, it would 
take over 850 days for all the triclosan to be released from the catheter balloon. 
The biocide also became impregnated into the silicone along the whole length of 
the catheter.
6. The physical properties of catheter balloons inflated with 5% PEG or 10 mg/ml 
triclosan in 5% PEG and soaked in water for eight weeks were not significantly (P
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> 0.05) different from those of the control catheters inflated with water or from 
catheters taken straight from their packaging.
7. On incubation, the urinary pH in the control models infected with Pr. mirabilis 
rose from 6.1 to over 8, which precipitated encrustation. The control models fitted 
with all-silicone, silicone-coated latex and biocath catheters all blocked. LV-SEM 
revealed that the Pr. mirabilis control models was heavily encrusted at blockage.
8. By inflating catheter balloons with triclosan solutions it was possible to prevent 
catheter blockage for the duration of the seven day bladder model experiments. 
Electron microscopy on test catheters taken out of the models after seven days 
revealed little sign of encrustation. By introducing triclosan into the catheterised 
urinary tract it was also possible to maintain acidic urinary conditions and control 
the numbers of viable Pr. mirabilis cells. The ability of triclosan to prevent 
catheter blockage after a severe challenge with Pr. mirabilis suggests that it could 
have practical applications in controlling catheter encrustation.
9. Catheters impregnated with triclosan in the bladder models or in their packaging 
were shown to prevent catheter blockage or significantly (P < 0.05) delay catheter 
blockage, as well as significantly (P <0.05) lowering the viable cell count and pH 
of the residual urine. The results showed that to protect catheters from encrustation 
by pre-loading them with triclosan prior to their placement in the bladder, it would 
be necessary to retain the triclosan in the catheter balloon for over an hour, 
restricting the clinical usefulness of this strategy.
10. Introducing triclosan into the balloon of catheters where encrustation had already 
begun, had no significant (P > 0.05) effect on delaying subsequent catheter 
blockage. This suggested that if the strategy is to be effective in patients who are
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“blockers” it will be necessary to change catheters and then inflate the new 
catheter with the triclosan solution.
11. Triclosan in 0.1M sodium carbonate solution is much simpler to produce and 
sterilize than the emulsion in 5% w/v PEG. It is equally as effective in preventing 
crystalline biofilm formation and would be an appropriate formulation for use in 
clinical trials.
12. Of the nine different uropathogens tested in the bladder models, only Pr. mirabilis 
was able to produce alkaline urine and form crystalline bacterial biofilms. This is 
despite the ability of the strains of Ser. marcescens, S. aureus, K. pneumoniae, Ps. 
aeruginosa and M. morganii tested to produce the urease enzyme in conventional 
bacterial identification tests. With the exception of Ps. aeruginosa, the 
development of biofilms by all these species was inhibited by triclosan.
13. If clinical trials introducing triclosan into the catheter care regime go ahead, the 
microbial ecology of the urinary tract should be monitored closely for any 
untoward shifts in microbial flora.
14. In the laboratory it is possible to generate mutants of Pr. mirabilis that are 
resistant to triclosan. Tests in the bladder model indicate that these mutants could 
form crystalline biofllms on catheters that had been treated with triclosan. All the 
strains of Pr. mirabilis from encrusted catheters were shown to be extremely 
sensitive to triclosan, but if resistant strains arise in clinical practice, the efficacy 
of the strategy would be undermined.
15. It is important that this study has highlighted the potential for the development of 
Pr. mirabilis strains with decreased sensitivities to triclosan, however, the only 
way to determine if resistance will occur outside the laboratory is to run clinical 
trials and monitor performance in clinical practice.
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16. The triclosan resistant mutants generated in the laboratory were not cross-resistant 
to any of the eight antibiotics tested.
17. The results from this study suggests that if this novel strategy for controlling 
catheter encrustation could be transferred successfully from the laboratory to the 
clinic, it could improve the quality of life and well-being of many elderly and 
disabled people who are currently enduring the complications associated with 
long-term indwelling bladder catheterisation.
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5. APPENDICES
Appendix 1: Calibration curves used to prepare standardised inocula of 1 x 
109cfu/ml for use in the bactericidal tests. The standardisation curves were 
produced from three individual experiments. On each graph, the equation 
for the gradient of the curve is indicated.
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Appendix 2: LV-SEM images taken down the length of control and 
triclosan inflated catheters inoculated with different uropathogens.
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Appendix 2a: Electron micrographs of control and triclosan treated catheters inoculated with
Ser. marcescens after 48 h. The positions o f sections A-D are indicated in Figure 6.
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Appendix 2b: Electron micrographs of control and triclosan treated catheters inoculated with EnL
faecalis after 48 h. The positions o f sections A-D are indicated in Figure 6.
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Appendix 2c: Electron micrographs of control and triclosan treated catheters inoculated with M.
morganii after 48 h. The positions o f  sections A-D are indicated in Figure 6.
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Appendix 2d: Electron micrographs of control and triclosan treated catheters inoculated with Pv.
stuartii after 48 h.The positions o f sections A-D are indicated in Figure 6.
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Appendix 2e: Electron micrographs of control and triclosan treated catheters inoculated with K.
pneumoniae after 48 h. The positions o f sections A-D are indicated in Figure 6.
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Appendix 2f: Electron micrographs of control and triclosan treated catheters inoculated with
S. aureus after 48 h. The positions of sections A-D are indicated in Figure 6.
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